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INCORPORATION OF MOLECULAR DIAGNOSTICS INTO MEDICAL LABORATORY 
SCIENCE CURRICULUM: CLINICAL FACILITIES EXPECTATIONS. 
AN ASYNCHRONEOUS, ITERATIVE, ONLINE DELPHI STUDY. 
By Barbara Kraj 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2015. 
 
Major Director: Teresa Nadder, PhD, MLS(ASCP)CM  
Chairman and Associate Professor, 
Department of Clinical Laboratory Sciences 
 
The medical laboratory science (MLS) profession is in need for published molecular 
diagnostics competency-based standards and curriculum. To assess their expectations of new 
MLS graduates, professionals performing and supervising performance of clinical molecular 
assays were surveyed to rate the importance of relevant cognitive and psychomotor learning 
objectives. A modified, asynchronous, iterative online Delphi process was utilized for 
assessment of consensus on the importance of the objectives. The survey was delivered through 
 
 
 
 
online REDCap application. Program directors of 221 MLS programs accredited by the National 
Accrediting Agency for Clinical Laboratory Science (NAACLS) were asked to forward the first 
Delphi survey to target participants at their affiliated clinical sites. Ninety-four experts submitted 
complete surveys, including 88 who provided email addresses, indicating agreement to 
participate in future Delphi rounds. Most of the participants were certified by ASCP or NCA 
(81.9%), had over 10 years of laboratory experience (76.6%), and worked in a hospital setting 
(43.6%). The reliability of the surveys, assessed using Cronbach’s alpha, was 0.96 and 0.97. In 
the second survey, the objectives assigned low importance by the majority were removed; and 
others, assigned high importance were expanded. Respondents were given the opportunity to 
confirm or change their opinion on the objectives after reviewing quantitative results and 
narrative comments collected in the preceding survey. Upon completion of the Delphi process, 
25 essential items were identified as necessary for inclusion in the entry-level MLS curriculum. 
These concepts and objectives focused on basic molecular biology principles and general 
molecular laboratory operations, including practical knowledge of techniques designed to 
maintain specimen integrity and intense theoretical background of the polymerase chain reaction, 
as well as comprehension of the principles of laboratory assays designed for pathogens most 
commonly tested for using molecular methods. In this study, the investigator also provided 
information on the preferred number of contact hours devoted to each group of the identified 
essential items. The goal of creating the list of essential concepts and objectives was to share it 
with MLS educators, the NAACLS and the provider of MLS certification exam, the American 
Society for Clinical Pathology Board of Certification (ASCP-BOC), to contribute to the existing 
exam content guidelines. 
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Chapter One: Introduction 
 
This introductory chapter provides the reader with background information regarding the 
addition of new content area, molecular diagnostics, to the curriculum in clinical/medical 
laboratory science (hereafter referred to as medical laboratory science). The chapter is divided 
into seven sections. In the beginning, the incorporation of molecular methods to the laboratory 
testing menu is addressed with focus on obstacles and factors that contributed to the introduction 
of this methodology. Next, the initial efforts to include molecular diagnostics content into the 
medical laboratory science (MLS) educational curricula upon the National Accreditation Agency 
for Clinical Laboratory Science (NAACLS) requirements are described. The subsequent sections 
present a brief overview of a previous study performed by the author/principal investigator to 
assess the extent to which these requirements were adhered to in 2005 and the American Society 
for Clinical Laboratory Science (ASCLS) Levels of Practice taskforce efforts to delineate the 
competencies of the practitioners in view of the changes in scope of practice prompted by the 
inclusion of molecular methodology. The justification for seeking input from practicing experts 
when modifying MLS curriculum is provided. The chapter concludes with the description of 
molecular diagnostics teaching experience of the author and the statement of dissertation purpose 
and research questions. 
Incorporation of Molecular Methods in the Clinical Laboratory Testing 
Various laboratory techniques based on nucleic acid testing, commonly known as 
“molecular methods,” have been used in basic science research for about half a century, since the 
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memorable deciphering of DNA double helix (Watson & Crick, 1953). The development of 
molecular methods rapidly increased following Kary Mullis’ discovery of polymerase chain 
reaction (PCR), an efficient, sensitive and relatively quick method of nucleic acid amplification 
utilizing impressively small quantities of source material (Saiki, 1988). However, the 
introduction of molecular based methods into clinical setting initially stumbled on some 
difficulties due to large amount of manipulation to detect the amplified PCR product, which 
included laborious gel castings, carcinogenic ethidium bromide staining, and UV-light 
photography (Kraj & Nadder, 2007). The risk of cross-contamination among samples and lack of 
molecular diagnostics training among medical technologists have also contributed to the absence 
of this technology in medical laboratories. And finally, the delay may have been caused by some 
ethical concerns regarding the use of human genetic material for diagnostic purposes (Kraj & 
Leibach, unpublished).  
In 1987 an Ad Hoc Committee on DNA Technology, DNA Banking and DNA Analysis 
of the American Society of Human Genetics compiled several recommendations regarding DNA 
based testing, specifically the ownership of the deposited DNA samples, risks of 
misunderstanding of the results by the lay public, conditions of the release of genetic information 
gained upon testing to third parties, and evaluation of the competency of the laboratory’s 
director. The recommendations of the Committee were published as “Points to Consider” 
(ASHG, 1988).  
Outside factors have initiated the incorporation of molecular assays to microbiology, 
immunology, hematology and blood bank testing menus. In 1997 the European Committee for 
Proprietary Medicinal Products had requested that as of July of 1999 all fractionated plasma 
products are tested for HCV using nucleic acid testing (NAT) assays. This had prompted NAT 
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implementation in the United States (US) since many blood banks exported blood and blood 
products to Europe (Gallarda & Dragon, 2000). High sensitivity and specificity of molecular 
procedures have caused FDA to approve many of the assays for clinical use which in turn 
encouraged diagnostic laboratories to offer molecular based assays in their test services. 
However, the average hospital laboratory was limited in the types of molecular assays due to cost 
of newly developed automated instruments adaptable to high throughput technologies. Because 
of the cost limitation, molecular diagnostics was and still is mostly performed in reference 
laboratories which is the reason for limited number of internship sites for students trained in 
molecular methods.  
To help the medical laboratory science professionals become more familiar with the new 
methodology upon entry of molecular diagnostics into the clinical setting, the researchers from 
the Departments of Clinical Laboratory Sciences and Pathology at Virginia Commonwealth 
University discussed the advantages and limitations of molecular-based clinical methods, 
identified the gold standard assay by which other molecular tests may be evaluated, compared 
principles and applications of hybridization, amplification and sequencing based techniques 
available at the time and described quality control issues in molecular testing (Nadder & 
Langley, 2001). This work was published as American Society for Clinical Laboratory Science 
sponsored continuous education (PACE) resource for the clinical laboratory professionals on 
molecular diagnostics. 
According to 2007 Washington G-2 Report on Business Strategies for Molecular 
Diagnostics in the Lab (Murg & Terry, 2007), the average number of billable molecular tests 
performed by 300 surveyed laboratories across the United States increased almost 30% from 
January 2004 to December 2006 and will continue to grow as more traditional procedures are 
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converted into molecular tests (Bogert, 2007).  The inclusion of growing numbers of molecular 
based assays into the available clinical laboratory test menu justifies review of the traditional 
MLS responsibilities and expansion of their training.   
Inclusion of Molecular Diagnostics in the MLS Curriculum 
Due to increasing demand for medical laboratory scientists to be proficient in molecular-
based techniques, the National Accreditation Agency for Clinical Laboratory Science expanded 
their Accreditation Standards to include molecular diagnostics in the MLS curriculum 
(NAACLS, 2001): 
“The curriculum shall include […] components of laboratory services such as 
hematology, hemostasis, chemistry, microbiology, urinalysis, microscopy, 
MOLECULAR DIAGNOSTICS, immunology and immunohematology. This 
includes […] PERFORMANCE OF ASSAYS […]”.  
 According to workforce analysis by the Bureau of Health Professions, introduction of 
molecular content (Figure 1) was the most frequent curricular change among the programs 
surveyed by the American Society for Clinical Pathology in 2001 (Ward-Cook, Daniels, & 
Gueroguieva, 2002; USDHHS, 2005). It is logical to infer that the changes were a direct result of 
the revised NAACLS Standards. However, with few resources available in this new content area, 
educators of MLS programs expressed dissatisfaction with molecular diagnostics instruction they 
provided (Miller & Abbate, 2002).   
 The idea for the study presented in this manuscript began to emerge during an intense 
search for molecular diagnostics educational materials appropriate for students pursuing a 
Bachelor of Science (BS) degree in Medical/Clinical Laboratory Science. A search in 2005 
revealed that there was not one repository available to new molecular diagnostics instructors  
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Figure 1. New Content of Program Curricula per ASCP Board of Registry Survey of MLS 
Programs. From: “The Clinical Laboratory Workforce: The Changing Picture of Supply, 
Demand, Education and Practice” with permission (USDHHS, 2005). 
 
where they could find materials describing specific molecular diagnostic tests performed in  
clinical laboratories even though the market offered numerous basic science molecular biology 
textbooks. Some of the sources were dated prior 1995. Other resources included only lecture 
outlines for MLS instructors but lacked accompanying text or were too complex for a BS level 
student Textbook (Farkas, 1993; Tsongalis & Coleman, 1997; Tsongalis & Coleman, 2002). An 
instructional CD, “DNA 101: A Simple Guide to DNA & Its Use in Laboratory Testing” and a 
National Institute of Health sponsored website with information on molecular diagnostics of 
cancer were available (Polancic, 2003; Kelly & Kerrigan, 2005). However, these sources were 
not familiar to the majority of MLS instructors informally inquired by the author (personal 
communication, 2005).  The lack of readily available textbooks and procedure manuals could be 
the source of the frustration revealed by the surveyed educators (Miller & Abbate, 2002). 
Previous Study Results 
 To determine if the incorporation of molecular diagnostics information into MLS 
programs has improved since 2002 and to identify teaching materials that had gained the 
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acceptance of the molecular diagnostics instructors, a brief informal electronic survey containing 
six questions was emailed in June 2005 to over 220 accredited MLS (formerly CLS/MT) 
program directors listed on the NAACLS website (NAACLS, Accredited and Approved 
Programs, 2005). All but one out of the total of 40 respondents stated that molecular diagnostics 
was taught in their programs although only in one-third of the programs was this topic covered as 
a separate course. Less than one-third of the programs included student laboratory instruction. 
Respondents’ comments about teaching materials have revealed frustration among the educators 
and approximately 40% recommended specific sources. Not one textbook was preferred by a 
statistically significant number of instructors. One institution revealed their plans to open a 
Diagnostic Molecular Scientist (DMS) program in 2006. Only 15% reported familiarity with the 
“Human Genetics Curricula for the Health Professionals Project” in which the NAACLS 
participated since 2000. These results indicated that in 2005 MLS educators still needed 
guidance with incorporating molecular diagnostics into their curricula in order to comply with 
NAACLS requirements. The results of this informal survey were presented at Clinical 
Laboratory Educators Conference in San Antonio (Kraj B. , Status of Molecular Diagnostics 
Incorporation into Clinical Laboratory Science Curricula: Results of a National Survey, 2006) 
and during the annual American Society for Clinical Laboratory Science – Georgia meeting in 
Macon, GA (Kraj B. , Molecular Diagnostics Issues Discussed at CLEC, 2006). Graph 
representations of survey results are summarized in Appendix A. The survey, although informal, 
contributed significantly to the author’s knowledge about the status of introducing molecular 
diagnostics into medical laboratory science curricula in the United States four years after the 
NAACLS mandated teaching molecular diagnostics as one of the accreditation requirements. 
Results of the survey revealed that even though the MLS community was well aware of the 
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accreditation Standards, the programs represented by the respondents were not uniform with 
regards to the extent of teaching theoretical concepts and laboratory performance of assays. This 
could be partially due to the fact that programs that have received NAACLS accreditation 
renewal prior to September 30, 2001; and new programs that requested renewal between October 
1, 2000 and September 30, 2001 had a choice of using either the 2001 or the 1995 Standards. 
This suggests that some programs may not have introduced molecular diagnostics as they would 
still be in compliance with the old Standards until September 2008. The survey had also revealed 
lack of preferred teaching resources, recognized by the majority of instructors.  It should be 
mentioned here that high frequency with which the respondents were avoiding answering certain 
questions pointed to less than ideal survey design which justified development of a new, 
improved instrument. 
Addressing the Need for Students Trained in Molecular Diagnostics – Reevaluating the 
MLS Scope of Practice 
 The Clinical Laboratory Workforce: The Changing Picture of Supply, Demand, 
Education and Practice document addressed to a certain extent the dynamic character of medical 
laboratory scientist scope of practice (USDHHS, 2005). Periodic reevaluating the scope of MLS 
practice and levels of practice is warranted due to dynamic nature of the profession resulting 
from continuous changes that occur in the clinical laboratory, one of which is frequent 
implementation of newly developed technologies, especially in the area of broadly understood 
genetic testing. In 2005, the Board of Directors of ASCLS, the professional organization that 
represents the medical laboratory workforce and leadership, has initiated formation of a special 
taskforce with the goal of evaluating the levels of practice in the laboratory based on knowledge, 
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skills, competencies, and defined attributes. The taskforce has proposed a model for Levels of 
Practice (LOP) in MLS (formerly CLS) (Table 1).  
Table 1.  
 
Clinical Laboratory Levels of Practice Assigned to Established Credentials. 
 
 Title Credential 
Level I Clinical Laboratory Assistant I CLA 
Level II Clinical Laboratory Assistant II CLA 
Level III Clinical Laboratory Technician I CLT 
Level IV Clinical Laboratory Technician II CLT 
Level V Clinical Laboratory Scientist I CLS 
Level VI Clinical Laboratory Scientist II CLS 
Level VII Clinical Laboratory Specialist CLS 
Level VIII Doctor of Clinical Laboratory Science DCLS 
 
Note: Table from “Report of the Implementation workgroup of the Levels of Practice Task 
Force” (ASCLS, 2008). 
 
The model, consisting of total of eight levels, also attempted to define the skills expected of the 
new professionals (ASCLS, 2008). How do molecular skills and knowledge fit these levels as 
defined by the taskforce? Generally described molecular skills are found under levels IV, V and 
VI presented in Appendix B (ASCLS, Levels Of Practice Position Paper, 2009). Practice skills 
listed for level IV (experienced, associate degree CLT/MLT certified technician) are described as 
“simple molecular testing that follows established protocols including DNA probes”. Practice 
skills listed for level V, appropriate for an entry level practitioner with a baccalaureate and 
certification as a clinical laboratory scientist, are “advanced molecular testing that follows 
established protocols including DNA probes”. Exact “established protocols” are not specified for 
either level in the paper, and qualities that set the “simple” testing apart from the “advanced” 
testing are not provided. Various target and signal amplification methods are currently the 
standard established molecular based diagnostic assays offered by clinical laboratories.  
However, PCR, one of the first amplification assays, is not found in the model until level VI 
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which is reserved for the MLS who, in addition to being certified BS level practitioners, have 
completed unspecified additional education required to perform microarrays and PCR, listed as 
Advanced Techniques in Body Fluids. Additional description of the term “DNA probes” is also 
lacking. Practice level VI, according to the model, also includes personnel holding specialty 
certification in an area such as blood bank, hematology, coagulation, cytogenetics, etc. In this 
model, the MLS with specialty in molecular biology would be qualified to modify, troubleshoot 
and evaluate molecular assays categorized as “Advanced Techniques in Body Fluids (Micro 
Array and PCR)”. They would also be involved in research and development of molecular 
methods. Perhaps careful defining the molecular practice skills applicable to each level in the 
model could be a project on its own. The model was developed by the taskforce and then 
distributed with a request for feedback from representatives of ASCLS and ASCP, as well as 
American Medical Technologists (AMT), and Clinical Laboratory Management Association 
(CLMA). Practice skills attributed to each level and listed as they are in the 2009 position paper 
have been chosen based on the feedback, which may not be representative of the total workforce 
(ASCLS, 2008). From the documentation available from ASCLS website, it cannot be inferred 
whether input was received from experts experienced in performance of molecular testing.  
The Necessity to Seek Input from Practitioners 
 Aside from discussion with colleagues who teach, input from experts who are current 
practitioners is necessary to design a program (course) which will produce desirable qualities of 
graduates. A senior lecturer in the Professional Development Centre at the University of New 
South Wales, in her extensive text Designing Courses for Higher Education (Toohey, 1999), 
Susan Toohey cites the Australian education authorities to describe these desirable qualities, 
categorized in three major groups: generic skills, body of knowledge, and professional/technical 
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skills (National Board of Employment Education and Training, Higher Education Council, 
1992). In summary, the academics are known to emphasize the generic analytical skills. 
However, the employers or future co-workers may expect the graduates to be able to efficiently 
perform specific tasks and troubleshoot. It may be anticipated that the expectations regarding the 
extent of new graduates knowledge base and manual dexterity required to work in molecular 
environment will be different in a hospital laboratory and in a reference laboratory. For example, 
a facility in which the only molecular test offered is Neisseria gonorrhoe/Chlamydia trachomatis 
(NG/CT) assay (like many hospital laboratories) would not require the knowledge of cycle 
sequencing principles upon hire. According to Emmes Survey of US Laboratories Report, the 
focus of molecular diagnostics is on the topics presented in Table 2 (Who's Doing What in 
Molecular Diagnostics? , February 2009).  
Table 2.  
 
The Focus of Contemporary Molecular Diagnostics.  
 
Test categories Conditions/Pathogens 
Infectious Disease Testing Chlamydia and Gonorrhea  
HBV Viral Load 
HCV Viral Load, HCV Genotyping 
HIV Viral Load, HIV Genotyping 
HPV, HPV Genotyping 
Herpes Simplex Virus (HSV) 
Hospital Acquired Infections MRSA, VRE 
Coagulation Factors Factor II, Factor V Leiden 
Oncology Testing BCR/ABL, Bladder Cancer, Her2Neu, MTHFR 
Transplant Medicine HLA Typing 
Hereditary Disorders Cystic Fibrosis (CF), Fragile X 
Respiratory Infections Influenza A/B, Group A Strep, MTB (Tuberculosis), 
Bordetella pertussis, Adenovirus, Respiratory Virus 
Communicable Diseases CMV (Cytomegalovirus), EBV (Epstein-Barr Virus) 
 
Note: Data adapted from “Emmes Survey of US Laboratories Report” Summary (Who's Doing 
What in Molecular Diagnostics? , February 2009) 
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The current diagnostic test menu offered by a particular clinical site could be the factor 
contributing to the laboratory’s expectations towards the incoming MLS. Further, the opinion 
regarding the skills required of entry level practitioners may be also influenced by the current 
employees’ educational and certification status. Presently, under Clinical Laboratory 
Improvement Amendment (CLIA’88 - 42 CFR §§493.1461 and 1462), the supervisory personnel 
in the molecular diagnostic laboratories do not have to be a certified MLS (CLIA, 2004); (CDC, 
2009). This and other nuances of the contemporary molecular diagnostic facility should be taken 
into consideration when assessing the laboratory’s expectations. 
Development of Molecular Diagnostics Instructional Materials  
In addition to defining the LOP, the goals of the ASCLS taskforce listed in the position 
paper are the development of a process that would evaluate the changing practice needs and 
matching the educational curriculum to these needs (ASCLS, 2008). These goals are in 
concordance with the general aim of this study to assess expectations of clinical laboratories that 
offer molecular diagnostic services which would facilitate development of teaching materials for 
clinical molecular methods educational course. In order to meet the needs of the contemporary 
clinical laboratory to hire competent personnel, specific content must be taught in educational 
programs.  
 The American Society for Clinical Pathology Board of Registry (ASCP BOR) Study 
Guide for the Clinical Laboratory Certification Examinations contains a “Molecular Pathology” 
section providing examples of molecular questions that could be expected on the exam (Tanabe 
& Holladay, 2009). However; the examination guidelines for new graduates applying for the 
Medical Laboratory Scientist (MLS) certification, available online  on ASCP Board of 
Certification (ASCP-BOC) website until September 2014 only included unspecified ”Molecular 
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Techniques” under “Instrumental and Analytical Techniques” in the Laboratory Operations 
section. This entire section contributed overall 6% to the exam content (ASCP, 2009). The 
updated, guidelines mention molecular concepts without much detail in three areas: molecular 
genetics of blood group systems, and molecular methodologies required for identification and 
detection of microorganisms and antimicrobial susceptibility testing, and in laboratory operations 
(ASCP, 2014). The document provides Matrix Assisted Laser Desorption Ionization Time-Of-
Flight (MALDI-TOF) as an example of the “molecular methodologies”. No other types of assays 
are listed. This example does not represent a typical technology based on nucleic acid testing as 
it is based on mass spectrometry of vaporized proteins (Lehman & Manuselis, 2015). It should 
be noted here that ASCP-BOR united with the National Credentialing Agency for Laboratory 
Personnel (NCA) in the fall 2009, at which time NCA ceased to exist and ASCP-Board of 
Certification (ASCP-BOC) was created (ASCP BOR and NCA Form Single Certification 
Agency. News Release, 2009). Merging of the two certification agencies resulted in a change in 
nomenclature of the credentials awarded to those passing the examination.  The MT and CLS 
credentials were replaced with MLS. 
The NCA, which was founded in 1978 by the American Society for Clinical Laboratory 
Science (ASCLS) to ensure the credibility of the profession, had periodically published 
examination content guidelines based on job market analyses (Beck, Doig, & Nettles, 1997; 
Doig, Beck, & Kolenc, 2001; AGT, 2009). Table 3 lists the molecular content of CLS 
certification exam, which became effective in January 2009 (NCA, 2007). The content is no 
longer available online and the items listed in the table are not found in the current ASCP-BOC 
content guidelines for entry-level MLS certification. 
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Table 3. 
National Credentialing Agency for Laboratory Personnel Molecular Content for CLS. 
VII. MOLECULAR TECHNIQUES 
A. Specimen Suitability and Processing 
1. Evaluate specimen suitability and process specimens according to laboratory 
protocol to isolate/extract nucleic acids considering type and test required 
2. Evaluate suitability of processed specimen (e.g., nucleic acid yield and quality) 
B. Analytical Techniques 
1. Perform nucleic detection and manipulation to include 
• digestion 
• labeling (e.g., amplification, nick translation) 
• separation 
• detection 
2. Perform nucleic acid amplification (e.g., PCR, RTPCR, real-time PCR) 
3. Perform molecular technique applications according to lab protocol, analyze data to 
accept/reject results, recognize factors interfering with test results, and take corrective 
action, record/report results for: 
• organism detection (e.g., M. tuberculosis) 
• viral load (e.g., HIV, HBV, HCV) 
• genetic disease (e.g., cystic fibrosis, Factor V Leiden) 
• malignancy (e.g., CML, bcr/abl oncogene) 
• transplantation matching 
• forensics 
• paternity matching 
4. Correlate results to available information including: 
• diagnosis, patient history 
• results from previous / concurrent tests 
5. Respond to inquiries from other health professionals about tests, results, reference 
intervals, and specimens 
 
Note: Content from: Section VII. Molecular Techniques. “Clinical Laboratory Scientist (CLS) 
Content Outline”. National Credentialing Agency for Laboratory Personnel, 2007. 
 
In 2012 the ASCLS formed a Body of Knowledge Committee in an effort to redefine the 
medical laboratory technician and medical laboratory scientist areas of expertise. The Committee 
asked scientific assemblies’ members to provide comments on documents developed by medical 
laboratory scientists selected by the committee (Ray & Rydell, 2013). The molecular scientific  
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assembly members (including the author of this proposal) received the respective document 
outlining molecular diagnostics BOK in August 2013 and provided feedback by October 1, 2013. 
Although the ASCLS BOK document listed molecular diagnostics terms and techniques, not all 
of them were linked to specific learning objectives.  
Another stakeholder, the Training and Education Committee Medical Laboratory 
Scientist Curriculum Task Force of the Association for Molecular Pathology (AMP), was 
engaged in seeking opinion on employee expectations in molecular diagnostics laboratories. In 
fall 2012 the Director of Scientific Programs distributed a survey to managers of molecular 
diagnostic laboratories (Limson, 2012) for the purpose of developing a curriculum in molecular 
pathology and genomics for MLS (Taylor, Bennett, Deignan, Hendrix, Orton, Verma, 
Schutzbank, 2014).  The respondents were asked to rate the expected expertise of recent 
graduates of a baccalaureate degree program in medical laboratory science and Master’s degree 
program in molecular diagnostics in a variety of molecular tests/skills using the following levels:  
unfamiliar, familiar with concept, familiar with skill and expert. The graph representing the data 
showed, side by side, the levels of expertise in 20 diagnostic techniques expected of 
baccalaureate degree graduates and master’s degree graduates though no differentiation was 
made between graduates of MLS and DMS programs. Nevertheless, the authors provided 
recommendations for molecular pathology curricula for baccalaureate programs in medical 
laboratory science, baccalaureate programs in diagnostic molecular science; and master’s 
programs in diagnostic molecular science.  The authors’ recommendations consisted of a list of 
topics and techniques for a molecular curriculum but did not include specific cognitive or 
psychomotor objectives. 
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To fulfill the NAACLS requirement of introducing molecular diagnostics into the 
curriculum, in response to emergence of some molecular techniques in student internship sites, 
and in anticipation of the possibility of molecular content on certification exams in the future, the 
author of this study developed a week-long molecular diagnostics module that was incorporated 
in the clinical chemistry course at her institution. In 2005, the module only consisted of a lecture 
sequence supplemented with virtual exercises (Goss, Warren, & Hallick, 1996; Amagai, Bonetta, 
Liu, Relman, Buffington, Pietsch, non-dated), while in 2006 and 2007 manual rapid DNA 
isolation from finger stick blood deposited on FTA Elute cards (Whatman Ltd., cat# WB120401) 
and PCR-based DNA typing laboratory exercises were included (Edvotek, Bethesda, MD, cat # 
334 and 333). Course exam performance of the students exposed to virtual versus hands-on 
laboratories was compared to assess whether the inclusion of assay performance resulted in 
significantly higher test scores. Ten multiple choice questions derived from the molecular 
module (numbered 86-96) were included in the written final clinical chemistry course 
examination. The hands-on group scored significantly higher than the virtual laboratory group in 
their responses to the test questions (Figure 2). Upon closer examination of the data, it became 
evident that scores achieved by students performing in the middle percentiles were responsible 
for the overall outcomes as the inclusion of advanced hands-on exercises did not significantly 
improve the scores of students performing in the lowest and in the highest percentiles. These 
results were presented at Clinical Laboratory Educators Conference in Savannah, GA (Kraj, 
Pretlow & Russell, 2008) and published (Kraj, Pretlow, & Russell, 2011). In fall 2008, the 
department introduced a revised curriculum with a three credit hour lecture and two credit hour 
laboratory courses to be offered in the senior year. In 2009 a working version of laboratory 
manual was developed by the author and included guidelines for 12 laboratory sessions. The  
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Figure 2. Scores Achieved on Molecular Questions in the Final Clinical Chemistry Course Exam 
(Kraj, Pretlow, & Russell, Student Molecular Laboratory Performance Outcomes in a 
Baccalaureate CLS Program., 2011). Reprinted. 
 
manual was updated yearly and available for the students online in the learning management 
system (Kraj, 2013 unpublished).  Out of 12 laboratory activities designed, nine were hands-on, 
two were computer based and one included a visit to a reference lab. One activity, involving 
PCR primer design, included an additional assignment designed for graduate MLS students 
(Russell, Kraj, Pretlow, Ranne, & Leibach, 2011). 
Purpose of the Study and Research Questions 
 The purpose of the presented project was to survey molecular diagnostics experts who 
were supervisory personnel at clinical sites offering molecular testing to assess their expectations 
from graduating entry-level MLS with regards to molecular skills. Interviewing experts has been 
frequently achieved using questionnaire based method known as Delphi (Aichholzer, 2009). For 
this project, an asynchronous, iterative, online Delphi was used as a method to identify and 
prioritize the expected molecular skills.  
 The skills identified by the experts are anticipated to match most closely with practice 
level V in the current ASCLS LOP model, plus or minus one level, pending better definition of 
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“established procedures” and clarification of “molecular probes”. The questions regarding the 
desired skills reflect modified instructional cognitive and psychomotor objectives listed in the 
syllabi for Clinical Molecular Methods courses developed and taught by the author in the MLS 
program at Georgia Regents University (Kraj, 2013 unpublished). 
 The research questions addressed in the study are: 
1. Which molecular cognitive skills are expected of an entry level MLS upon hire in 
facilities that offer molecular diagnostics services? 
2. Which molecular psychomotor skills are expected of an entry level MLS upon hire in 
facilities that offer molecular diagnostics services? 
3. Which of the cognitive and psychomotor skills are considered the most important to be 
included in the MLS curriculum? 
4. In which areas (e.g., hematology, microbiology, chemistry, blood banking, immunology, 
body fluids) of the clinical laboratory are entry level skills in molecular diagnostics 
utilized?  
 The outcomes of the analysis will be shared with the stakeholders involved in 
development of competency-based curricula: laboratory professionals, educators, and relevant 
certifying, accrediting and other professional organizations: the NAACLS, ASCP and ASCLS. 
Chapter Summary 
 In this chapter, the author reviewed the emergent process of inclusion of molecular 
diagnostics discipline into clinical/medical laboratory science practice and presented the results 
of a previous study conducted to informally assess the extent of new content incorporation into 
the MLS curriculum. The author chose engaging medical laboratory professionals currently 
practicing in laboratories offering molecular diagnostics services in defining expectations 
      
18 
 
relevant to this discipline in graduating entry-level MLS with an ultimate goal of sharing the 
information so that it may be used in the development of curriculum reflecting current 
knowledge and scope of practice. Research questions were listed and Delphi survey was 
identified as study tool.  The following two chapters will review several Delphi studies 
performed to develop various healthcare curricula and the methodology of Delphi. 
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Chapter Two: Literature Review 
 
This literature review begins with the description of the outcomes of the study performed 
by Miller and Abbate (2002) which ignited the initial interest of the author with the incorporation 
of molecular diagnostics into the MLS curriculum.  The following sections reviewed the current 
science of interviewing experts using Delphi survey with focus on studies that had utilized this 
method in needs assessment and education research, especially studies on competence-based 
curriculum development to include but not limited to curricula in several healthcare disciplines 
such as medicine (especially genetics and pathology), dentistry, nursing and allied health. Delphi 
studies relevant to clinical laboratory were also presented. The chapter also provided an 
overview of the method, focusing on its validity and general research guidelines; it addressed 
recruitment of subjects, anonymity, and attrition, number of rounds, survey question formats and 
rating scale, feedback on answers and analysis of numeric values. Various types and 
modifications of the conventional Delphi method were described. 
The Extent of Molecular Diagnostics Education in MLS Programs in 2001 
In 2001 the NAACLS introduced new Standards of Accredited Educational Programs for 
the Clinical Laboratory Scientist/Medical Technologist which specified the inclusion of 
molecular diagnostics in the MLS curriculum (NAACLS, Standards of Accredited Educational 
Programs for the Clinical Laboratory Scientist/Medical Technologist, 2001). It should be noted 
here that Programs that received NAACLS Accreditation Renewal prior to September 30, 2001 
and new programs that submitted an interest of renewal between October 1, 2000 and September 
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30, 2001 had a choice of using either the 2001 or the 1995 Standards (which did not require the 
inclusion of molecular diagnostics). As a result, some MLS programs may not have introduced 
molecular content into their curriculum upon new Standards release, yet were still in compliance 
until September 2008 because the maximum accreditation period was seven years. 
Concurrently with the introduction of the 2001 NAACLS Standards,  researchers from 
the SUNY Upstate Medical University at Syracuse and Samaritan Medical Center, Watertown, 
NY, mailed a multiple choice survey to 263 MLS programs in order to assess the extent in which 
genetics and molecular diagnostics concepts were taught at the time (Miller & Abbate, 2002). 
The relatively high response rate (62%) indicated that this was a timely topic; when the survey 
was distributed, program directors may have already heard about the upcoming changes in the 
NAACLS Standards. Many educators who responded to the survey (44%) expressed 
dissatisfaction with the instructional delivery of the genetics/molecular content. The listed factors 
that contributed to the dissatisfaction were lack of time in the curriculum to teach the material, 
lack of knowledgeable faculty, and prohibitive cost. Less than 5% of the dissatisfied respondents 
listed lack of affiliated clinical sites that performed molecular methods as the reason of 
dissatisfaction. These results may reflect the fact that 44% of the respondents were from hospital 
based programs and 17% were from state academic medical center programs. The respondents 
were program directors (86.8%) or faculty and clinical coordinators (13.2%). The survey 
addressed the methods that were taught in theory and with hands-on practice and provided useful 
information regarding some specific applications taught (Tables 4 and 5). However, it is not 
known if these concepts and applications reflected the expectations of technologists and 
supervisory personnel responsible for molecular testing of patients’ specimens.  
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Table 4.  
Survey Results on Molecular Diagnostic Methods in MLS Curricula. 
 
 
Note. Adapted and reprinted from “Genetics and molecular diagnostics in the clinical laboratory 
science curriculum” (Miller & Abbate, 2002) with permission. 
 
Table 5.  
 
Survey Results on Clinical Applications of Molecular Methods in MLS Curricula. 
 
 
 
Note.  Adapted and reprinted from “Genetics and molecular diagnostics in the clinical laboratory 
science curriculum” (Miller & Abbate, 2002) with permission. 
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Therefore, it is not clear if the curricula were designed based on competencies expected of the 
graduating MLS upon entry to the profession. 
Collecting Information Regarding the Requirements of the Profession 
 The common methods to gather information on the current requirements of professional 
practice and on its anticipated future directions include surveys and interviews with professional 
practitioners and employers (Toohey, 1999). These requirements are typically collected by 
professional organizations and translated into sets of competency standards. NCA compiled a list 
of molecular objectives from which examinees should expect related questions on the 
certification exam (Table 3). Since the organization’s dissolution, the ASCP-BOC has not 
published specific molecular competence standards for an entry level MLS. However, the 
examination guidelines updated in September 2014 included molecular genetics of blood group 
systems, molecular methodologies for identification and detection of microorganisms and 
antimicrobial susceptibility testing, and list unspecified “Molecular Techniques” under 
Laboratory Operations section which constitutes total of 5-10% of the exam content (ASCP, 
2014). The profession is in need for published molecular competency standards and competency-
based molecular diagnostics curriculum.  
 There are many examples of studies performed to develop competency-based curricula in 
a variety of disciplines. They all require a thorough review of information on the current 
requirements of professional practice which may be gathered using several research techniques 
to include critical incident analysis, functional analysis, DACUM (Developing a Curriculum) 
technique and various types of face-to face interviews and written surveys (Toohey, 1999). A 
significant number of such studies have been undertaken using the Delphi technique (Burke, 
Martyn, Stone, Bennett, Thomas, Farndon, 2009; Choudaha, 2008; Edgren, 2006; Elder & Nick, 
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1997; Fried & Leao, 2007; Perkins, Barrett, Bullock, Gabbott, Nolan, Mitchell, Short, Smith, 
Smith, Todd, Bion, 2005; Sizer, Felstehausen, Sawyer, Dornier, Matthews, Cook, 2007).   
The Delphi method was originally used in military and industry forecasting and planning 
and involves gathering information in several sequential rounds of surveys sent to the same 
experts to either generate ideas or answer a number of questions with a purpose to reach a 
consensus on the investigated subject. The participants of Delphi surveys do not know the other 
participants’ identity which prevents intimidation due to dominance of the discussion by the 
authority of the most persuasive members of the group, a phenomenon known as “halo” or 
“bandwagon effect” (Linstone & Turoff, 1975; Francis, 1977; Landeta, 2006). Gathering the 
information in several rounds (instead of one) gives the experts the opportunity to change their 
opinion based on the summarized outcomes of the analysis of the previous round provided by the 
researcher, without fear of being called indecisive, or to maintain the original opinion without 
confrontation, even if not in agreement with the majority. The first Delphi study was published 
by RAND Corporation (Gordon & Helmer, 1964). The method was soon adopted for research in 
social studies and characterized as “a method for structuring a group communication process, so 
that the process is effective in allowing a group of individuals, as a whole, to deal with complex 
problems” (Linstone & Turoff, 1975). As noticed by Toohey (1999), the Delphi is useful to 
collect information from practitioners when significant changes occur in the profession. Such 
changes call for revisions of the competencies taught in programs graduating practitioners 
entering the occupation.  
Choudaha used a three round online Delphi survey to assess theoretical and conceptual 
foundations for developing a competency-based curriculum for an interdisciplinary master's 
degree program in Service Science, Management and Engineering (Choudaha, 2008). The study 
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was conducted as a doctoral dissertation under advisement of Frank Tuitt, assistant professor in 
the Department of Higher Education, University of Denver, CO (Choudaha, 2008). Choudaha’s 
study lists other doctoral dissertations using Delphi method for curriculum development (Table 
6). A comprehensive analysis of number of defended and published Delphi studies, 
encompassing the years of 1970 through 2004 was provided by Landeta (Landeta, 2006). 
Table 6:  
 
Doctoral Dissertations using Delphi method for Curriculum Development. 
 
Dissertation Title and Author 
Defining a competency framework to shape the professional education of national security 
master strategists: A web-based Delphi study (Clark, 2005). 
Use of a Web-based Delphi for identifying critical components of a professional science 
master’s program in biotechnology (Kantz, 2004). 
An investigation and critique of competencies needed by human resource development 
(HRD) master's degree graduates in Korea (Lee, 2006). 
Consensus of academic and industry experts and practitioners on essential information 
systems curriculum elements: A Delphi study (Matkin, 2000). 
Key competencies for institutional researchers in the first decade of the twenty-first century: 
A Delphi technique for curriculum planning (Polk, 2001). 
Cross-cultural competencies in international management curricula: A Delphi study of 
faculty perspectives (Senyshyn, 2002). 
 
Note: Table from “Competency-based curriculum for a master's program in Service Science, 
Management and Engineering (SSME): An online Delphi study” with permission (Choudaha, 
2008) available at http://gradworks.umi.com/33/37/3337048.html 
 
Competency-Based Curricula in Healthcare Education 
Literature reveals various completed and still ongoing traditional or modified Delphi 
studies used in the development of competency-based curricula in healthcare education 
worldwide. The British Journal of General Practice published a study designed to identify key 
knowledge, skills and attitudes required of physicians undergoing training in genetic testing at 
the Royal College of General Practitioners (Burke, et al., 2009). The authors pointed out that the 
curriculum developed based on the outcomes of the study was “firmly grounded in clinical 
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practice”. The approach represented a modified Delphi survey which in the first round was not 
only distributed among the experts who included educational program directors and geneticists 
but also to the general practitioners who were the anticipated students in the curriculum, and, as 
such, couldn’t be considered experts.  
A consensual curriculum developed using a four step Delphi was described by faculty 
from the Federal University of Rio de Janeiro Dental School (Fried & Leao, 2007) who recruited 
40 dentists who were lecturers in nine Brazilian dental schools. The researchers stated that the 
study was prompted by changes in periodontics practice and therapeutic approaches that 
occurred during several decades due to new advances in science, including the completion of 
human genome sequencing. In the initial phase of the study, the participants identified 339 items 
that should be considered for inclusion in the curriculum. The items were grouped into two 
categories: a) foundational concepts or basic principles and b) laboratory training or clinical 
experience. In the next phase a 1-5 Likert-type scale was used for rating the importance of 
inclusion of the items in the curriculum (Likert, 1932). The subsequent stage of the Delphi 
process included only the participants who gave the most extreme ratings of the items, described 
as “indispensable“ and “should not be included”. Inclusion of only the “extreme raters” in the 
third round was a departure from the classical Delphi technique and no information on the 
validation of the approach was provided. In the last stage, each item for which consensus could 
not be reached were put on the questionnaire distributed to all original participants for a definite 
“yes” or “no” decision. Twenty broadly defined items, such as “identification of periodontal 
instruments” or “laboratory training” were included in the resulting syllabus. 
In Great Britain, the Resuscitation Council has awarded a research grant to identify 
consensus-based core competencies which graduating medical students should have relevant to 
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care of patients acutely ill or in cardiac arrest. The study was conducted by researchers from 
several universities and hospitals who created a website to which 359 physicians, nurses, other 
health professionals; educators and students submitted a total of 2629 suggested competencies 
which were then grouped into 88 common themes by two authors of the study (Perkins, et al., 
2005). The terminology describing each theme was discussed for 7 hours by a group of seven 
experts (a nominal group consisting of physicians, nurses and one student) who, upon editing the 
themes, rated them on a 1-5 Likert-type scale. The median scores obtained for each theme were 
posted on the website for feedback from the professionals who originally suggested the 
competencies. Upon 14 comments provided during two months after posting, the nominal group 
decided that 71 themes which obtained scores 4 and 5 would be considered essential 
competencies, necessary at graduation. It should be noted that, even though the term “theme” 
suggests a broad description, the themes were actually very specific skills, for example 
“describes how to recognize and initiate treatment for meningococcal septicemia”. The inclusion 
of the face-to-face discussion is not a common practice in the Delphi process due to authority 
effect. 
Another example of identification and evaluation of competencies using Delphi process 
was a study initiated by nursing education researchers after 1999 American Medical Informatics 
Association (AMIA) Congress on the informatics education of health professionals. The study 
targeted informatics competencies for nurses (Staggers, Gassert, & Curran, 2002). To justify 
their study, the researchers claimed that previous surveys on perceptions about nursing 
informatics (NI) competencies mostly included educators rather than bedside clinical nurses and 
that there was a very limited number of computer literacy skills integrated into nursing curricula. 
They also stated that, even though the changing nursing practice would benefit from informatics 
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skills, there was no research-based, validated master list of NI competencies available to guide 
formal education curricula. Before the three-round Delphi process was initiated, the researchers 
reviewed literature to identify 1159 various competencies described in 35 articles published from 
1986 to 1998 and in 14 job descriptions of practicing informatics nurse in the Washington, DC, 
area (Staggers, Gassert, & Curran, 2001). The next step included consolidation of the 
competencies into 313 items by the authors of the study, who then decided to ask a panel of 26 
AMIA Working Group Members to state if each of the items actually reflected the nursing 
practice. This step was unsuccessful, which the authors attributed to failure to provide context 
and had to recruit a panel of doctoral prepared nursing experts in informatics to refine the 
competencies through discussions. This “refinement” process resulted in separation of the 
competencies into the four informatics levels of nursing practice defined as beginning, 
experienced, informatics specialists and informatics innovators and included application of 
Bloom’s taxonomy to the competencies for clarity (Bloom, Engelhart, Furst, Hill, & Krathwohl, 
1956). Further consolidation of some items ended with the final number of 304 competencies. At 
this point the list of competencies was ready for the Delphi three-round survey to achieve 
consensus on the validity in the nursing practice and assignment into beginning, experienced, 
informatics specialists and informatics innovators levels. Out of 110 invited nurses with set 
criteria, 82 agreed to participate in the study and 79 were confirmed to qualify. The number of 
usable responses was 72 in the first round. In the subsequent rounds only the items for which no 
consensus was reached were redistributed for opinion. After three rounds (lasting 14 months), 
13% attrition rate and 80% consensus threshold in each round, 92% of the competencies were 
identified as valid and properly assigned to the respective levels.  
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Most competencies identified and evaluated in the study by Staggers et al., were specific 
cognitive or psychomotor skills. Nursing professionals have also utilized a 5-round Delphi 
consensus process to identify critical thinking components which were characteristic of an 
affective domain and included confidence, creativity, flexibility, contextual perspective, 
intuition, inquisitiveness, intellectual integrity, open-mindedness, perseverance and reflection 
(Scheffer & Rubenfeld, 2000).  
Delphi technique was also used in various allied health disciplines to develop a 
competency-based curricula to include cognitive, psychomotor and affective domains. A study to 
identify orthopedic manual therapy (OMT) skill sets, essential in physical therapist education, 
was conducted by researchers from Texas Tech University Health Science Center and Duke 
University Medical Center who used data reduction via factor analysis following an online three-
round Delphi survey administered to 80 PT educators who taught manual therapy at entry or 
post-entry level (Sizer, et al., 2007). To help the educators choose teaching methods which 
would improve learning outcomes and successful transition of a student from the classroom into 
the clinical setting, the authors “distilled” critical OMT skill sets out of numerous stand-alone 
skills, identified in the Delphi process via 75% consensus threshold. 
Four Delphi studies were simultaneously conducted to reach consensus regarding 
knowledge and skills required of graduates from the programs of physical therapy, health 
information management, occupational therapy and medical laboratory science (Elder & Nick, 
1997). The studies focused on knowledge and skills that extended beyond and above what was 
required to satisfy the criteria for programs’ accreditation and successful completion of national 
and state credentialing exams by the graduates (e.g., “oral communication skills at a level 
commensurate with college degree,” “knowledge of ethical codes and principles of practice of 
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own profession”). The panel experts who participated in the studies were chairs of educational 
programs from the above allied health disciplines. They were asked to make their own 
suggestions and to rate 19 items previously identified in another study of allied health school 
deans  and were able to define components of a core allied health curriculum (Elder & Andrew, 
1992). Delphi technique was also successfully used by the deans of allied health schools 
accredited by the Southern Association of Colleges and Schools (SACS) to identify 13 most 
important educational goals related to student learning and valid feasible outcome measures that 
were applicable to the set goals (McKenzie, 1994). During the process, the author realized that 
inconsistency in definitions contributed to problems in identification of the outcomes.   
Dr. Richard Haspel from Beth Israel Medical Center was awarded in 2007 a Rabkin 
Fellowship Project to use the Delphi method to develop a clinical pathology curriculum for the 
third year medical students (Haspel R. , 2010). The Fellowship is awarded yearly to the faculty 
affiliated with Harvard Medical School to support studies in medical education research. The 
specifics of the project have not yet been published. In a personal communication, Haspel said 
the survey was adopted from a Swedish Delphi study conducted by Dr. Gudrun Edgren at Lund 
University Centre for Teaching and Learning to develop a competence-based curriculum for 
“biomedical scientists” who, in Sweden, are the laboratory personnel working in clinical 
laboratories  (Haspel, personal communication, 2010a). In the initial phase of the study, 26 
participants were asked by Edgren to identify competencies that they considered absolutely 
necessary for a recently graduated biomedical scientist upon beginning their first job (Edgren, 
2006). The 407 identified competencies were classified into skills, knowledge, attitudes and 
generic categories and were used to form a first round questionnaire in which the participants 
were asked to grade the importance of the competencies on a 1-4 Likert-type scale. 
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Competencies with a mean score ≥ 3.25 and competencies scored the highest (4) by all 
participants from the same type of laboratory were used for a second round questionnaire in 
which the participants were to state if they did or did not agree that these entry-level 
competencies had indeed been essential. The final list of 77 competencies to be included in the 
biomedical scientist curriculum consisted of those that were deemed necessary by 75% of the 
respondents. Some skills relevant to molecular diagnostics were: the specific knowledge of 
DNA, RNA, amino acids, protein structure and synthesis, replication, transcription, and 
techniques such as polymerase chain reaction (PCR), Northern blot and unspecified “work with 
DNA, RNA and proteins”. There were no procedures designed for diagnosis of specific 
pathogens or conditions on the list. The author has noted that many of competencies, such as 
knowledge of molecular biology, genetic analysis and gene therapy, although identified in the 
initial phase of the study, were lost during the consensus process which resulted in the final list 
being representative of a traditional rather than modern curriculum, possibly due to perceived 
inability to include everything. In personal communication via e-mail, Edgren stated that the 
competencies were expressed in general terms (such as “ability to use pipettes, centrifuges or 
electrophoresis equipment” or “ability to work with isotopes and antibodies”) and that the initial 
list was not available in English (Edgren, electronic communication 6/10/11). 
Several learning objectives relevant to molecular diagnostics in laboratory medicine 
curriculum courses for medical students were suggested by an ad hoc committee appointed by 
the Academy of Clinical Laboratory Physicians and Scientists (Smith, et al., 2010). These 
objectives (e.g.,  “Explain the general principles of molecular diagnostics testing in the 
screening, diagnosis, and/or monitoring of infectious, genetic, and oncologic diseases”) were 
very broadly defined and would have to be extensively modified to address specific 
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competencies necessary for an entry level clinical laboratory scientist. Some objectives 
pertaining to genomics and personalized medicine were suggested for medical residents (Haspel, 
et al., 2010).  
Delphi Studies in Medical Laboratory Science Performed in the US 
 Edgren (2006), in the introduction to her publication on competencies for an entry level 
biomedical scientists in Sweden, refers to a modified Delphi survey performed in the United 
States in order to develop a competency-based, career-entry certification examination for clinical 
laboratory personnel (Davis, 1978). The survey was described by the author, the Chairman of the 
American Society for Medical Technology (ASMT) Certification Examination Subcommittee, as 
the first formally performed process to include such large number of practicing professionals and 
result in the generalist examination at career entry for the two levels of practice defined at the 
time: medical technologists and technicians. In order to delineate competencies appropriate for 
the two levels of practice, over 200 professionals practicing in the field nationwide were asked to 
modify and apply Bloom’s taxonomy to the competencies previously described in another 
document (ASMT, 1976). The professionals represented staff, technologists who performed 
administrative functions, faculty and laboratory directors. Consensus was reached after six 
review cycles performed by 12 groups of participants representing three regions: East, Middle 
and West. The lengthy process described by Davis would benefit from using Bloom’s taxonomy 
in the original document and from more contemporary methods of electronic survey distribution. 
Another three-round Delphi study relevant to clinical laboratory focused on development 
of indicators which could be used to compare performance efficiencies among laboratories (Zinn 
& Zalokowski, 1999). Through Delphi process, six different expert panels representing different 
stakeholders (hospital executives, referring physicians, laboratory managers, etc.)  identified and 
      
32 
 
prioritized the areas of performance but were not able to prioritize performance indicators as a 
result of differences in environmental pressures for different stakeholders which may suggest 
that Delphi produces better results when the expert panel is relatively homogenous.  
Indicators of student professional behavior were successfully identified in a small scale 
modified, non-anonymous Delphi in the process of development of student professional behavior 
evaluation tool implemented at the proposal’s author’s institution (Russell B. , Owen, Leibach, 
Meaders, & Kraj, 2011). Didactic and clinical faculty have successfully used the tool in the 
programs of clinical laboratory science, diagnostic medical sonography, nuclear medicine 
technology, and radiation therapy. 
Originally, designed for industry forecasting, the Delphi method was used to complete a 
study on the future of the medical laboratory science to predict events that would occur in the 
profession within the next two decades, as identified from among 147 events by a panel of 24 
experts (Kirby, 2008). The events for which a three-round Delphi-based consensus was achieved 
were used for development of future scenarios including continuous decrease in reimbursement 
for laboratory services, critical shortage of laboratory workforce, development of clinical 
doctorate in CLS and technological advances changing the scope of practice. Examples of events 
relevant to technological advances in molecular diagnostics which were predicted by the study to 
have significant impact on practice were as follows: the contribution of pharmacogenomics to 
laboratory testing, increased assay development rate by means of proteomics, use of genetic and 
molecular testing for disease prevention, and use of DNA-based assays as sole technology in 
microbiology testing. These predictions provide further justification to identify the expectations 
of the professionals currently involved in performance of molecular-based assays towards the 
incoming graduates to develop a competency-based curriculum appropriate for future workforce. 
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Historical Remarks on the Name and Definition of the Delphi Method  
 
 In 2003, at the United Nations Industrial Development Organization (UNIDO) 
Technology Foresight Seminar in Prague, a German author implied that the famous ancient 
Greek oracle Pythia’s predictions may have resulted from the knowledge accumulated in the 
Delphic monastery located 173 km northwest of Athens, by the slope of Mount Parnassus. The 
monastery was a destination of numerous ambassadors whose questions for the oracle (along 
with the answers) were written on stone or metal plates (Cuhls K. , The Delphi Method, 2003). 
Named by UCLA’s professor of philosophy, Dr. Kaplan, after the place where Pythia foretold 
the future (Kaplan, Scogstad, & Girshick, 1950), the Delphi method was originally used in 1950s 
in a military “Project Delphi” designed by the Californian Rand Corporation in Santa Monica, 
CA (Dalkey & Helmer, 1963).  Delayed by 12 years, publication of this Air Force sponsored 
project was a measure of military security (Landeta, 2006). As described in lay terms by 
Linstone and Turoff in their seminal book discussing the method, Project Delphi, through a 
series of questionnaires, sought an opinion on the estimated number of A bombs that would have 
to be used [by the Soviets] on strategic industrial U.S. targets to decrease the strength of the 
American defense system by a certain value (Linstone & Turoff, 1975). Rand Corporation also 
sponsored the first not-strictly-military study that applied the Delphi method to predict scientific 
breakthroughs, population growth, automation, future weapon systems, war prevention and space 
progress (Gordon & Helmer, 1964).  
Linstone and Turoff estimated that by mid-1970s, over a thousand Delphi studies were 
conducted which prompted both plausible and opposing assessments (Linstone & Turoff, 1975). 
A critique of conventional Delphi technique, described as a “new version of an old crystal ball,” 
was prepared by one of Rand’s own analysts for the United States Air Force and approved for 
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public release in the 1970s (Sackman, Delphi Assessment: Expert Opinion, Forecasting and 
Group Process, 1974). Fifty years later, the method enhances effective decision making in policy 
development, social sciences and health care; it is used in major national, holistic endeavors with 
large impact on society, such as periodic Science and Technology Agency foresight studies in 
Japan and Germany, as well as in smaller business and education applications, including doctoral 
dissertations (Cuhls, 2003).  
The survey-based Delphi research method is considered a structured group facilitation 
technique, which through an iterative, multistage process, allows the group to deal with complex 
problems and aims at transformation of opinions into a group consensus (Linstone & Turoff, 
1975). The four classical research objectives which could be achieved using the technique were: 
a) to explore or expose underlying assumptions or information leading to differing judgments; b) 
to seek out information which may generate a consensus on the part of the respondent group; c) 
to correlate informed judgments on a topic spanning a wide range of disciplines; and d) to 
educate the respondent group as to the diverse and interrelated aspects of the topic (Turoff, 
1970).  
Reliability and Validity of the Delphi Method  
 
In his oppositional critique of conventional Delphi, Sackman (1974) claimed that the 
conventional method could only be used as an exploratory technique because the investigators, 
participants and end-users neglected the standards jointly established by the American 
Psychological Association (APA), the American Educational Research Association and the 
National Council on Measurement in Education to evaluate development and use of 
psychological tests (American Psychological Association, 1966). As a riposte to this accusation, 
Linstone stated that the procedures developed by the APA to evaluate the testing of individuals 
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should not be assumed as appropriate to evaluate opinion questionnaires (Linstone & Turoff, 
1975).  
A researcher from the Institute of Applied Business Economics at the University of the 
Basque Country at Bilbao, Spain, evaluated the validity of Delphi using a three-partite approach 
(Landeta, 2006). First, he reviewed several articles which authors had compared the method with 
other interaction techniques used in decision making, such as group interviews or nominal 
groups technique (NGT) where the participants openly present their opinions or problem 
solutions and then vote on each solution presented. For example, two researchers from Western 
Kentucky and Louisiana State Universities indicated that the Delphi produced the highest quality 
decisions because they had a higher level of acceptance than decisions made using other 
consensus, interacting, and NGT methods (Erffmeyer & Lane, 1984). Landeta concluded that in 
other reviewed studies where the comparison resulted neither in favor, nor against Delphi, the 
outcome could be attributed to the disappointment with the method by researchers who lacked 
the knowledge required to use the technique successfully. To further justify the validity of 
Delphi, Landeta quoted researchers from East Carolina University in Greenville, North Carolina, 
who analyzed the numbers of studies performed using this technique over the period of 1970-
1994. He concluded that, starting in 1975, 53-57 Delphi studies were consistently published per 
year (Gupta & Clarke, 1996). Landeta used four online databases (ABI inform, Science Direct, 
Medline and Psycho) to continue the search until 2004 and has shown an increase in yearly 
numbers of Delphi studies in each database. The analysis of the numbers of doctoral dissertations 
utilizing Delphi has shown that after the peak in the 1980s attributed to the novelty effect, the 
number has slightly declined but remains at a steady level which, according to the author, results 
from the acceptance of the method by the scientific community.  
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Finally, Landeta performed three Delphi studies in the area of social science himself. In 
the first study the participants (tourism experts) were providing information that would allow the 
Statistics Institute of Catalonia for a reliable estimation of minimum tourist expenditures of 
Catalonia visitors coming from other regions in Spain. Similarly, in the second study, the 
participants (Catalan firm directors) were providing information which would allow the Statistics 
Institute of Catalonia to create the economical input-output tables for the region. In the third 
study, opinions from the university lecturers were sought in order to design a Basque University 
Organization Act. Landeta concluded that with respect to the validity of the method, the input 
obtained was as intended and usable, and that it contributed to either reliable estimates of the 
parameters sought by the Statistics Institute of Catalonia or to successful design and passing of 
the Act (Landeta, 2006). 
The researchers from the University of Ulster, Ireland, stated that the evidence of 
reliability of Delphi was lacking because it was not known if different panels of experts could 
ever arrive at the same results if provided the same information (Hasson, Keeney, & McKenna, 
2000). However, a study performed in Australia to identify nursing management competencies 
using two different panels of experts reported a 92.86% convergence of results (Duffield, 1993). 
Hasson and his colleagues have suggested that the criteria for reliability of Delphi were the same 
as for other qualitative studies, namely the assurance of subjects’ truthfulness (credibility), 
applicability (fittingness), consistency (auditability) and confirmability (Lincoln & Guba, 1985).  
Major threats to the validity of Delphi, as discussed by these authors, were the response rate and 
pressure for reaching consensus. The remedies aimed at these threats were: 1) the fact that 
several people were less likely to make an incorrect decision than a single person (Kaplan, 
Scogstad, & Girshick, 1950), 2) knowledge and interest of the subjects in the topic, and 3) the 
      
37 
 
process of iteration in which successive rounds of surveys are accompanied by feedback of 
results of the preceding round to the participants which allowed for a thoughtful revision or 
clarification of individual responses.  However, two British researchers from De Montfort 
University and Kings College thought that the knowledge of other respondents’ answers which 
could prompt change in opinion was a threat to the reliability as it, by nature, prevented 
reproducibility (Beretta, 1996; Goodman 1987). Cuhls (2003), who at the UNIDO seminar 
addressed predominately the forecasting applications of Delphi, questioned the validity of the 
sample of experts due to frequent self-estimation of the expertise and suggested that not only the 
anticipated “users” of the results (such as educators) should be surveyed but also the decision-
makers who are responsible for future implementation (practicing professionals and supervisors 
responsible for hiring). It may be implied from Cuhls’ presentation, that Delphi studies are more 
appropriate to conduct when researching highly innovative fields because the experts in such 
fields are open minded and less prone to bias. Delbecq, Van de Ven, and Gustafson (1975) 
insisted that high motivation of the participants increased the validity.  Duffield agreed that the 
selection of the panel participants by nomination rather than by random sampling increased 
response rate and the validity because it prevented the classification of the participants as experts 
due to overinflated self-estimation (Duffield, 1993). Penelope Mullen, an experienced Delphi 
researcher and senior lecturer at Health Services Management Centre of the University of 
Birmingham, UK, discussed the critique of Delphi, specifically with regards to psychometric 
validity and non-random sampling (Mullen, 2003).  She concluded that Delphi was best 
defended by Olaf Helmer, who claimed that Delphi was not an opinion poll and, as such, did not 
require random sampling. Helmer, the designer of the pioneering Santa Monica study and over a 
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dozen of other Rand projects, described Sackman’s paper (1975) as a “singularly vituperative 
attack” (Helmer, 1977).  
The inter-rater reliability of the Delphi surveys resulting in quantitative data may be 
assessed mathematically using Cronbach’s alpha coefficient of equivalence (Cronbach, 1951; 
Tevacol & Dennick, 2011). This coefficient is a measure of internal consistency defined as the 
relationship between all the results obtained from a single survey (round). To compute the 
coefficient, all responses to a single question are randomly split in two sets (split-half test). Then 
the scores achieved for both sets are correlated. This process is performed for all questions in the 
survey to achieve an estimate of the average of all split-half estimates (Roberts & Priest, 2006). 
An example of a Delphi study where reliability was checked using Cronbach’s alpha concerned 
clarifying diagnostic criteria for carpal tunnel syndrome (Graham, Regehr, & Wright, 2003). In 
another study of curriculum assessment conducted by nursing students upon completion of 
evaluated learning modules, high coefficients were reported indicating a good consistency 
among rated curriculum items (Hartley, 1995). A lecturer from the Jagiellonian University in 
Poland reported specific values of 0.944 and 0.85 in two rounds of Delphi study on the 
development of hypertension guidelines for family physicians. This indicated that the reliability 
decreased over time in that particular study (Tomasik, 2010). The author stated that 6 months 
elapsed between the two rounds of survey, distributed by mail (Tomasik, electronic 
communication 1/10/14). 
General Guidelines 
 
Many authors have summarized the Delphi preparation process, its steps and challenges, 
and provided guidance for researchers willing to use the method.  Whitman (1990), Beretta 
(1996), Hasson et al., (2000), and Mullen (2003) focused on guidance for nursing researchers. 
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Similar aspects of Delphi must be considered in the study presented in this proposal. The 
following subsections will summarize the guidelines published by the above authors as well as 
the authors representing other professions and will conclude with description of various types 
and modifications of the method. 
Recruitment of subjects (experts) 
 
A fundamental feature presented as both its strength and disadvantage of the Delphi 
process is the non-probability, purposive or criterion sampling process, where the participants of 
the study are selected by the investigators based on their expertise in the topic. These “informed 
individuals” (panelists, experts) could identify themselves by self-reporting of their expertise in 
the initiating question of the survey. Alternatively, they could be selected based on objective 
evidence of expertise (such as a record of scholarly publications), or by nomination by 
“gatekeepers” who help the investigator in the recruitment process because they know 
individuals knowledgeable in the subject (Hasson, 2000).  
The “objective evidence of expertise”, specifically the mentioned record of scholarly 
publications (“research performance”, “citation rate”), is well respected in the area of basic 
science research. However, publishing productivity may be still lacking in the medical laboratory 
science profession. Dr. Gudrun Edgren, the author of the Delphi study on competency based 
curricula for Swedish MLS (Edgren, 2006), has shared her opinion that “respected professionals 
usually didn´t have publications, because that is not common in Sweden” (Edgren, electronic 
communication 6/10/11).  Another medical technologist from a large diagnostic laboratory in 
Northwestern US, when approached to co-author an instrument validation study manuscript 
based on a national competition winning poster presentation, stated: 
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“To be honest, [the company] does not particularly support publication. Our focus 
is more on adding efficiency internally and across our system.  So while I think it 
is appropriate to share the data for use by other labs, the path that involves the least 
time investment (posters) works best for me. My current focus is now in 
implementation of two [other instruments] (Suter, 2011)”. 
Nomination by the gatekeepers has been also referred to as chain referral sampling 
(Heckathorn, 2002) or a “snowball” or “ripple” sampling technique (Lincoln & Guba, 1985). 
Initially, the snowball technique was defined as a method which started with random sample of 
individuals drawn from a finite population. These randomly selected individuals were to name 
other individuals from that population (Goodman, 1961). Other researchers have not strictly 
adhered to the requirement of random selection in the initial stage of the process. A graduate 
student from Texas A&M University utilized this technique in a study which aim was to identify 
components of a novel Master’s program in biotechnology combined with business (Kantz, 
2004). Another graduate student from Walden University used the technique to seek respondents 
for a survey on factors that affect use and acceptance of information and communication (ICT) 
among laboratory science students (Barnes, electronic communication, 6/18/2012). The 
“gatekeepers” in her study were not randomly selected. They were the MLS subscribing to the 
ASCLS educators listserv and NAACLS listserv. 
The controversy over the Delphi does not end with expertise assessment of the subjects. 
The opinions also vary significantly with regards to the recommended number of participants.  
As noted by Beretta (1996), a British author reviewed published studies in which the size of the 
panels ranged from 10 to 1685 and claimed no justification for the size had been provided (Reid, 
1988). Hasson and colleagues, outlining the guidelines for conducting Delphi, reported a 
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narrower range of 15 to over 60 experts (Hasson, Keeney, & McKenna, 2000). Smaller numbers 
of panelists would be more appropriate if the participants were to be personally approached 
(invited) to the study by the principal investigator, as recommended by one of the co-authors of 
the guidelines based on his previous experience (McKenna, 1994). With the widespread 
acceptance of electronic communication (e-mail) following McKenna’s report inviting expert 
numbers, oscillating in the upper range for participant number became more feasible.  
An argument against the high number of participants is that generation of large amount of 
data may cause difficulties in the analysis. Hasson and colleagues specifically referred to such 
difficulties in the traditional Delphi studies when the first, qualitative round of questionnaire is 
conducted to identify the problems, issues or competencies that would be discussed or rated in 
the following rounds. In modified Delphi studies, deprived of the initial round due to 
investigator’s own expertise or existing preliminary data, the difficulties resulting from 
participation of large numbers of experts could be diminished. Cuhls stated that in national 
foresight studies it is desired to obtain about 100 responses on a subject, but she also pointed out 
that the sought number of respondents should realistically reflect the number of experts existing 
in the country in the investigated field of study (Cuhls, 2003). She reported that an “almost 
perfect” correlation was found between the number of experts and their rating of German 
research performance. In her study, molecular biology was considered an area represented by the 
largest percentage of the total of 73 experts in the field of biotechnology.  
A researcher from the University of Virginia reported that some nurse investigators 
recommended using 10-50 participants in a Delphi study while others claimed that a sample of 
only 15 participants could be satisfactory with careful selection process (Whitman, 1990). In her 
review, she also mentioned an in-service education needs assessment Delphi study with 120 
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participants conducted over a three and a half week period (Chaney, 1987). Whitman stated that 
if the decisions made based on a Delphi study were to affect a large number of nurses (with over 
500 being considered a large number), a minimum of 10-15% of the affected population should 
be surveyed.  
Anonymity 
 
 The anonymity of Delphi participants among each other has been considered superior 
over traditional group interaction methods because it prevents the negative psychological 
influence of dominant personalities and intimidation due to the status of some experts known as 
“bandwagon effect” or “halo effect” (Linstone & Turoff, 1975; Francis, 1977; Landeta, 2006). 
Typically, the identities of the participants are known to the investigator since the investigator 
selects the panelists based on their expertise or due to nomination. This is referred to as the 
“essential anonymity” (Mullen, 2003).  In some Delphi studies, the participants may know each 
other, but their answers and comments remain anonymous throughout the study (Landeta, 2006). 
Landeta (2006) reported that some researchers thought this incomplete anonymity (quasi-
anonymity) due to the investigator’s active role in subject recruitment contributed to “impurity” 
of answers (Becker & Bakal, 1970). On the other hand, knowing the PI may motivate the 
surveyed individuals and prevent them from providing thoughtless or irresponsible answers or 
even from neglecting the survey. Sackman claimed that anonymity of the participants in the 
conventional Delphi prevented accountability for their responses (Sackman, 1975). 
The anonymity was abandoned completely in a small scale modified Delphi process 
conducted at Georgia Regents University (at the time the Medical College of Georgia) to identify 
indicators of student professional behavior subsequently used in the student professional 
behavior evaluation tool (Russell et al., 2011). The tool had been used successfully by university 
      
43 
 
professors and clinical preceptors for five years prior to publication, and the validity of behavior 
indicators selected in the process was not questioned by the users. This fact attests to the limited 
value of complete anonymity and serves as proof that non-anonymous Delphi processes may be 
successful. Mullen (2003) reported that Delphi studies had been described previously with face-
to-face meetings in the beginning or at the end of the study and concluded that Delphi required 
the anonymity to be preserved only for part of the study, not throughout the entire process.  
Attrition 
 
 As reported for studies conducted in the era of pre-electronic communication, a positive 
correlation existed between the size of the panel and attrition rate (Reid, 1988). High attrition (or 
dropout) rate has been attributed to the iterative process of Delphi which includes gathering 
information in several rounds of a modified survey sent to the same panel of experts. This causes 
a phenomenon of panel exhaustion or fatigue which results in dropouts between the rounds. 
Sackman, in his critique, noted that other authors had not provided empirical data supporting the 
reported 50% or lower response rate to the initial questionnaire of the study.  He further 
categorized the reasons for the participants to stay in the study as either positive, such as high 
interest in the subject and motivation, or negative, such as personal acquaintance with the 
investigator (Sackman, 1974). From this critique it could be implied that efforts should be made 
to nurture the positive reasons, while diminishing the influence of the negative ones. According 
to some researchers, in order to maintain the acceptable rigor of the study, the investigator 
should be aiming at response rate of at least 70%; however, much lower and much higher rates, 
ranging from 8 to 100%, have been documented (Walker & Selfe, 1996). The main purpose of 
the reported personal (including face-to-face) contacts between the investigator and participants 
of Delphi studies is to prevent high attrition by ensuring that the participants are compelled to 
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contribute to the success of the project and understand the significance of their dedication 
throughout all rounds of the study until the iterative process is completed.  
In Chaney’s study of over 120 nurses surveyed by the staff development educator on the 
in-service education, the investigator personally hand-delivered the questionnaires, allowed three 
days to fill them out, avoided weekends to prevent misplacing of the questionnaires and made 
reminder phone calls to expedite the pick-up (Chaney, 1987). Despite the time consumed in these 
efforts, this personal approach for the purpose of decreasing attrition was recommended by 
McKenna (1994). However as noted in the guidelines which he co-authored later, time 
consuming undertakings, such as personal contact, apply to many qualitative studies and are not 
limited to Delphi (Hasson, Keeney, & McKenna, 2000). Due to current acceptance of electronic 
communication as a norm, the necessity of face-to-face meetings to explain the process and 
personal delivery of questionnaires is not as evident.  
Number of rounds: reaching consensus or diminishing returns 
 In the cornerstone paper by Linstone and Turoff, the authors stated that Delphi was a 
structured group communication technique characterized by a repetitive (iterative) process which 
required that the experts were consulted at least twice on the same question so that they could 
reconsider the answer based on the information provided by other experts dealing with the same 
complex problem (Linstone & Turoff, 1975). In other words, the multistage iteration was 
designed to make sure the participants have a chance to either confirm their original standing on 
an investigated subject or stand corrected upon consideration of other participants’ views with 
the ultimate goal of reaching a consensus. However according to Landeta, in order to assure 
continuous participation and hence decrease panel fatigue and subsequent attrition, it may be 
necessary to sacrifice the number of survey questions and rounds of surveys (Landeta, 2006). 
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Towards the end of the 1980s, it has been postulated that three or four rounds allowed the 
participants to react to the ideas of others, yet minimized the fatigue and urge to conform, which 
certainly was a factor in studies with number of rounds as high as 25 (Whitman, 1990). A 
tendency towards decreasing number of rounds and attempts of conducting a roundless (real-
time) Delphi can be found in literature (Gordon, 2009; Turoff & Hiltz, 2010).  
 Hasson and colleagues, in their guidelines for Delphi survey technique, listed several 
items, which determined the number of rounds that would have to be conducted in order to reach 
a consensus, namely  the desired level of agreement, the type and breadth of questions, amount 
of time available and consideration of the predicted level of sample fatigue. They noted that 
various authors had suggested that there was no established desired level of agreement between 
the respondents; the recommended numbers ranged from 50 to 80% (Hasson, Keeney, & 
McKenna, 2000). Instead of a set value, stability of the results between subsequent rounds, a law 
of diminishing returns or a prior decision regarding the number of rounds may dictate the end of 
iteration, with understanding that searching a consensus is no longer possible or obligatory 
(Landeta, 2006). Cuhls noted that high level experts tend not to change opinion so it may be 
implied that if level of disagreement is high in the beginning of the study in which the majority 
of experts are high level experts, reaching a consensus would be very difficult (Cuhls, 2003). A 
Swiss researcher from the Institute of Management in Technology at the University of Freiburg 
published an article on an exploratory online Delphi with “dissensus” approach aiming to 
maximize range of expert opinions entered into the system by the participants and to expose all 
differing positions and arguments that supported these positions (Steinert, 2009). 
 As for the type and breadth of intended questions, these significantly influence the 
investigator’s decision on the necessity of the initial Delphi round, which in the original, 
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classical design had an exploratory, qualitative, open-ended character. This exploratory round  
permitted collection of multitude of data which were subsequently grouped into a “seed list” of 
categories of issues, problems, competencies, skills or events which the participants would 
evaluate (rank) in the following rounds (Linstone & Turoff, 1975). Mullen (2003) summarized 
examples of items explored in typical initial rounds by various nursing researchers. She reported 
that panelists have been asked to predict the future of nursing education or to identify issues in 
clinical research (Mullen, 2003). A researcher from the University of Denver inquired which 
courses and competencies were considered important for inclusion in a master’s program in 
Service Science, Management and Engineering (Choudaha, 2008).  A Clinical Laboratory 
Scientist from West Virginia University asked a panel of 24 experts to predict events that would 
occur in the profession within the next 20 years (Kirby, 2008). 
As an alternative to conducting a classic first exploratory round, an investigator with 
sufficient level of expertise in the subject or with access to existing preliminary data gathered 
from literature or in focus groups, may themselves prepare the seed list of items that require 
evaluation by the Delphi panel, thus decreasing the number of rounds and shortening the 
duration of the study (Mullen, 2003). As an example, Mullen cited a study performed in 
Australia by a researcher from Northern Territory University who himself compiled a list of 
factors contributing to the length of hospital stay based on available literature (Xiao, Lee, & 
Vemuri, 1997). Mullen herself authored a project in which a seed list of 52 impact factors was 
generated during two invited workshops and several meetings (Mullen, 2009). A curriculum 
development Delphi study was conducted without the typical first round by Canadian educators 
who themselves developed the content of pediatric trauma curriculum and distributed across 
Canada for feedback from 11 trauma centers (Valani, Yanchar, Grant, & Hancock, 2010). 
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Another example of a Delphi deprived of the exploratory round was a study performed to 
investigate the application of statistics to measure the consensus achieved in evaluation of 
previously published statements (Holey, Feeley, Dixon, & Whittaker, 2007). Successful 
decisions made based on studies completed without the classical initial round justified the 
development of the seed list of competencies by the author of the project presented in this 
manuscript due to prior experience in performing and teaching molecular methods.   
The discussion on the number of recommended Delphi rounds is not exhausted without 
referring to a roundless Delphi, also called real-time Delphi, concurrently developed by two 
independent groups of researchers once affiliated with Rand Corporation (Gordon & Pease, RT 
Delphi: An Efficient, "Roundless" Almost Real Time Delphi Method, 2006), and with the 
Information Systems Department at New Jersey Institute of Technology (NJIT) (Turoff, Hiltz, 
Cho, Li, & Wang, 2002). The term “real-time Delphi” was defined originally by Linstone and 
Turoff to describe computer-aided “Delphi Conference” in which the computer compiled the 
results (Linstone & Turoff, 1975). However, the meaning of “real-time” has evolved 
significantly and currently refers to feeding back the compiled results immediately to the 
participants who do not have to wait for the next round to modify their responses.  The 
implementation of real-time feedback is based on a concept of continuous,” dynamic voting” that 
allows for a reciprocal group process in which an anonymous participant’s comment or a change 
in ranking an item, visible to others, may influence their position as they are entering their own 
vote. This phenomenon of making one’s opinion while knowing how others have voted (or 
ranked the items) has roots in the Thurstone’s Law of Comparative Judgment (Thurstone, 1927).  
Researchers, encouraged by the immediate availability of real-time Delphi results, 
seemingly superior over the delays caused by the classical method’s iteration, have attempted to 
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assess correlation of the results achieved using the two processes (Zipfinger, 2007; Gnatzy, 
Warth, von der Gracht, & Darkow, 2011). These researchers from Johannes Kepler University in 
Linz and the Center for Futures Studies and Knowledge Management, European Business School 
(EBS), Germany, have concluded that the results of their studies were not affected by the type of 
the method. Zipfinger (2007), who in her doctoral dissertation compared the opinions on Delphi 
method using the two types of Delphi, stated that the feasibility of the round-based method might 
have been “more workable in practice at the time”. Improved access to an affordable tool with 
good information technology support may be the necessary incentive for more ubiquitous 
utilization of the real-time technique in the future. Successful implementation of real-time Delphi 
could prevent the two threats to the validity of the method: panel fatigue and attrition. 
Besides factors already discussed, time available to perform the study and predicted level 
of panel fatigue should be taken into consideration when making decisions concerning the 
number of survey rounds. The current tendency is to complete Delphi based projects within two 
or three rounds (Hasson, Keeney, & McKenna, 2000).  
Survey questions’ rating scale 
The feature distinguishing the Delphi from other methods used in typical qualitative 
studies is the required format of questions which must be designed in such a way that the 
answers can be summarized quantitatively and analyzed statistically (Linstone & Turoff, 1975) 
(Landeta, 2006). The Delphi guidelines, as published by Whitman (1990), Mullen (2003), and 
Cuhls (2003) describe several approaches to ranking the non-open ended questions, typically 
following the first classical Delphi round which reveals a list of items that subsequently require 
grading of likelihood of occurrence, importance, priority, urgency, desirability, feasibility, 
probability of success, etc.  
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The desirability, feasibility and importance, along with confidence, were the four scales 
originally identified by Turoff as these voting dimensions which represented the minimum 
information necessary to evaluate the investigated problem or event. The confidence scale 
consisted of four levels: certain, reliable, risky and unreliable. All levels of confidence, as well 
the levels of the other three scales were defined by brief statements (Turoff M. , The Policy 
Delphi, 1975).  
Grading of the likelihood of occurrence was and  is a typical process in seeking opinions 
in early and current business and industry forecasting Delphi studies (Gordon & Helmer, 1964), 
(Cuhls, Beyer-Kutzner, Ganz, & Warnke, 2009). One study which utilized this process addressed 
the events that would occur in the medical laboratory science profession within the next two 
decades (Kirby, 2008).  However, a researcher from the University of Michigan stated that 
making probability estimates for fixed periods of time (for example for a period between 1971 
and 1980) and fixed levels of probability (for example 25, 50 or 75 percent) appeared to be 
difficult for the respondents (Ludlow, 1975).  
According to Whitman (1990), the participants of the study on nursing staff ideas on in-
service education, ranked the educational topics and procedures on a 5-point Likert scale from 
extremely important (5), through very important (4), important (3), minimally important (2) to 
not important (1). The numerical values assigned to each level of importance are used to 
compute descriptive statistics, such as modes, medians, means and interquartile ranges. Whitman 
stated that the means were most often used to provide a measure of the final ranking of the items, 
while the interquartile ranges were helpful to identify the boundaries of middle responses. The 
participants who provided responses beyond these ranges would be approached to comment on 
their choice.  
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There are many examples of studies that follow similar guidelines, with the highest 
numerical value being attributed to the highest ranked item. However, the highest numerical 
value may also be assigned to the lowest ranked item. In a 1974 national drug abuse study, three 
such scales were used to assess a) feasibility/practicality, b) desirability/benefits, and c) 
importance of 55 drug abuse policy objectives for the next five years (Jillson, 1975).  
Specific definitions for each reference value on each scale were provided and closely 
resembled those outlined by Turoff (1975). For example, on the feasibility/practicality scale 
“definitely unfeasible”, assigned the value of 5, was defined as “cannot be implemented 
(unworkable), basic research needed (no relevant technology exist, basic scientific knowledge 
lacking), unprecedented allocation of resources would be needed, politically unacceptable, 
completely unacceptable to the general public”. The definitions used in the importance scale are 
shown in Table 7. It should be noted that many studies do not explicitly define all values with 
such detail, assuming the definitions as obvious.  
Table 7. 
 
Definitions of Values for Scale of Importance of Drug Abuse Policy Objectives. 
 
Scale Reference Definitions 
1. Very important A most relevant point, first order of priority, has direct bearing 
on major issues, must be resolved, dealt or treated 
2. Important Is relevant to the issue, second order of priority, significant 
impact but not until other items are treated, does not have to be 
fully resolved 
3. Moderately 
important 
May be relevant to the issue, third order of priority, may have 
impact, may be a determining factor to major issue 
4. Unimportant Insignificantly relevant, low priority, has little impact, not a 
determining factor to major issue 
5. Most unimportant No priority, no relevance, no measurable effect, should be 
dropped as an item to consider 
 
Note.  Adapted from “The National Drug Abuse Policy Delphi: Progress Report and Findings to 
Date” (Jillson, 1975), in (Linstone & Turoff, 2002) with permission, available at 
http://is.njit.edu/pubs/delphibook/delphibook.pdf  
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Three to six-point scales starting at one (1) or zero (0) have been used most frequently. British 
researchers from the University of Manchester, in cooperation with RAND, have used a nine-
point scale in their study on indicators of quality of primary care in the United Kingdom 
(Campbell, Hann, Roland, Quayle, & Shekelle, 1999). In some studies, “yes” or “no” choices are 
being provided or a scale without numerical values assigned is used. 
A graphic rating scale may replace the numerical scale to allow the rater evaluate an item when 
they cannot decide between two adjacent values. The values/ratings (also called scale 
alternatives) are connected by horizontal lines so the rater may place a check anywhere on the 
line, including intermediate points (Gronlund, 1971). Visual analog scale was used in a study 
designed to achieve a consensus on the best criteria for the clinical diagnosis of carpal tunnel 
syndrome (Graham, Regehr, & Wright, 2003). See Appendix C for further examples of rating 
scales used in published studies.  
Likert scale based ranking allows for generation of priority lists; however, it does not 
allow for assessment of interval distance between each item on the list (Walker & Selfe, 1996). 
In a study on desired allocation of funds to seven major health services, researchers from 
Medical School of London addressed this by the application of a “budget pie” system which 
required distribution of a given set of points between items on the list (Charlton, Patrick, 
Matthews, & West, 1981).  Walker and Selfe (1996) stated that this system may be very 
frustrating to the respondents due to the necessity to use arithmetic. However; Mullen (1983) 
concluded that the budget pie system was simple enough for the respondents to use without 
extensive explanation as only one participant did not understand it but acknowledged he had not 
read the instructions. She also concluded that the rank positions of the problems identified by the 
study participants were different when using multi-vote verses budget pie systems. Some 
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problems voted on by a small number of participants received high number of combined points 
in the pie system due to intensity of the personal preference of these problems over others. These 
results indicated that the scoring method chosen for a study had to be carefully considered 
(Mullen, 1983).  
Mullen also conducted a Delphi study seeking a relationship between characteristics that 
impact successful business performance, as well as successful health and policy outcomes 
(Mullen, 2009). She stated that variations in assessment of potential impact of the selected 
characteristics could reflect differences in knowledge of panel members. In order to properly 
weigh the responses, the researcher, in the first Delphi round, asked the participants to assess the 
degree of confidence (ranging from very, through fairly, to not very confident) in their own 
responses. Mullen did not provide any recommendations with regards to inclusion or exclusion 
of subjects with low degree of confidence. 
Cuhls (2003) used two approaches called “agreement ranking” and “qualitative 
clustering”  In a multiquestionnaire study, global megatrends, such as the increase of 
unemployment rate, rationing of energy or population growth, were ranked based on the number 
of participants who agreed or disagreed that the trend would occur (Cuhls, Blind, & Grupp, 
1998). The “qualitative clustering” referred to ranking topics which could be described under a 
joint headline (e.g. “product recycling and sustainable agriculture”). She illustrated the clusters 
of two or more topics on a timeline based on the anticipated decade to which the respondents 
assigned the forecasted events representative of the topics (Cuhls, 2003).   
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Analysis of answers and feedback on numeric values  
As previously mentioned, the ability to analyze Delphi outcomes statistically, 
distinguishes this method from other qualitative methods (Linstone & Turoff, 1975; Landeta, 
2006). There are several statistical approaches that deserve consideration.  
Researchers from the University of Cambridge described three types of graphical 
presentations of means and standard deviations illustrating the stability of group opinion over the 
course of several rounds as well as the extent of agreement (or consensus) between the panelists 
rating the investigated items using a selected interval scale. The graphs were defined as “item”, 
“fountain” and “trajectory” graphs (Greatorex & Dexter, 2000). The “item” graphs plotted the 
means and standard deviations (recorded on the Y axis) for each rated item across the 
appearances of the item in the questionnaire. The “fountain” graphs were formed by plotting 
standard deviation against the mean of all items rated in individual round. On the “trajectory” 
graphs several item’s rating means were plotted against their corresponding standard deviations 
calculated for all rounds. The authors monitored consensus and opinion stability during the 
Delphi process by checking how mean rating and standard deviations of the items changed over 
the rounds. They stated that, over time, the decreasing standard deviations and means getting 
closer to the integer values indicated stabilization of the entire Delphi process. In conclusion, 
Greatorex and Dexter (2000) pointed out that the results of any Delphi process must not be 
interpreted in the context of the outcomes of the final round only and that what happens between 
the rounds contributes to the reliability and thus must be taken into consideration when making 
decisions based on the results. 
 Researchers from the University of Teesside and Kings Mill Hospital assessed the 
percentage of agreement and compared the rankings of items between the rounds by computing 
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weighted Kappa () statistics for the within-subject level of agreement using Excel Hospital 
(Holey, Feeley, Dixon, & Whittaker, 2007). The agreement was assessed as poor when the 
Kappa statistics ranged from zero to 0.2, while it was considered an almost perfect agreement 
when ranging from 0.81 to 1. An increasing trend in Kappa values was considered a 
demonstration of reaching stability.  
According to Rosner (2006), the Kappa statistics, quantifies the degree of association 
between variables (in this case the ranks as assigned by the same panelist in different rounds) and 
is used to check the reproducibility of the variable when measured or surveyed more than once 
(Rosner, 2006). The statistics is computed according to the formula: 
po – pe)/1-pe 
where po denotes observed probability of concordance (agreement) between two surveys (rounds 
of Delphi) and pe denotes the expected probability of concordance between the two surveys. 
Rosner’s guidelines stated that excellent reproducibility was demonstrated by  values exceeding 
0.75 and marginal reproducibility was demonstrated by  values below 0.4. To provide 
justification for using the within-subject Kappa values, Holey et.al. (2007) cited the researchers 
from Old Dominion University who claimed that individual panelist’s stability of opinion across 
the rounds provided more information than the group’s stability (Chaffin & Talley, 1980).  
 Besides Kappa coefficient, other means of stability measures used by Delphi researchers 
are Kendall’s W coefficient of concordance and several interclass correlation coefficients, ICCs , 
(Kendall & Smith, 1939; Okoli & Pawlowski, 2004).  Some researchers have cautioned that 
different ICC may produce significantly different results when used with the same data (von der 
Gracht, Darkow, Walter, Jahns, & Thomsen, 2008). Kendall W statistics was recommended as a 
nonparametric coefficient appropriate for ranking type Delphi studies (Schmidt, 1997). The 
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interpretation of Kendall W approaching the value of 1 is that all raters ranking the investigated 
items are using the same criteria in assessing the rank (Brencheau & Wetherbe, 1987). Schmidt 
assessed confidence in survey ranking from none when (K = 0.1), through fair (K=0.5) to very 
high confidence (K=0.9). This coefficient was used as a measure of stability in a survey Board of 
Directors and members of Research Advisory Committee of the Clinical Laboratory 
Management Association to develop indicators of laboratory performance (Zinn & Zalokowski, 
1999). The study allowed a much lower Kendall W values than the ones recommended by 
Schmidt (1997). 
 Delphi process outcome analysis has not been limited to tracking patterns in opinion 
stability and consensus. Factor analysis was applied to distinguish five different expert types 
(Blind, Cuhls, & Grupp, 2001). Factor analysis is used when investigated items form 
independent subsets of variables which correlate among each other (Tabachnik & Fidell, 2007). 
The primary goal is the reduction of number of variables to smaller number of interpretable 
factors (parsimony). The subset of correlating variables (for example politeness, eloquence and 
having multiple siblings) may be given a common description as a factor, such as “predisposition 
to work with others”.  
The process of “extraction” of the factors from among the multitude of investigated 
variables is based on eigenvalues, which are defined as values representing percent variance 
explained by the factor relative to the number of variables. A set of variables may be considered 
a factor if the eigenvalue is greater than 1. The types of experts, as identified by Blind et.al 
(2001), were determined based on their attitudes towards multiple research and development 
trends. Factor analysis was also used by therapists from Texas Tech University and Duke 
University Medical Center who were able to identify several sets of skills important to achieve 
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competency in orthopedic manual therapy, OMT (Sizer, et al., 2007). References to factor 
analysis in Delphi process evaluation were made by others as well (Hasson, Keeney, & 
McKenna, 2000; Sackman, 1974; Derian & Morize, 1973). 
Meaningful analysis of numeric values must follow correct protocols depending on type 
of data collected. These protocols are different for Likert scale data, and for Likert-type data 
(Boone & Boone, 2012). Likert scale was originally developed to measure character and 
personality traits (Likert, 1932). The analysis of Likert data is based on a composite score (a sum 
or a mean) from a series of survey answers that, when combined, represent a particular trait. 
Likert-type data are collected when a composite score has no merit as each question is asking 
about a different aspect. Surveys used in Delphi studies are not psychometric tests and so the 
values collected in Delphi ranking process fall into Likert-type data category. The Boones’ 
(2012) suggested that the Likert-type data are in the ordinal measurement scale and that the 
analysis should include computation of median or mode rather than the mean (more appropriate 
for interval scale) and that frequencies of answers are used as a measure of variability rather than 
standard deviation. Perkins et al. used analysis of median ratings to identify competencies for 
acute care curriculum. The competencies with median ratings equal to two top scores on the 
scale (4 and 5) were considered essential, the competencies with median rating of 3 were 
considered optional, while ratings of 2 and 1 eliminated the competencies from considerations 
(Perkins, et al., 2005). Fried & Leao analyzed frequencies of importance ratings obtained in a 
four stage Delphi to successfully select items for inclusion in periodontics curriculum. They 
considered an item for inclusion if at least 50 percent plus one respondents rated the item 
“important” or “indispensable”, which were the two top values on the scale (Fried & Leao, 
2007). 
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Comments on answers 
 
 One of the main characteristics of the original Delphi, according to the method authorities 
and their followers, was a controlled feedback (Linstone & Turoff, 1975; Landeta, 2006). This 
meant that the exchange of information between the experts was not direct but occurred by 
means of study coordinator (principal investigator) which allowed for elimination of information 
considered irrelevant. This feature of Delphi would be challenged in the real-time surveys 
(Gordon & Pease, 2006). In real time applications the narrative comments provided by the 
participants are readily visible to all who access the survey online which diminishes the ability of 
the investigator to have control over the released information. Theoretically the investigator 
could delete or hide comments he/she deems irrelevant or inappropriate. Practically this would 
mean, however, that the investigator must be on continuous watch for incoming survey answers 
and comments. Gordon and Pease (2006) stated that, typically, the feedback sent by the 
researcher to the participants before starting the next round included, besides the numerical 
values, comments submitted by individuals who represented extreme positions. These comments 
were provided as justification for ratings that significantly differed from the averages or medians. 
However, a graduate student who designed a Delphi survey on Delphi implementation (round 
based vs. roundless) and administered it to Delphi method experts, concluded that helpful and 
desired narrative comments provided by the participants were not only these made by extreme 
raters but also comments made by those who provided answers representing the average 
(Zipfinger, 2007). 
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Types and Modifications of the Method 
 There are several types of Delphi methods and different ways to classify them. The 
classification may be based on 1) the generally understood purpose of the study, 2) iteration (or 
its lack) and 3) delivery mode (paper-based verses electronic).  
Early classification based on the purpose distinguished between classical, policy and 
decision Delphi (Rauch, 1979; Turoff, 1975; Zipfinger, 2007).  Classical Delphi was a tool for 
obtaining a group opinion about forecast statements and was referred to as “conditional scientific 
prognosis” relevant to natural sciences and engineering advances. Policy Delphi was considered 
a tool of analysis of social and political events determined by the existing laws and cultural 
context. Finally, the decision Delphi was a tool used to implement regulations. According to this 
classification, the classical and policy Delphi processes seek an opinion of experts, while the 
decision Delphi uses individuals who are in position to make decisions, regardless of their 
expertise. Although this theoretical classification is frequently referred to, in reality every 
practical application of Delphi is a modified blend of the three types (Rauch, 1979). The types of 
the method distinguished depending on survey delivery (iterative verses roundless) were 
discussed in the section on number of rounds.  
A rather straightforward but nevertheless worth mentioning is the classification into 
paper-based and electronic methods (Zipfinger, 2007). The electronic method may be divided 
into computer-aided (understood as off-line) and online. A British study reported that, when 
offered a choice, 37% questionnaires were completed electronically and returned by e-mail; 63% 
were returned by traditional mail delivery (Mullen, 2009). Several software options have been 
described, including easily available Excel, online survey software such as Zoomerang (currently 
merged with Survey Monkey) or proprietary programs owned by the institutions which 
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developed them (Choudaha, 2008; Gordon & Pease, 2006; Turoff & Hiltz, 2010; Zipfinger, 
2007). 
Chapter Summary 
In this chapter, a study by Miller and Abbate (2002) was reviewed to provide context for 
development of this current project. Their study assessed the extent in which concepts relevant to 
molecular diagnostics were being taught in the NAACLS accredited MLS programs in the 
United States and described some reasons for dissatisfaction of the educators with teaching this 
subject area. The Delphi method was introduced as a technique used to gather information from 
and achieve consensus among experts to develop competency-based curricula in healthcare 
education, specifically in medicine, dentistry and several allied health professions, to include 
medical laboratory science. Several studies reviewed in this chapter are a testament of 
application of the Delphi process to identify broadly defined curricular goals and affective 
components or specific skills which may be used to develop cognitive and psychomotor 
objectives necessary in an effective curriculum. The articles presented in this literature review 
outlined the specifics of Delphi survey data collection and analysis as the methodology for the 
study on expectations of clinical laboratory professionals performing or supervising the 
performance of molecular based assays towards entry-level MLS with regards to their relevant 
skills. 
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Chapter Three: Methodology 
 
This chapter restates the research questions and outlines the specific plan for conducting 
the approved study on clinical molecular facilities’ expectations from clinical/medical laboratory 
scientists entering the profession starting with the selection of experts through questionnaire 
design and revision to analysis of outcomes. Some studies presented in the Chapter 2 are recalled 
to illustrate the technical details of Delphi process. 
Objectives and Research Questions Addressed by the Study 
 
 The project was undertaken to achieve the following objectives: 
A. Assess expectations of clinical laboratories that offer molecular diagnostic services 
for entry-level MLS with regards to their relevant molecular skills.  
B. Share the outcomes and developed learning objectives with the stakeholders involved: 
laboratory professionals, educators, certifying and accrediting organizations. 
 To achieve the above objectives, survey data were collected using a modified, 
asynchronous, iterative, online Delphi process. The analysis of the data provided answers to the 
following research questions: 
1. Which molecular cognitive skills are expected of an entry level MLS upon hire in 
facilities that offer molecular diagnostics services? 
2. Which molecular psychomotor skills are expected of an entry level MLS upon hire in 
facilities that offer molecular diagnostics services? 
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3. Which of the cognitive and psychomotor skills are considered the most important to 
include in the MLS curriculum? 
4. In which areas (e.g., hematology, microbiology, chemistry, blood banking, 
immunology, body fluids) of the clinical laboratory are entry level skills in molecular 
diagnostics utilized? 
 Prior the start of the study, the PI provided Virginia Commonwealth University 
Institutional Review Board (IRB) with proper documentation, including proof of completion of 
required training. Due to low probability of risk of harm or discomfort resulting from survey 
participation and due to essential anonymity of the subjects, VCU IRB classified the study as 
exempt from review based on guidelines for exemption provided by the Written Policies and 
Procedures Section VIII, Title 1 (WPP, 2013). On August 7, 2014, VCU IRB notified the 
Principal Investigator that study HM20002003 was approved on July 29, 2014. 
Selection of Experts and Anticipated Survey Response Rate.  
The intended participants of the study were medical laboratory professionals actively 
involved in or supervising the performance of diagnostic assays based on molecular technology. 
These professionals due to their scope of practice are considered informed individuals or 
“experts” for providing relevant information which would enable the selection of molecular 
diagnostics objectives corresponding to skills expected from entry-level MLS and ultimately the 
development of competency-based curriculum. The selection of participants was conducted 
using chain referral (snowball) sampling (Heckathorn, 2002; Lincoln & Guba, 1985). Participant 
selection was facilitated by directors of the NAACLS accredited MLS programs (221 programs 
at the time the study was initiated) in the US who were contacted using e-mail addresses 
published on the NAACLS website (NAACLS, Accredited and Approved Programs, 2014). It 
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was assumed that the educators in each program, due to their close collaboration with 
laboratories providing internship experience for their students, were able to identify at least one 
clinical facility where molecular-based assays were performed and as such were credible 
candidates for the “gatekeeper” role.  
The response rate for an informal survey of NAACLS accredited programs conducted by 
the author of this manuscript in 2005 was 18% (Kraj, 2006). To determine the response rate 
achieved in formal surveys conducted by other researchers a PubMed search using “NAACLS 
survey” keywords revealed seven studies published in the journal Clinical Laboratory Science 
between 2000 and 2011. According to the authors, at least some of the surveys in each of these 
studies were distributed to NAACLS accredited programs. One study did not report response rate 
due to inability to assess the total number of electronic survey recipients. Response rates reported 
for the remaining six surveys are presented in Table 8.   
Table 8.  
 
Survey Response Rates Published in Clinical Laboratory Science (2000-2011). 
 
Survey study  Response rate (%) 
(Laudicina, et al., 2011) 7.3 
(Mundt & Shanahan, 2009) 10 
(Stevens, 2000) 26.6 
(Bamberg, 2004) 47 
(Delost & Nadder, 2011) 47.3 
(Beck & Doig, 2002) 58 
Median 36.8 
 
To achieve the response rate representative of the median published response rate, at least 81 
Program Directors or their designees would have to forward the survey to at least one 
professional at their affiliated clinical site where molecular based testing was performed. This 
was a very conservative expectation. It was speculated that for this study, the response rate 
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among the program directors would actually be higher than the median because they were only 
to serve as gatekeepers forwarding the survey and, thus, not investing much time and effort in the 
process, yet indirectly benefitting from the outcomes of the study. An assumption was made that 
the response of the gatekeepers would be reflecting the published response rate’s upper limit of 
58% which corresponded to 128 forwarded surveys. It was difficult to predict how many of the 
128 forwarded surveys would be actually completed by the target experts. Beck and Doig (2002) 
in their article on entry-level competencies had not only sent their survey to educators but also to 
managers and laboratory practitioners and reported that the corresponding response rates in each 
of these last two groups were 39% and 28%, respectively. Based on these results, the expected 
minimum number of completed surveys was 36 (as it corresponded to 28% of 128). This 
expected minimum sample size was confirmed by VCU Statistics and Analytics Consulting Lab 
on February 12, 2014. If the number of surveys completed in the first Delphi round was below 
36, the PI would consider using the professional online listserv maintained by the NAACLS 
(CLSEDUC) as well as the listserv maintained by the American Society for Clinical Laboratory 
Science to solicit further snowballing.  
Questionnaire Design and Iteration  
      The first Delphi survey (Appendix D) was created and distributed on August 8, 2014, to five 
previously recruited testers using a secure, web-based REDCap (Research Electronic Data 
Capture) survey and data storage software developed at Vanderbilt University (Harris, Harris, 
Taylor, Robert, Payne, Gonzales & Conde, 2009). The software is offered by Virginia 
Commonwealth University Technology Services free of charge to VCU faculty and graduate 
students (CTSA Award Number UL1TR000058). The testers were five professionals from 
clinical laboratories affiliated with the author’s institution: technical and education program 
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director (Quest Diagnostics, Tucker, GA), former laboratory manager (Georgia Esoteric and 
Molecular Labs, Augusta, GA), molecular medical technologist (Mid America Clinical 
Laboratories, Indianapolis, IN), director of Clinical Molecular Genetics (Oregon Health Science 
University, Portland, OR), and education coordinator (PeaceHealth Laboratories, Springfield, 
OR).  The author of the study also sent the survey link to herself and her advisor to check for any 
technical errors and contacted VCU Statistics and Analytics Consulting Lab to confirm (per 
REDCap instructions) appropriate length of all variables’ names to allow proper data export.  
In the first of three sections of the Delphi survey (Participant Demographics) the 
respondents were to provide information on completed education, professional credentials, years 
of experience in clinical laboratory overall and in performing molecular based assays in clinical, 
as well as other settings, the state they worked in at the time of the study, the type of facility they 
were employed at, number and type of molecular tests run at their facility, and their experience 
as a MLS students’ preceptor. In the second section (Basic Concepts in Molecular Biology) the 
respondents were asked to rate the importance of teaching five basic concepts in molecular 
biology, as a basis for understanding the scientific background of molecular diagnostic 
procedures. These five concepts included breakthrough genetic discoveries, modes of gene 
inheritance, chemical and physical features of nucleic acids, and molecular processes of the cell 
cycle. The third section (Specific Cognitive and Psychomotor Learning Objectives in Molecular 
Diagnostics) contained a seed list of learning objectives developed by the author and taught in 
university based NAACLS accredited, entry-level medical laboratory science program in 
Georgia since fall 2005 (Kraj, 2013 unpublished). The list contained 41 cognitive and 
psychomotor objectives. These objectives were grouped in seven categories: molecular lab 
operations, pipetting skills, nucleic acid isolation, DNA polymorphism, gel electrophoresis, 
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polymerase chain reaction and its modifications, and specific molecular applications in clinical 
diagnosis. The basic concepts in the second section of the survey and learning objectives in the 
third section of the survey were to be rated on a modified 5 point Likert-type scale of importance 
(with 0 being not important, 1 being of little importance, 2 being of moderate importance, 3 
being very important and 4 being the most important) used in numerous studies (Fried & Leao, 
2007; Perkins, et al., 2005; Elder & Nick, 1997). Presenting a seed list of competencies for rating 
instead of an open ended request to suggest the skills has been successfully utilized in modified 
Delphi studies (Staggers, Gassert, & Curran, 2002; Xiao, Lee, & Vemuri, 1997; Mullen, 2009; 
Valani, Yanchar, Grant, & Hancock, 2010). Following the three sections, one open-ended 
question asked the participants if they would expand the existing objectives developed by the 
author or if they would include any additional objectives for entry-level MLS curriculum. The 
purpose to include the open-ended question was to allow for narrative comments which, upon 
completion of each survey round, by Delphi design, would be shared with the participants along 
with a summary of quantitative results before proceeding to the next round.  
Following examples of other studies (Mullen, 2009; Edgren, 2006; Zinn & Zalokowski, 
1999; Jairath & Weinstein, 1994) and based on provided feedback, several amendments were 
made upon survey testing: 
1. The participants were told the survey would take less than 15 minutes and were provided 
with a specific date by which the survey should be submitted before they started answering 
the questions. 
2. The question regarding participant’s education distinguished between baccalaureate in 
medical technology (CLS/MLS) and baccalaureate in another field, and asked to specify the 
field of study of the highest degree achieved. 
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3. The question regarding professional credentials spelled out specialist credentials vs. 
categorical credentials. 
4. The question regarding molecular laboratory workflow specified “unidirectional (clean to 
dirty) workflow”. 
5. The question regarding reporting the results specified FDA regulation of laboratory 
developed tests. 
 The email to MLS Program Directors with a public link to the edited survey (Appendix 
E) was distributed on September 4, 2014 with an initial due date of September 19, 2014. 
Additionally, the author, being a program director herself, also distributed the survey to 38 
individuals at her MLS program’s clinical affiliates. She also asked 11 members of ASCLS 
Molecular Diagnostics Scientific Assembly and educators participating in the CLSEDUC listserv 
if they would like to be sent the link if they had not been already reached by other gatekeepers. A 
request for the link was made by six individuals. Finally, the executive director of the 
Association for Genetic Technologists who expressed interest in the study in the past, distributed 
the link to their membership. On September 15, 2014 a reminder was sent to CLS/MLS program 
directors in the states from where no surveys were submitted. On September 19, 2014 a final 
reminder was sent to all gatekeepers thanking them for their role and offering to extend the due 
date over the weekend. The gatekeepers were informed that all communication from then on 
would be directly with the respondents. Upon request, the link remained active for five additional 
days. 
Seeking expert opinions has been frequently achieved using Delphi (Aichholzer, 2009). 
The repetitive process characteristic of Delphi requires that the experts are consulted at least 
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twice on the same question so that they can reconsider the answer based on the information 
provided by other experts dealing with the same complex problem (Linstone & Turoff, 1975).  
The multistage iteration, typical of Delphi, allows the participants to have a chance to 
either confirm their original opinion on an investigated subject or stand corrected upon 
consideration of other participants’ views with the ultimate goal of reaching a consensus. In the 
study presented here, the target participants were told that there would be at least two, but no 
more than three Delphi surveys to complete to prevent the anticipated panel fatigue and attrition, 
two major threats to Delphi validity (Hasson, Keeney, & McKenna, 2000; Landeta, 2006). The 
first survey started with a request to provide the preferred email address so that the subsequent 
Delphi surveys could be emailed by the REDCap system using a personal instead of a public 
link. Providing email address by the respondent of the first round was considered an agreement 
to participate in subsequent rounds. Among 41 objectives rated in the first round, there were 13 
learning objectives, predetermined for expansion in subsequent Delphi rounds, if deemed at least 
moderately important by at least 70% of the first Delphi respondents (those who assigned the 
objectives a rating of 2, 3 or 4). The reason behind this was that if a particular objective, such as 
an objective to extract nucleic acids from blood samples, was not considered important, there 
was no point asking if the preferred method taught in class was a manual or automated method. 
This “staging” process was another way to prevent the anticipated panel fatigue while answering 
too many survey questions in the first round. The list of these objectives and their predicted 
follow-up Round II objectives is provided in Appendix F.    
The purpose of the first survey was to collect respondents’ demographic data and to 
identify learning objectives that could be excluded from further considerations due to low 
number of participants considering it at least moderately important (participants who assigned 
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the item a score of 2, 3 or 4). The items to be retained in the second round were the ones 
assigned scores 2, 3 and 4 by at least 70% of the respondents.   
VCU IRB specified that prior releasing any new survey in the approved study, the survey 
must be submitted as an amendment for an exempt review along with all anticipated 
communications with the respondents. The second Delphi survey was built upon the analysis of 
the results of the first survey, and it included a total of 100 learning objectives. Per Delphi 
design, counts and frequencies of each objective rating provided in round one were shown below 
each objective in round two so that the participant could review the outcomes of the first round 
before re-rating. As in the case of the first round, the last question of the survey was open-ended 
and asked if the participant would include in the curriculum any additional methodologies, 
pathogens and diseases other than already listed. Upon suggestion from Statistics and Analytics 
Consulting Lab, the second survey also contained eight questions asking to select the most 
appropriate amount of time the respondents thought should be devoted to each group of concepts 
and learning objectives (given that a semester lasts 16 weeks on average) to provide additional 
way to choose objectives to be included in the curriculum. The choices were 1-3 contact hours, 
4-6 contact hours and over 6 contact hours. A list of all participants’ narrative comments made in 
the first round to be emailed to all respondents a few days prior release of the second round was 
also created and submitted to the IRB along with the survey and corresponding email text 
(Appendix G). The amendment was approved on November 13, 2014. Narrative comments were 
sent to the respondents on November 14 for their review, and round two Delphi was released 
using REDCap invitation feature on November 17 with due date of December 1, 2014 (Appendix 
H). The REDCap release was followed by a confirmatory message sent using VCU email on 
November 19, 2014 to ensure the participants received their personal link. Several participants 
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asked to resend the link and confirmed that they received it. Reminders were sent on November 
24 and December 1, 2014. Upon request, Round Two survey remained opened after due date. It 
was closed on December 8, 2014. Upon analysis of round two data and permission by the 
doctoral committee, the study was considered complete and the third Delphi survey was not 
released. A thank you email was sent to the respondents announcing the end of the study on 
January 16, 2015.    
Analysis of Data 
The data collected during both surveys were transferred into Excel 2013 installed on a 
password protected Dell Latitude E6530 laptop using REDCap export data tool. Cronbach’s 
alpha coefficient of equivalence was used to assess survey reliability of each Delphi round 
(Cronbach, 1951). The coefficient was computed by R statistics system, also referred to “R 
environment”, Version 3.1.1 (2014-07-10), using Latent Trait Models (ltm) application package, 
Version 1.0.0 (2013-12-20) (Rizopoulos, 2006). The selection of the package was determined by 
the necessity to handle missing data and was approved by VCU Statistics and Analytics 
Consulting Lab on September 28, 2014.  
The demographic data collected in Round I were analyzed to characterize the sample and 
indirectly assess the validity of expert opinion provided in the surveys. Percentages of 
respondents were tabulated according to geographic location, education, professional credentials, 
experience in clinical laboratory setting and experience with molecular testing, as well as 
experience as medical laboratory science student preceptor. 
In this descriptive study objective rating data were analyzed according to 
recommendations published for data collected using Likert-type scales typical in questionnaires 
with unique, stand-alone items that cannot be combined into a composite score  (Boone & 
      
70 
 
Boone, 2012). The ratings assigned to each learning objective were analyzed in terms of 
frequencies, expressed as percentage of respondents who rated an objective with the same score. 
Computation of frequencies and graphical data representation was performed by REDCap 
software. Upon computation, the data were manually tabulated.  The selection of objectives to be 
included in entry-level curriculum was determined using modified recommendations of Fried & 
Leao (2007) who stated that competencies to be included in the curriculum were the ones 
assigned the two top values on the scale (i.e., “very” and “most important”) by a significant 
number of participants. The percentage of participants considered significant by Fried & Leao 
(2007) was 50 plus one respondent. To increase the stringency of the choice, in this study the 
cut-off percentage of participants determining the objectives necessary to include in the entry-
level competency-based MLS curriculum was 70, meaning that upon completion of round II, 
objectives rated “very” and “most important" by at least 70% participants were identified as 
necessary. Objectives rated “very” and “most important” by 50-69% were considered optional, 
depending on the number of credit hours available to teach molecular diagnostics; and objectives 
rated “very” and “most important” by 25-49% were suggested for extra credit. The objectives 
rated “very” and “most important” by less than 25% of the respondents were not recommended 
for inclusion in entry-level curriculum. In addition to selection using rating frequencies, the data 
were also analyzed following the example of the study by Perkins et.al. (2005) who suggested 
that competencies included in the curriculum are the ones with median rating scores equal to 3 
and 4.  
The narrative comments provided in each Delphi round were compiled into a list with a 
purpose to identify items important for inclusion in the curriculum that were not present on the 
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seed list of learning objectives developed by the author of this study. The comments were only 
redacted for spelling errors.  
Chapter Summary 
 In this chapter the objectives of the study were verbalized and the research questions 
were re-stated. Selection of experts, anticipated response rate, survey development, testing and 
delivery as well as data analysis were described. Survey instruments were presented along with 
the corresponding communication with the participants. The following chapters include 
presentation of results, data analysis, discussion and conclusions. 
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Chapter Four: Results 
 
In this chapter, study results are presented including demographic features of the 
respondents, analysis of participants’ ratings assigned to specific molecular diagnostics cognitive 
and psychomotor learning objectives regarding their importance in entry-level medical 
laboratory science curriculum, the amount of time to teach objectives as recommended by study 
participants, and summary of narrative comments provided in two Delphi survey rounds. 
Participant Demographics 
 
Ninety-four experts from 32 states submitted usable surveys in the first Delphi (Table 9). 
Table 9. 
Demographic Characteristics of Round I and Round II Respondents: Geographic Location.  
Number of 
Respondents from 
the State            
U. S. States Represented in Each Round 
Round I  Round II  
1 AL, HI, ID, IL, KS, KY, LA, NE, NM, NC, OH, OK, RI, UT 
AL, FL, HI, KS, LA, MO, NJ, NM, 
NC, RI, UT  
2 MD, MA, NH, VA  CO, MD, MA, NH, VA  
3 FL, NJ, SD  DE, OR, PA, SD  
4 CO, DE, MO, PA  IN, TX, WA  
5 IN, OR, MI, WA  MI  
6 TX  GA  
7 N/A MN  
10 MN  N/A 
11 GA  N/A 
Total Number of 
Participating States 32 26 
Total Number of 
Respondents 94 63 
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Eighty-eight experts provided email addresses, indicating agreement to participate in future 
rounds. Sixty-three respondents (71.6%) submitted usable surveys in the second Delphi, almost 
twice as many respondents as the expected sample size calculated based on the median response 
rate reported in surveys published in Clinical Laboratory Science between 2000 and 2011 
(Stevens, 2000; Beck & Doig, 2002; Bamberg, 2004; Mundt & Shanahan, 2009; Delost & 
Nadder, 2011; Laudicina, et al., 2011).  
In the first round, the largest number of surveys was submitted by respondents from 
Georgia (11.1%), followed by Minnesota (10.6%) and Texas (6.4%) with other states being 
represented by 1-5 respondents (1.1 – 5.3% of all respondents each state). In the second round 
Idaho, Illinois, Kentucky, Nebraska, Ohio and Oklahoma were no longer represented. In other 
states the observed attrition ranged from 20% (Indiana) to 75% (Missouri). The states where 
there was no attrition were Alabama, Hawaii, Kansas, Louisiana, Maryland, Massachusetts, 
Michigan, New Hampshire, New Mexico, North Carolina, Rhode Island, South Dakota, Utah and 
Virginia. Minnesota was represented by the largest number of respondents in the second round. 
More than 73% of the respondents had a Bachelor of Science degree in clinical/medical 
laboratory science or post-baccalaureate certificate in medical technology, and approximately 
55% held a Master’s or Doctoral degree. The most represented field of study of highest degree 
were education and molecular biology/biochemistry and cell biology (Table 10). Nearly 82% of 
the participants were certified by the American Society for Clinical Pathology (ASCP) or by the 
National Credentialing Agency (NCA). Nearly 24% of respondents in the second round were 
certified as Technologist in Molecular Biology, MB(ASCP) and over 18% planned to achieve 
that credential in the future (Table 11). Over 76% of the respondents had over 10 years of 
laboratory experience, and 71.3% had at least 5 years of experience performing molecular tests  
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Table 10.  
Demographic Characteristics of Round I and Round II Respondents: Education Completed. 
Education Completed 
(% Respondents) 
 
Field of study of highest degree* 
(% Respondents) 
 
Round  % Round  % Round  % 
I 
A.A. degree 
1.1 I 
Education 
9.6 I Genetics/ 
Medical 
Genetics 
2.1 
II 1.6 II 9.5 II 3.2 
I 
CLT/MLT 
certificate 
 
3.2 
I Mol. Biol/ 
Biochem/Cell 
Biology 
 
8.5
I 
 
Chemistry/ 
Toxicology/ 
Pharmac. 
Sciences 
 
3.2 
II 3.2 II 9.5 II 4.8 
I 
 
BSMT (BS-
CLS/MLS) 
 
45.7 I 
Biology 
8.5 I  
Molecular 
Pathology 
1.1 
II 44.4 II 6.3 II 0.0 
I 
Other  BS 
23.4 I 
Administration 
6.4 I  
Immunology 
1.1 
II 23.8 II 6.3 II 0.0 
I MT/CLS/ 
MLS post-
baccal. 
certificate 
27.7 I 
Biomedical 
Sciences 
4.3 I  Blood 
Transfusion 
Medicine 
1.1 
II 28.6 II 3.2 II 1.6 
I Masters 
degree 
37.2 I 
Microbiology 
4.3 I  
Natural 
Resources 
1.1 
II 32.3 II 4.8 II 0.0 
I Doctoral 
degree 
19.1 I 
MLS 
5.3 I  Neuroendo-
crinology 
1.1 
II 22.2 II 6.3 II 1.6 
I 
Other degree 
1.1 I Public Health/ 
Epidemiology 
3.2 I  
Kinesiology 
1.1 
II 1.6 II 3.2 II 1.6 
 
Note: *Field of study categories: Education also included Adult Education, MLS Education, 
Science Education, Education Administration Leadership, Educational Psychology; 
Administration included Business Administration, Health Services Administration, Health Care 
Management/Administration; Biomedical Sciences also included Basic Medical Sciences, 
Biotechnology/Genetic Engineering, Biomedical Informatics; Microbiology also included 
Medical Microbiology and Molecular Microbiology; MLS also included dual MLS and Biology. 
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Table 11.  
 
Demographic Characteristics of Round I (RI) and Round II (RII) Respondents: Professional 
Credentials. 
Professional Credentials  
(% Respondents) 
Type of ASCP or 
NCA specialist 
credential 
Type of ASCP or 
NCA categorical 
credential 
Plan to obtain 
MB(ASCP) 
credential 
Round  % Round  % Round  % Round  % 
I MLS 
(ASCP) 
27.9 I SBB 4.3 I BB 0 I Y 14.7 
II 24.6 II 4.7 II 0 II 18.8 
I MT 
(ASCP) 
58.1 I SC 0 I C 0 I N 64 
II 57.9 II 0 II 0 II 64.6 
I CLS 
(NCA) 
11.6 I SCT 0 I CT 1.1   
  
 
II 10.5 II 0 II 1.6    
I ASCP or 
NCA 
specialist 
19.8 I  
SH 
4.3 I  
H 
1.1      
II 15.8 II 1.6 II 1.6      
I ASCP or 
NCA 
categorical 
certification 
22.1 I  
SM 
7.4 I  
M 
3.2      
II 26.3 II 6.3 II 4.7      
I Other** 
certification 
10.5 I SV 2.1 I MB 17.0    
II 12.3 II 3.2 II 23.8    
 
Note: ** Other certifications listed: NRCC, FACMG, ABMG in cytogenetic (1 of each in both 
rounds); MLT (2 in both rounds including 1 also with a Canadian credential of Registered 
Technologist: RT (CSMLS); and MT(AMT) (2 including 1 who did not participate in round II). 
in clinical laboratory. In the first Delphi round, over 43% of respondents worked in hospital 
setting. In the second round that number decreased to 33%, as a result of an increase of the 
percentage of respondents working in academic medical centers and reference laboratories.  
Almost 13% of the second round respondents were at a university based health science/MLS 
program at the time the study was performed, and nearly 10% worked in public health 
laboratories. The respondents had experience with a variety of molecular based assays (Tables 12 
and 13). 
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Table 12.  
 
Demographic Characteristics of Round I and Round II Respondents: Experience. 
 
Number of years in clinical 
laboratory (% respondents) 
Number of years performing 
molecular tests in clinical 
laboratory 
Prior experience with 
molecular assays in 
research or industry  
Round  % Round  % Round  % 
I Less than 5 
years 
5.3 I Less than 5 
years 
28.7 I Y 26.6 
II 3.2 II 20.6 II 28.6 
I 5-10 years 18.1 I 5-10 years 50.0 I N 73.4 
II 20.6 II 55.6 II 71.4 
I Over 10 
years 
76.6 I Over 10 
years 
21.3    
II 76.2 II 23.8    
 
Table 13. 
Demographic Characteristics of Round I and Round II Respondents: Laboratory Setting and 
Assays Performed. 
Delphi Round 
 
Place of 
employment 
(% respondents) 
I II  I  II  I  II I  II 
Hospital 
Laboratory 
Academic Medical 
Center 
Reference 
Laboratory 
Other 
Setting* 
43.6 33.3 14.9 19.0 19.1 23.8 22.3 23.8
Number of 
molecular assays 
run in the lab** 
1 to 3 4 to 10 More than 10     
24.7 25.9 29.2 22.4 46.1 51.7     
 
Note: * Other setting: Currently at University (not academic medical center) with Health Professions/CLS 
Program: 10 (10.6%) in Round I and 8 (12.7%) in Round II; Public Health State/Government Lab: 9 
(9.6%) in Round I and 6 (9.5%) in Round II; Pathology Group: 1 (1.1% in Round I and 1.6% in Round 
II). One respondent selected "other setting" but did not state what setting it was. 
**Assays listed for facilities where the number of molecular assays was 1-3, starting with most common: 
GC/Chlamydia (w/ or w/o Trichomonas), C. difficile, Influenza A/B, MRSA, Respiratory Viral Panel, 
RSV, HCV viral loads, HPV, Human Erythrocyte Antigen BioArray, B. pertussis, EBV, Enterovirus, 
Mycobacteria probe hybridization, Dengue, Gene expression arrays, qPCR for multiple gene markers.  
Additional assays listed for facilities where the number of molecular assays was more than 3 
(alphabetically): Arbovirus, Array comparative genomic hybridization, Argininosuccinic aciduria 
mutation  test, B&T cell rearrangements, Bioterrorism agents, BK, chimerism analysis, CMV, CYP2C19, 
Cystic Fibrosis, DNA fingerprinting, Factor II and Factor V, FISH -leukemia/lymphoma, glioma, sarcoma 
tests, Fragile X, GI virus panel, Group A/B strep, HbS, HBV, HCV genotyping, Hereditary Hemo-
chromatosis HFE, HIV Viral Load, HSV I and II, KRAS, Norovirus, Prostate LDT Mutation analysis, 
Pyro- sequencing mutation analysis/ methylation/Sanger sequencing/MLPA, Shigella Toxin, t(9:22) 
BCR-ABL, Varicella zoster. 
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Over 60% of the respondents in both rounds had experience as a preceptor for MLS students, 
most of them in the area of microbiology and molecular diagnostics (Table 14).  
Table 14. 
Demographic Characteristics of Round I (RI) and Round II (RII) Respondents: Experience as an 
MLS Preceptor. 
Experience as MLS 
student preceptor  
(% respondents) 
Area of preceptorship 
Satisfaction with performance 
of students trained in 
molecular testing 
Round  % Round  % Round  % 
I Y 64.9 I Blood bank 11.5 I Very 
Satisfied 
20.0 
II 61.9 II 10.3 II 20.7 
I N 35.1 I Chemistry 11.5 I Satisfied 51.1 
II 38.1 II 5.1 II 41.4 
   I Hematology 11.5 I Somewhat Satisfied 
26.7 
   II 2.6 II 34.5 
   I Immunology 19.7 I Not Satisfied 2.2    II 15.4 II 3.4 
   I Microbiology 50.8    
   II 41    
   I Molecular 
Testing 
72.1    
   II 71.8    
 
Those with experience as a preceptor in hematology and chemistry contributed most to survey 
attrition. However, the proportion of respondents with experience in preceptorship in the area of 
molecular diagnostics remained stable over the two rounds. 
Survey Reliability 
The reliability of the first survey, assessed by Cronbach’s alpha computed using ltm 
package for R statistics system, was 0.96. In the second Delphi round, the coefficient was 0.97. 
Delphi Round I Results 
 Aside from collecting the respondents’ demographic data, the purpose of the first survey 
was to identify learning objectives that could be excluded from further considerations due to low 
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number of participants considering them at least moderately important, to determine which 
objectives were to be retained and expanded in the second round, and to inquire about items 
important for inclusion in the curriculum that were not present on the seed list of learning 
objectives developed by the author of this study. 
 To identify learning objectives that could be excluded from further considerations, the 
author of the study identified objectives that were assigned a score of 2, 3 or 4 by less than 70% 
of the respondents (Appendix I). The search revealed only one such item in the group of 
objectives relevant to general laboratory operations: “Identify companies that manufacture 
molecular assays utilized in the clinical laboratory.” Only 61% of the respondents considered the 
item at least moderately important in round one. All other 5 basic concepts and 40 learning 
objectives were given a score of 2, 3 or 4 by at least 76% of the respondents and were, thus, to be 
retained and expanded in the second round as shown in Appendix F. Aside from the one 
excluded objective, the items that were rated at least moderately important by the lowest 
percentage of the respondents were in the group of objectives relevant to DNA polymorphism 
(“predict the sizes of DNA fragments obtained following restriction enzyme digestion”) and 
objectives relevant to specific molecular applications (“apply basic karyotyping terms to 
chromosomal localization of clinically important genes”). The item that was rated at least 
moderately important by 100% of the respondents was a psychomotor objective in the group of 
objectives of general laboratory operations: “observe precautions against nucleic acids 
degradation and contamination”. The ranges and average percentages of respondents who 
considered each concept or learning objective at least moderately important within each group of 
objectives are presented in Table 15.   
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Table 15.  
Delphi Round I Ranges and Average Percentages of Respondents Who Considered Each 
Concept or Learning Objective at Least Moderately Important Within Group. 
Groups of Concepts or Objectives Rated in 
Delphi Round I 
Range of 
percentages of 
respondents with 
ratings 2, 3 or 4 
Average percentage (%) 
of respondents with 
ratings 2, 3 or 4 
Basic Concepts in Molecular Biology  
(5 concepts) 
83-95 90 
General Laboratory Operations (7 items) 92-100  92 
Pipetting Skills (2 items) 80-98  89 
Nucleic Acids Isolation (6 items) 84-98 90 
DNA Polymorphism (4 items) 76-88 82 
Gel Electrophoresis (3 items) 91-95 94 
Polymerase Chain Reaction and Modifications  
(5 items) 
90-99 96 
Specific Molecular Applications (13 items) 76-96 87 
Three learning objectives assigned the highest score of 4 (most important, absolutely 
must be included in MLS curriculum) by the largest number of respondents were cognitive 
objectives: “explain the principle of the Polymerase Chain Reaction” (70.2%), followed by 
“justify the unidirectional (clean to dirty) workflow in the molecular laboratory” (61.7%) and a 
psychomotor objective “perform Polymerase Chain Reaction” (60.9%).  
The narrative comments provided by the respondents in the first Delphi Round are listed 
in Appendix G. The purpose of seeking comments was, according to instructions, to modify the 
second round of the Delphi to include expansion of items offered in the first round or additional 
items absent in the first round. There were 10 narrative comments that either addressed 
molecular course prerequisites, stated that the list was extensive, or that the curriculum should be 
basic and not include all the objectives. Eighteen respondents specifically mentioned concepts 
and learning objectives they considered the most important including clinical presentation of 
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most common viral/bacterial infections detected by Polymerase Chain Reaction, comparison of 
molecular methods with other assays and the correlation of molecular test results with diagnosis 
and disease.  These comments appeared as items in round one or were designed to appear in 
round two. Appendix J presents the objectives corresponding to the narrative comments of these 
respondents. Due to the fact that clinical presentation, correlation of laboratory tests with 
diagnosis and method comparison are taught throughout the MLS curriculum, these single 
comments were not verbalized into new objectives to be rated in round two. 
Delphi Round II Results 
Per Delphi design, the respondents were given the opportunity to confirm or change their 
opinion on the importance of the objectives after reviewing the results of the first survey, 
including narrative comments. The items to be retained in the second round were those assigned 
scores of 2, 3 or 4 by at least 70% of the respondents in round one.   
In the development of the second survey, one low level cognitive learning objective was 
removed due to insufficient number of participants considering it at least moderately important 
in the first round; other objectives (listed in Appendix F), were expanded. The total number of 
evaluated items was 100. Sixty-three respondents (71.6% of all who provided email addresses, 
indicating agreement to participate in subsequent rounds) submitted usable surveys in the second 
Delphi round.  
 All quantitative results are presented in Appendix I. The ranges and average percentages 
of respondents who considered each concept or learning objective at least moderately important 
within each group of objectives are presented in Table 16. Following the example of Fried and  
Leao (2007), the author determined the percentage of respondents who assigned the two top 
scores (3 and 4) to each rated concept or objective. 
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Table 16.  
Delphi Round II Ranges and Average Percentages of Respondents Who Considered Each 
Concept or Learning Objective Very and Most Important Within Group. 
Groups of Concepts or Objectives Rated in 
Delphi Round II 
Range of 
percentages of 
respondents with 
ratings 3 or 4 
 
Average percentage 
(%) of respondents 
with ratings 3 or 4 
Basic Concepts in Molecular Biology  
(5 concepts) 
16-95 71 
General Laboratory Operations (7 items) 84-100 91 
Pipetting Skills (2 items) 59-94 76 
Nucleic Acids’ Isolation (7 items) 38-71 60 
DNA Polymorphism (7 items) 23-56 42 
Gel Electrophoresis (9 items) 36-78 52 
Polymerase Chain Reaction and Modifications 
(17 items) 
24-89 62 
Specific Molecular Applications (46 items) 12-82 46 
 
The concepts and objectives were separated into 4 groups based on the percentage of respondents 
who assigned them a score of 3 and 4, as also shown in Table 17. 
Table 17.  
 
Groups of Concepts and Objectives by Percentage of Respondents with Ratings of 3 and 4.  
 
% of Round II 
Respondents with 
ratings 3 and 4  
Concepts or Learning Objective (as numbered in Round II) 
Cognitive Psychomotor 
70% and up #2-9, 12, 29, 38, 40-42, 44-45, 54-
55, 66-68 
# 10-11, 13, 18  
50-69% #15, 17, 22-23, 35, 39, 43, 52-53, 
56, 61, 63-65, 69-73, 76-79, 81-82, 
84, 87, 92 
#14, 19-21, 30, 33-34, 46-47 
25-49% #16, 24-26, 32, 36-37, 48, 57-60, 62, 
74-75, 80, 85-86, 88-91, 93-96 
#27, 31, 49 
Less than 25% #1, 28, 83, 97-100 #50 
The second Delphi round, revealed 4 concepts and 21 learning objectives (17 cognitive 
and 4 psychomotor) rated “very” and “most important" by at least 70% of the participants. These 
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items were identified as necessary for inclusion in the competency-based, entry-level MLS 
curriculum. There were 37 learning objectives (28 cognitive and 9 psychomotor) rated “very” 
and “most important” by 50-69% of the respondents. These were considered optional for an 
MLS curriculum, depending on the number of credit hours available to teach molecular 
diagnostics. There were 30 learning objectives (27 cognitive and 3 psychomotor) rated “very” 
and “most important” by 25-49% of the respondents and suggested for extra credit. Finally, there 
were 7 learning objectives (including one psychomotor) and one basic concept considered “very” 
and “most important” by less than 25% of the respondents. These would not be recommended for 
entry-level MLS curriculum. 
Following the example of Perkins et.al. (2005) who suggested that competencies included 
in the curriculum are the ones with medians equal to 3 and 4, median rating scores were recorded 
(Appendix I). The concept of DNA melting point (#4) and objectives pertaining to unidirectional 
workflow and precautions against nucleic acids’ degradation and contamination (# 7 and 11), as 
well as proper micropipetting (#13) were the only ones with median rating equal 4. Objective 
#42 referring to PCR controls had a median equal to 3.5. The objectives with medians 3 and 4 
are the same objectives that are rated “very” and “most important” by at least 50% of the 
respondents. All objectives rated as “very” and “most important” by less than 50% of 
participants had a median equal 2, except for objective #61 (importance of inclusion of 
automated Sanger sequencing) which had a median equal 2.5. 
The median method does not seem to be useful to separate the extra credit objectives 
from the ones that should be removed as there were no objectives with median equal 1. Lack of 
objectives with medians equal to 1 indicates that there were not any objectives that would be 
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deemed unimportant, validating the seed list of the objectives used in the survey and justifying 
forfeiture of the exploratory round typical of classical Delphi. 
Based on good separation of the necessary, optional, and extra credit objectives, it was 
decided that a third Delphi round was not necessary. It would be necessary if most or almost all 
objectives fell into the optional or extra credit category. Fried and Leao (who used 50% of 
respondents as the cutoff) recommended taking the objectives that could not be clearly accepted 
or rejected (such as the extra credit objectives) and sending these back for re-rating to the 
participants who provided extreme ratings of these objectives (such as 0 or 4).  In this current 
study, the number of such respondents would be very small (as most rated these objectives as 
moderately important); therefore, even if the rating changed, it would not have affected the 
outcome. The response rate in the third round was likely to decrease. 
In the second Delphi round survey, the researcher also included eight questions asking to 
select time the respondents thought should be devoted to each group of concepts and learning 
objectives, given that a semester lasts 16 weeks (on average). The results are shown in Table 18. 
Table 18.  
 
Instructional Time Assigned to Each Objective Category Group (% respondents). 
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1-3  33.9 58.1 69.4 50 66.1 69.4 24.2 40.3 
4-6  40.3 24.2 25.8 41.9 27.4 24.2 59.7 40.3 
Over 6  25.5 17.7 4.8 8.1 6.5 6.5 16.1 19.4 
 
The last question in the second round Delphi survey asked the participants if, upon 
consideration of all learning objectives, they would add any methodologies, pathogens and 
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diseases/conditions, other than already listed, to include in entry-level medical laboratory 
scientist curriculum. There were five answers simply stating “no” or that the list covered the 
most important concepts and objectives. There were eight answers with specific comments as 
presented in Table 19. 
Table 19.  
Narrative Comments Provided in Delphi Round II. 
 
My thoughts are that you should cover the concepts pertaining to molecular methods and 
include information about specific conditions that concern any one target in particular.  The 
main thing is to cover the concepts that are common to many protocols.  You'll never know 
what types of work your students will be doing, so to spend a great deal of time working on 
one particular area (i.e. infectious diseases) may be wasted time if the person who is doing 
training will be working in a karyotyping lab.  The molecular concepts are KEY, along with 
QUALITY CONTROL and UNIDIRECTIONAL WORK!!! 
No, infectious disease and basic molecular is entry level. Human polymorphisms and 
cytogenetics as well as HLA is NOT B.S. level molecular diagnostics. 
I would only add that any dedicated MDx course should annually assess 'which 
methodologies, pathogens/conditions, etc.' should be considered. In other words, a MDx 
course syllabus may need to be adjusted annually due to this fields rapid evolution. For 
instance, we may need to stop teaching basic gel electrophoresis b/c of the rapidly expanding 
platforms for direct fluor detection of nucleic acids and/or proteins. 
Troubleshooting failed runs. 
Perhaps diabetes and lupus. 
There is limited time to teach the concept for every gene mutation or pathogen, so I generally 
select one from each area (infectious disease, gene mutations, HLA) to teach in lab and cover 
some of the more common test methods in lecture. 
Non-small cell lung cancer and melanoma. 
 
Chapter Summary 
 In this chapter the results of the study on the importance of inclusion of specific 
molecular diagnostics cognitive and learning objectives in entry-level medical laboratory science 
curriculum were presented. The chapter started with presentation of participant demographic 
data, followed by quantitative data as well as narrative comments collected in both Delphi 
rounds. In the next chapter, answers to specific research questions are provided based on the 
results.  
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Chapter Five: Discussion 
 
This chapter presents a summary of the descriptive study on clinical molecular facilities’ 
expectations from medical laboratory scientists entering the workforce and conclusions based on 
data reported in Chapter Four. It provides a discussion of findings, limitations of the study and 
implications for MLS educators and the profession. 
Summary of the Study 
The medical laboratory science profession is in need for published molecular diagnostics 
competency-based standards and curriculum. To assess their expectations of new MLS 
graduates, professionals performing and supervising performance of clinical molecular assays 
were surveyed to rate the importance of relevant cognitive and psychomotor learning objectives, 
developed by the author while teaching molecular methods courses in an MLS Program. 
Following the approval by VCU Institutional Review Board, a modified, asynchronous, 
iterative online Delphi process was completed in two survey rounds using Research Electronic 
Data Capture (REDCap) application. The reliability of the first and second surveys, assessed by 
Cronbach’s alpha computed using R statistics system, was 0.96 and 0.97, respectively. Program 
directors of 221 MLS programs accredited by the National Accrediting Agency for Clinical 
Laboratory Science (NAACLS) were asked to serve as “gatekeepers” and forward the first 
Delphi survey to target participants. Ninety-four experts from 32 states submitted usable surveys 
in the first round. Eighty eight experts provided email addresses, indicating agreement to 
participate in future Delphi rounds. 
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More than 73% of the respondents had Bachelor of Science in clinical/medical laboratory 
science degree or post-baccalaureate certificate in medical technology. Nearly 82% of the 
participants were certified by the American Society for Clinical Pathology (ASCP) or by the 
National Credentialing Agency (NCA). Almost 77% had over 10 years of laboratory experience 
and 71.3% had at least 5 years of experience performing molecular tests in clinical laboratory 
(over 43% in hospital setting).  
Per Delphi design, the respondents were given the opportunity to confirm or change their 
opinion on the importance of the objectives after reviewing the results of the first survey, 
including narrative comments. One low level cognitive objective was removed from the second 
survey, due to insufficient number of participants considering it at least moderately important; 
and 13 other objectives were expanded so that the total number of evaluated items was 100. 
Sixty three respondents (71.6%) submitted usable surveys in the second Delphi Round.  
Upon completion of Delphi process four groups of concepts and objectives emerged, 
depending on the percentage of round two respondents who deemed the item “very” and “most 
important" with thresholds of 70, 50, and 25% of the respondents. The recommended essential 
items identified as necessary for inclusion in the entry-level MLS curriculum focused on basic 
molecular biology principles and general molecular laboratory operations, including practical 
knowledge of techniques designed to maintain specimen integrity and intense theoretical 
background of the polymerase chain reaction, as well as comprehension of laboratory assays for 
pathogens most commonly tested for using molecular methods. In addition to the essential MLS 
molecular learning objectives, the investigator also identified optional objectives that could be 
used to expand the students’ knowledge, depending on the number of contact hours available to 
teach molecular diagnostics; The remaining objectives rated by the respondents of the survey 
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were suggested for extra credit beyond the available contact hours or were not recommended to 
include in entry-level MLS curriculum. The list was created with ultimate goal to share with 
MLS educators, accrediting agency (NAACLS) and the provider of MLS certification exam 
(ASCP), to contribute to the existing exam content guidelines. 
The Expert Opinion 
 Based on respondents’ credentials, work experience in the area of molecular diagnostics, 
as well as experience as a preceptor for MLS students in area of molecular testing (Tables 10-
14), it may be concluded that the Delphi study reached the intended target population sample, 
validating the provided expert opinion. The demographic characteristics of the sample confirm 
that the gatekeepers (program directors of NAACLS accredited MLS programs) have forwarded 
the initial public survey link as intended. 
 When seeking expert opinion, Delphi process has two advantages when compared to 
other methods: the selection of the participants by nomination rather than by random sampling 
and the essential anonymity of the experts (Duffield, 1993; Mullen, 2003). The selection of 
participants by nomination prevents self-classification as experts due to perceived estimation of 
one’s own knowledge, and the essential anonymity of Delphi respondents prevents the influence 
of dominant personalities, known as “bandwagon effect” or “halo effect”, which may result in 
pressure to conform regardless of personal opinion.   
 One cannot exclude the possibility that some respondents may have proceeded with the 
survey regardless of their actual or perceived knowledge.  In this study, one participant, despite 
nomination, reported that she lacked sufficient knowledge to complete the first Delphi survey 
and withdrew from the project. One participant answered all the questions but, in the space 
devoted to the narrative comments, stated she had a limited knowledge base indicating low self-
      
88 
 
confidence. Upon review of this respondents’ credentials, it was noted that she had over 5 years 
of experience performing at least three clinical molecular assays at her institution. She 
participated in the second Delphi round. Mullen (2009) attempted to address this issue by asking 
the participants of her study to assess their own confidence in their answers. However, Mullen 
did not provide recommendations regarding exclusion of participants with low confidence levels. 
Hence, in this study, the collected demographic data provided means to evaluate the validity of 
the sample.  
 Delphi provides a safe environment for reconsideration of one’s own opinion upon 
review of the overall results and comments submitted by others in the previous round without the 
threat of being labeled as indecisive (Linstone & Turoff, 1975; Francis, 1977; Landeta, 2006). In 
this study, the anonymous narrative comments provided in the first survey (Appendix G) were 
sent to the respondents three days prior the release of the second survey. To assure that everyone 
had a chance to review the comments, the investigator had inquired twice if the respondents had 
not received the comments. In absence of such reports, it was assumed that everyone considered 
the comments when re-rating the objectives in the second survey and provided informed opinion.   
Cognitive and Psychomotor Skills Expected of an Entry-Level MLS 
 It is the author’s recommendation that, at a minimum, the entry-level MLS curriculum 
must include basic concepts of gene inheritance, cell cycle events, nucleic acids’ chemistry 
relevant to molecular techniques and fundamentals of quality assurance practices characteristic 
of molecular diagnostic laboratory including cognitive comprehension of the unidirectional 
workflow.  A graduating MLS must be versed in specimen transport and storage conditions 
recommended for specimens and purified nucleic acids and the regulations regarding reporting 
patients’ results obtained in laboratory developed tests. MLS training must also include practical 
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experience in micropipetting, manual extraction of nucleic acids using precautions to assure 
specimen integrity as well as handling chemical and biohazard waste. The curriculum must 
address theoretical background of gel electrophoresis and polymerase chain reaction, including 
the operation of thermal cycler, the specifics of reaction conditions, components and quality 
control. Furthermore, the MLS should recognize the difference between the standard and 
reverse-transcriptase PCR, be able to name specific applications of such assays, as well as real-
time and multiplex PCR assays; and have the cognitive ability to troubleshoot unsuccessful 
reactions. The MLS should differentiate between target and signal amplification assays and be 
able to provide examples of molecular technologies and instrumentation used in detection, 
quantitation and/or genotyping of the agents commonly assayed for using molecular tests: N. 
gonorrhoe/C. trachomatis; HIV-1, and HCV. This content reflects the expectations of a 
significant majority of those asked to provide their expertise in this study and is captured by 
specific learning objectives listed in Table 20.  
 Using the upper time limits recommended by the majority of round two respondents, the 
total instructional time devoted to molecular diagnostics is 32.5 contact hours (Table 21). In a 16 
week semester, this equals to approximately two hours per week, if the ratio of contact to credit 
hours is approximately 1:1 for didactic courses and 2:1 for laboratory courses (DOE, 2010). 
Thus, 1.5 credit hours is recommended for a single molecular diagnostics course with a 
combination of lecture and laboratory.  Alternatively, the psychomotor objectives could be 
covered during other courses that have a laboratory component and in clinical internships. This 
would allow for inclusion of more cognitive objectives in the lecture course.  
To make sure that the essential content corresponds to the expectations of a significant majority 
of experts, in this study a high threshold of 70% of the respondents was used as a criterion 
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Table 20. 
Essential Concepts and Objectives in Entry-Level MLS Curriculum. 
 BASIC CONCEPTS IN MOLECULAR BIOLOGY 
Modes of single gene inheritance: dominant, recessive, autosomal, X-linked. 
Chemical structure and bonds in DNA and RNA. 
DNA melting point and its relevance to DNA denaturation, renaturation, hybridization and 
annealing. 
The central dogma of molecular biology and the molecular processes occurring during the 
cell cycle. 
GENERAL LABORATORY OPERATIONS 
Recognize the differences in quality assurance practices utilized in clinical molecular 
diagnostic laboratories versus molecular biology laboratories.    
Justify unidirectional (clean to dirty) workflow in the molecular laboratory. 
Recommend proper transport for acceptable specimens for molecular pathology. 
Recommend proper storage conditions for specimens and purified nucleic acids according 
to Clinical Laboratory Standards Institute (CLSI) and College of American Pathologists 
(CAP) guidelines. 
Observe correct protocols for disposal of biohazard and chemical waste in the molecular 
laboratory. 
Observe precautions against nucleic acids degradation and contamination. 
Recognize the complexity of reporting patients’ results including regulation of laboratory 
developed tests and the FDA Analyte Specific Reagents (ASR) Rule. 
PIPETTING SKILLS 
Demonstrate proper use of automated, variable or fixed volume micropipettes. 
NUCLEIC ACIDS’ ISOLATION 
 Use manual DNA and RNA extraction protocols. 
GEL ELECTROPHORESIS 
State the principle of DNA gel electrophoresis. 
POLYMERASE   CHAIN REACTION METHOD AND MODIFICATIONS 
Provide temperature ranges appropriate for the molecular events of the denaturation, 
annealing and extension steps of a PCR cycle.  
Explain the role of each component of a standard PCR mixture in DNA amplification. 
Describe the operation of a thermal cycler. 
Distinguish among the positive, negative, internal, and reagent blank PCR controls. 
Differentiate between standard PCR and reverse transcriptase PCR. 
Provide at least one specific application of each: standard end-point PCR, real-time PCR, 
reverse-transcriptase PCR and multiplex PCR. 
Troubleshoot in case of unsuccessful end-point or real-time PCR product analysis outcome. 
SPECIFIC MOLECULAR APPLICATIONS 
Differentiate between target amplification and signal amplification. 
Identify methodologies and diagnostic equipment used in molecular assays developed to 
detect, quantify or genotype bacterial and viral agents: NG/CT, HIV-1, HCV 
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Table 21. 
Recommended Number of Hours to Teach Essential Concepts and Objectives.  
Groups of Concepts 
or Objectives  
Instructional 
Time (hrs)*  
                                           Content                       
                    Cognitive                           Psychomotor 
Basic Concepts in 
Molecular Biology  
4-6 nucleic acid chemistry,  
basic molecular theory, modes of 
inheritance 
N/A 
General Laboratory 
Operations 
1-3 quality assurance in clinical vs. 
molecular biology labs, 
unidirectional workflow, specimen 
transport and storage, complexity of 
reporting results and FDA regulation 
of laboratory developed tests 
disposal of 
waste, nucleic 
acid 
degradation and 
contamination 
precautions 
Pipetting Skills  1-3 N/A proper use of  
micropipettes 
Nucleic Acids’ 
Isolation 
1-3 none manual DNA 
and RNA 
extraction 
DNA 
Polymorphism 
1-3 none none 
Gel Electrophoresis 1-3 principle of DNA electrophoresis none 
Polymerase   chain 
reaction and 
Modifications 
4-6 reaction conditions and components 
including proper controls, 
knowledge how the thermal cycler 
works, differences between 
standard, reverse-transcriptase, end-
point and real-time PCR, 
troubleshooting unsuccessful assays 
none 
Specific Molecular 
Applications 
4.5** differences between target and 
signal amplification, methods and 
equipment for detection, quantitation 
and/or genotyping NG/CT, HIV-1, 
HCV 
N/A 
Total (using the 
upper limit for 
group) 
32.5   
Notes: *Based on a 16 week semester 
**40.3% of the respondents recommended 1-3 hours and 40.3% respondents recommended 4-6 
hours (4.5 is the average of the two recommended upper limits: 3 and 6). 
 
to identify the items. Fried & Leao recommended an ambivalent 50% plus one threshold to 
identify the items (Fried & Leao, 2007). In the study presented here, there were 62 objectives 
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that met Fried & Leao criteria (marked with dark and light green in Appendix I). To include all 
these objectives in the curriculum, one would have to significantly increase the instructional time 
beyond the 32.5 contact hours recommended by the largest percentage of the respondents. To 
respect the respondents’ preferences, only the concepts and objectives with ratings 3 and 4 
assigned by at least 70% of the respondents are suggested as essential, while the 37 objectives 
with such ratings assigned by 50-69% of the respondents may be considered optional, depending 
on available contact hours in an MLS program. These optional objectives (marked light green in 
Appendix I) are relevant to some more fundamental skills, such as evaluation of accuracy of 
micropipettes, spectrophotometric assessment of nucleic acid concentration and purity, 
comprehension of the principles and ability to perform automated nucleic acid extraction. The 
optional content also includes laboratory experience in gel electrophoresis with relevant safety 
precautions, as well as performance of the PCR. It is evident that completion of the optional 
objectives in the curriculum, would require not only additional contact hours but also physical 
and financial resources to purchase or access instrumentation, namely electrophoresis units, 
thermal cycler, and automated nucleic acid extractor. Availability of these resources may vary 
between university based and hospital based programs and should be taken into consideration 
when planning the curriculum. The cognitive objectives falling into the optional category may 
require seeking expertise outside the MLS program if the faculty teaching molecular course has 
no prior experience with such technologies as Sanger or Next Generation Sequencing, 
Microarrays and Fluorescent In Situ Hybridization. The topics covered by the optional objectives 
include applications of Single Nucleotide Polymorphisms (SNPs) and Short Tandem Repeats 
(STRs), deeper understanding of real-time PCR, comprehension of molecular diagnostic systems 
and ability to compare the principles of the technologies listed above, as well as identification of 
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instrumentation and diagnostic methods to detect multiple infectious agents (as listed in 
Appendix I). Finally, the category includes association of genetic markers with chronic 
myelogenous leukemia (CML), breast cancer and cystic fibrosis.  
 The objectives rated by the respondents in this study were developed while teaching 
molecular methods courses at the author’s institution where the MLS curriculum includes 3 
credit hours of lecture and 2 credit hours of laboratory in one semester. Thus, the number of 
hours dedicated to molecular diagnostics at that university exceeds the number of hours 
recommended by the participants of the study which permits for inclusion of a much higher 
number of learning objectives than may be taught during the 1.5 credit hour course 
recommended to cover the necessary objectives reflecting knowledge and skills expected from 
an MLS upon graduation. 
 Aside from objectives suggested as necessary/essential or optional, the author 
recommends 30 objectives (marked yellow in Appendix I) for extra credit beyond the available 
contact hours. These objectives were rated very and most important by 25-49% of the 
respondents in Delphi round two and are relevant to practical restriction enzyme fragment 
polymorphism (RFLP) analysis, principles of software-based PCR primer design, several 
molecular methods beyond PCR and genetic markers for a variety of conditions. The eight 
objectives (marked red in Appendix I) rated very and most important by less than 25% of the 
participants are not recommended for inclusion in the entry-level MLS curriculum. Most of these 
objectives, relevant to applications in transfusion therapy or tissue typing and pharmacogenomics 
may be more appropriate for a post-professional curriculum. Others (general concepts of 
scientific discoveries made by molecular scientists, usage of karyotyping terminology, manual 
PCR primer design and predicting DNA size fragments following restriction digestion) may have 
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been deemed obsolete or not representative of the scope of MLS practice. MLS program 
directors and educators have the responsibility to make sure the curricula reflect the scope of 
practice and follow the prescribed NAACLS guidelines to secure continuous accreditation and 
graduates eligibility for certification. 
 Traditionally, the NAACLS standards named seven areas of medical laboratory science: 
Clinical Chemistry, Hematology/Hemostasis, Immunology, Immunohematology/Transfusion 
Medicine, Microbiology, Urine and Body Fluid Analysis and Laboratory Operations. The 2001 
Standards added “molecular diagnostics” to the list (NAACLS, Standards of Accredited 
Educational Programs for the Clinical Laboratory Scientist/Medical Technologist, 2001). 
However, the most current standards, updated in January 2014, section VIII A (MLS Curriculum 
requirements) no longer verbalize “molecular diagnostics” (NAACLS, Unique Standards 
Medical Laboratory Scientist (MLS), 2012). This change occurred because the molecular testing 
is now integrated in all the areas listed in the Standards. For this reason, many programs do not 
have a separate course devoted to molecular diagnostics but include this content in other courses. 
The Description of Entry-Level Competencies of the MLS states: 
“At entry level, the medical laboratory scientist will possess the entry level 
competencies necessary to perform the full range of clinical laboratory tests in areas 
such as Clinical Chemistry, Hematology/Hemostasis, Immunology, 
Immunohematology/Transfusion medicine, Microbiology, Urine and Body Fluid 
Analysis and Laboratory Operations, and other emerging diagnostics, and will play a 
role in the development and evaluation of test systems and interpretive algorithms”. 
Hence the list of laboratory areas includes “other emerging diagnostics” instead of 
previously listed “molecular methods”. The goal of this project was to assess which 
molecular concepts and objectives may be considered essential for inclusion in the MLS 
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curriculum. To achieve meaningful results, the target experts in this study were the 
professionals experienced in molecular based clinical assays. 
 There could be several reasons why only one fourth of all concepts and objectives 
developed by the author were rated “very” and “most important” by at least 70% of the 
experts and why no additional content was suggested, with the exception of very few items 
(such as non-small cell lung cancer or lupus) listed by single respondents. Many of the 
respondents may have been satisfied with their own past on-the-job training and did not 
see a reason to change the paradigm.  If the respondents themselves were not allowed in 
the molecular section of the laboratory until they gained experience in other areas for 
several years, they may still identify molecular diagnostics with advanced education.  
 Some respondents, depending on how long ago they completed their education, 
may have graduated from programs where, based on the ASCP exam guidelines, students 
were not exposed to molecular diagnostics (ASCP, 2014). This may have triggered 
preconception that, since the certification agency did not place emphasis on certain 
concepts, one should not expect the new graduates to be versed and skilled in these 
concepts. On the other hand, the newest addition of MALDI-TOF technology to the ASCP 
BOC microbiology content guidelines in September 2014 was not reflected in the opinion 
of the surveyed experts as none suggested to include it in the objectives related to methods 
not considered PCR. Therefore, the impact of the guidelines on expert opinion is unlikely.  
 Another reason for only a small proportion of the items being selected may be that 
molecular diagnostic testing remains very costly, and as such is not considered appropriate 
for student training due to perceived risk of wasting or compromising the quality of 
reagents. Many educators share the same complaints of their students not being able to get 
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any hands-on training in the molecular area while in internships. Also, open opposition by 
an authoritarian individual in the laboratory to teaching certain concepts may have affected 
the opinion of some of the professionals. One respondent noted that the molecular testing 
was typically sent out in their area so laboratory directors and pathologists did not think 
molecular methods should be taught at all.  
 Finally, an important reason that only 25% of all molecular concepts and objectives 
were considered very and most important by at least 70% of the experts to include in MLS 
curriculum is the emergence of another laboratory professional: a Diagnostic Molecular 
Scientist (DMS). The informal survey distributed in 2005 revealed that one institution (out 
of 40 who responded) had planned to open a DMS program in 2006 (Kraj, 2006). In 
February 2015, the NAACLS reported that between 2007 and 2014 the number of 
accredited DMS programs in the US grew from four to eight (Simonian, 2015). There are 
three such programs in Texas and one in each of the following states: Connecticut, Kansas, 
New York, North Carolina and Michigan.  According to the NAACLS Standards: 
“Diagnostic molecular scientist professionals are qualified by academic and applied 
science education to provide service and research in the molecular diagnosis of 
acquired, inherited, and infectious diseases (NAACLS, Unique Standards Diagnostic 
Molecular Scientist (DMS), 2012)”.  
Graduation from a NAACLS accredited DMS program is one of several routes of eligibility for 
an ASCP categorical certification as entry-level Technologist in Molecular Biology, MB(ASCP). 
The content guidelines for the exam provide a detailed listing of molecular concepts, techniques 
and laboratory applications (ASCP, Technologist in Molecular Biology, MB(ASCP) and 
International Technologist in Molecular Biology, MB(ASCPi) Examination content Guideline & 
Outline, 2014). The existence of NAACLS standards for DMS and detailed guidelines for 
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Technologist in Molecular Biology suggest that the preference of the accrediting and 
certification agencies is to have a molecular diagnostics professional devoted to that area of 
laboratory medicine.  
 However, there are at least two reasons why MLS curriculum should include well defined 
molecular diagnostics content. Firstly, due to low number of accredited DMS programs, 
graduating between 1 and 30 (on average 12) students per year, it will be impossible to staff all 
laboratories performing the growing number of molecular based assays with DMS for many 
years. The U.S. Bureau of Labor and Statistics projected MLS employment to grow 22% from 
2012 to 2022 which translates to 70,600 more jobs in clinical laboratories (Occupational Outlook 
Handbook, 2012). Many of these jobs will require molecular testing expertise. The major 
resource for entry-level professionals for the laboratory workforce are the 221 NAACLS 
accredited MLS programs. In 2014, 3613 individuals received MLS(ASCP) certification and 492 
received MB(ASCP) certification. Only about 11% of those certified as MB(ASCP) were the 
graduates of DMS programs (Brown, 2015). Secondly, most hospital based laboratories where 
molecular testing is performed on site, reference blood banks and other laboratories need 
technologists qualified to perform and verify a variety of diagnostics assays, including other non-
molecular based tests which are not within the DMS scope of practice. It may be anticipated that 
a lab which is not a specialized molecular diagnostic facility would rather hire a generalist 
trained in molecular methods than a molecular diagnostic scientist, not trained in other laboratory 
areas. 
 Taylor et.al. (2014) in their report of the Association for Molecular Pathology Training 
and Education Committee provided recommendations for baccalaureate and master’s degree 
DMS programs. The authors based their recommendations on a single survey in which molecular 
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diagnostics laboratory managers rated the expected expertise of baccalaureate MLS graduates 
and master’s level DMS graduates in molecular tests and skills. There were no questions asking 
the respondents to rate the expected expertise of graduates of baccalaureate DMS programs, yet 
the authors provided recommendations for such programs. In the Delphi study presented here, 
the respondents rated the learning objectives considered for entry-level MLS curriculum in two 
surveys which gave them the opportunity to confirm or revise their opinion based on comments 
provided by other experts. The reported results only refer to the MLS curriculum and do not 
impose any content on the curriculum that was not explicitly named in the study. Although some 
similarities may be noted between the AMP’s task force outcomes and the Delphi, Taylor et.al. 
(2014) did not aim to develop specific cognitive or psychomotor objectives. The Delphi study 
allowed for extraction of essential learning objectives to share with MLS educators and also 
established the number of hours that should be devoted to each group of objectives. For this 
reason, the outcomes of the Delphi should be very useful to those designing the MLS curricula 
and certification exam content. Both studies revealed that MLS graduates should have 
conceptual knowledge in nucleic acid chemistry, basic molecular theory (central dogma) and 
modes of inheritance. However, Delphi results provided specific content that should be included: 
types of modes of single gene inheritance, the relevance of melting point to DNA denaturation 
and annealing, etc. With regards to general laboratory operations such contamination control, 
reagent storage and specimen collection/handling, Taylor et.al recommended that an MLS has a 
conceptual understanding of such practices. Two relevant objectives selected as necessary to 
include in the MLS curriculum based on the ratings provided by the respondents of the Delphi 
study presented in this manuscript are in the psychomotor domain and as such extend beyond 
conceptual understanding: observe correct protocols for disposal of biohazard and chemical 
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waste in the molecular laboratory and observe precautions against nucleic acids degradation and 
contamination. Two additional objectives that are recommended as necessary for inclusion in the 
MLS curriculum based on the Delphi study that were not listed in the AMP report were to 
demonstrate proper use of automated, variable or fixed volume micropipettes and troubleshoot in 
case of unsuccessful end-point and real-time PCR analysis outcome. Another essential 
psychomotor objective that was identified using the Delphi process was to use manual DNA and 
RNA extraction protocols. The AMP study recommended that an MLS only has a conceptual 
understanding of nucleic acid isolation and that laboratory training in this skill belongs in the 
DMS program. As opposed to nucleic acid isolation, the AMP recommended that the MLS has 
laboratory training in electrophoresis. However, the Delphi process revealed that the only 
objective referring to gel electrophoresis that was considered very and most important by 70% of 
the respondents was the cognitive objective to state the principle of DNA gel electrophoresis, 
while all psychomotor objectives relevant to this technique and its interpretation were considered 
very and most important by much smaller percentage of the respondents and as such not 
considered necessary to include in the curriculum. 
 Although the outcomes of both studies suggest that MLS graduates should have a 
theoretical knowledge of standard, reverse transcriptase and real-time polymerase chain reaction, 
the Delphi study provides more detail with regards to specific aspects of PCR (Table 20). As for 
infectious disease testing, the AMP study recommends the knowledge of molecular pathology of 
infectious disease in general. The Delphi study specifies the importance to identify 
methodologies and diagnostic equipment used in molecular assays developed to detect, quantify 
or genotype such organisms as N. gonorrhoe/C. trachomatis, HIV-1 and HCV. Besides basic 
knowledge of the assays designed for the three listed pathogens, all non-PCR molecular 
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techniques rated in the Delphi study were not recommended for inclusion in the entry-level MLS 
curriculum. However, several of the techniques (e.g. microarrays, pyrosequencing, Sanger 
sequencing) were recommended by the AMP study for conceptual understanding only.  
Clinical Laboratory Areas Where Entry-Level Molecular Diagnostics Skills are
Utilized  
 The vast array of molecular-based assays performed at the respondents’ institutions are 
listed in Table 13. However, the essential entry level skills reflected in the cognitive and 
psychomotor objectives identified as necessary for inclusion in the MLS curriculum based on the 
percentage of respondents who rated the objectives as very or most important included skills that 
primarily refer to general laboratory operations and infectious disease testing for the pathogens 
commonly tested for using molecular assays: CT/NG, HIV-1 and HCV. The skills relevant to 
molecular assays performed in cancer and cytogenetic diagnostics, HLA and immunohematology 
testing were not recommended for entry-level skill training. 
Limitations  
Panel fatigue and attrition are the largest threats to Delphi validity and should be 
monitored in order to avoid false consensus error resulting from drop out of participants with 
outlier opinions (Hartley, 1995). To prevent panel fatigue, the number of rounds was 
predetermined to be no more than three and the study was completed after the second round 
(Landeta, 2006). Another step that has been undertaken to prevent these two threats was using 
the seed list of objectives to be rated in the first round instead of conducting the exploratory 
round, typical of classical Delphi (Xiao, Lee, & Vemuri, 1997; Mullen, 2009; Elder & Andrew, 
1992). Additionally, the author made sure to remind the respondents of the deadlines to complete 
the surveys, stressed the importance of participation in all rounds and offered the extension of 
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due dates. Despite these precautions 28% of the first Delphi respondents, did not participate in 
the second round. Financial or other incentives were not available in this study.  
Other limitations of the study may be described in the context of common errors in rating 
process as described in the literature.  These errors are the personal bias, halo effect and logical 
error (Gronlund, 1971). The personal bias error may be recognized by assigning the same score 
to each graded item. Some raters tend to use the high end of the scale, which is known as the 
generosity error. Others, prone to criticize, commit the severity error. Finally, some have a 
tendency to deliver neutral responses (Graham, Regehr, & Wright, 2003). To avoid error rating, 
the rating scale was clearly defined. The lowest and highest points on the scale had additional 
descriptors to assure the raters understood the meaning of the terms describing the points. 
Assigning a rating of zero to the objective meant that the objective was not important and should 
not be taught in the MLS curriculum, while assigning a rating of 4 meant that the objectives was 
considered most important and absolutely must be taught in the MLS curriculum). 
The halo effect is decreased in Delphi by definition because of the essential anonymity 
feature.  The acquaintance of some of the respondents with the principal investigator could not 
be prevented due to similar professional interests. There is no consensus on whether the 
acquaintance with the investigator is a limitation in Delphi studies as it may serve as both: 
deterrent and motivator to stay in the study. It should be noted that the testers, asked to evaluate 
the survey before distribution to the respondents, did not participate in the study themselves.  
The logical error occurs when grading is based on preconceived assumptions. An 
example of simplistic preconception, provided by Gronlund, is that gifted students have poor 
social skills (Gronlund, 1971). This error is hard to avoid. One preconception regarding the rated 
objectives predetermined for expansion in the second round (Appendix F) was that if they were 
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not excluded following the analysis of the first round results, at least one of the follow-up 
objectives would end up on the list of essential items to be included in the curriculum. This 
assumption was incorrect in case of the objective relevant to clinical applications of DNA 
polymorphism analysis. Although 88 percent of the respondents in the first round evaluated this 
objective as at least moderately important, none of the specific polymorphisms were eventually 
assigned one of the two top scores on the scale by a significant number of respondents, which 
excluded them from the essential category. When asked about the preferred instructional time to 
assign to the polymorphism category, the respondents selected the lowest possible option (1-3 
contact hours); however there was no objectives to include in the curriculum. This could have 
been avoided by inclusion of an option to select zero hours. 
Future Implications 
  Ultimately, the outcomes of the study will aid in revision of the instructional objectives 
for clinical molecular methods educational courses in entry-level curricula in both baccalaureate 
and master’s MLS programs at the author’s institution with purpose to share with other MLS 
educators. Most importantly, the list is meant to share with the certifying agency to provide 
suggestions for inclusion of items in the MLS examination content guidelines which currently 
are limited. Additionally, upon distribution of the results, the list of skills expected of the MLS 
graduates may be used to re-evaluate the ASCLS Levels of Practice model and to contribute to 
the MLS Body of Knowledge (BOK).  
 Although the Delphi process successfully enabled identification of essentials of 
molecular diagnostics for an entry-level MLS, future studies conducted to re-evaluate the list of 
essentials should consider better approaches to retain the respondents and prevent their fatigue 
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due to the iterative process. Research indicates that with good information technology support, 
these approaches should be directed towards implementation of real-time Delphi. 
One group utilizing the real-time Delphi technique is centered around Theodore Gordon, 
who has been involved in the Millenium Project (Gordon T. J., 2009), a futurist organization 
formed by Smithsonian Institution, the United Nations University, United States Environmental 
Protection Agency, United Nations Development Programme, and UNESCO. The Millenium 
Project began publishing annual “State of the Future” global forecasting reports in 1997. Since 
2006, the reports have presented data collected using real time Delphi computer application 
developed by Articulate Software company, which was awarded a small grant from the U.S. 
Defense Advanced Research Projects Agency (DARPA). The 2006 “State of the Future” Report 
included the results of both  conventional and real time Delphis on the evolution of global energy 
resources and events significant to its utilization (Gordon T. , Energy Forcasts using a 
"Roundless" approach to running a Delphi study., 2006). In 2010 the software was available to 
researchers not affiliated with the Millenium Project for a fee of $5000 without IT support and 
$35000 per project with support.  
Additionally, several New Jersey Institute of Technology graduate students, under the 
advisement of Murray Turoff, have developed group decision projects based on a computer 
mediated, continuous, asynchronous process which is known as Social Decision Support System 
(SDSS). This voting system could be used in evaluating academic course objectives (Wang, Li, 
Turoff, & Hiltz, 2003) or in expeditious decision making during emergencies (White, Turoff, & 
Van der Walle, 2007). The system for emergency response decision making is free of charge and 
hosted by a Sahana Foundation at http://delphi.sahanafoundation.org/eden/default/index (White, 
electronic communication on July 5, 2012). In the current format, the SDSS does not allow for 
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ranking of the items. However, it may be anticipated that the product may be tailored towards the 
client needs. The MLS educators need to reach out for the expertise in technology that is best 
suited for regular updates of the MLS Body of Knowledge through an effective exchange of 
expert opinion. 
Conclusions 
 In this modified, online, asynchronous, two-round Delphi study, the author selected four 
basic molecular biology concepts and 21 molecular diagnostics learning objectives that should be 
included in entry-level Medical Laboratory Scientist curriculum. The selected concepts and 
objectives were considered either very or most important by 70% of the experts who participated 
in the second round of the Delphi. The 70% cut-off was chosen to assure that the selection 
represented an unquestioned majority of respondents. These concepts and objectives, in view of 
the limited guidelines provided for MLS molecular curriculum by the accrediting and certifying 
agencies are recommended as a minimum for the educators developing molecular content for 
their students. Based on the specific cognitive and psychomotor objectives identified as essential 
(Table 20), the author’s recommendation is that the guidelines specify the laboratory operations 
unique to molecular diagnostic laboratories such as unidirectional workflow, prevention of cross-
contamination and nucleic acid degradation; isolation and quantitation of nucleic acids; the 
theoretical fundamentals behind the polymerase chain reaction, including selection of proper 
controls, operation of thermal cyclers and troubleshooting unsuccessful PCR-based assays, 
comprehension of standard, multiplex and reverse-transcriptase PCR, distinction between end-
point verses real time assays; as well as target verses signal amplification and knowledge of 
principles of molecular assays used in testing designed for N. gonorrhoe/C. trachomatis, HIV-1 
and HCV. Depending on the available instructional time, the faculty may choose to expand the 
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content by the objectives that were considered very and most important by at least 50% of the 
respondents.  
 The 30 objectives that were deemed very and most important by 25-49% of the 
respondents could be selected by the faculty for extra credit beyond the available contact hours 
or for graduate assignments. At the author’s institution, the entry-level Master of Health Science 
in Clinical Laboratory Science (MHS-CLS) students have a 4 credit hour molecular internship 
which is not offered to entry-level undergraduate students. Whether there is any additional time 
devoted to molecular diagnostics in other entry-level master’s programs is not known. Currently 
there are eight accredited MLS programs at this level. The emergence of entry-level Master’s 
programs in MLS should be considered when selecting the objectives to include in the 
curriculum. Although graduates of both baccalaureate degree and master’s degree entry-level 
MLS programs are eligible for the same MLS(ASCP) certification exam, the expected skills, 
especially for the comprehension of concepts and aptitude for research, in master’s program 
graduates are higher than in the baccalaureate degree graduates. Thus, this may provide an 
advantage to graduate students seeking employment in molecular diagnostic facilities shortly 
after graduation. 
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Appendix A 
 
 
 
Results of an Informal 2005 Survey of NAACLS Accredited MLS Programs (Kraj, 2006). 
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Appendix A 
 
 
 
Results of an Informal 2005 Survey of NAACLS Accredited MLS Programs (Kraj, 2006). 
   
 
  
 
 
97.0%
3.0%
0% 50% 100%
Yes
No
Does your program include teaching 
molecular diagnostics?
33.3%
48.7%
15.4%
2.6%
0% 50% 100%
Separate course
Incorporated in
other courses
Incorporated and
separate
No answer
Is molecular diagnostics a 
separate subject or do you 
incorporate it in other disciplines?
28.2%
28.2%
25.6%
18.0%
0% 50% 100%
Lab included
Internship only
No lab
No answer
Does the course include 
laboratory exercises?
3.0%
50.0%
47.0%
0% 50% 100%
Yes
No
No answer
Are you planning to offer Diagnostic 
Molecular Scientist Track?
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Appendix A - continued 
 
 
 
 
 
 
 
 
 
  
38.4%
15.4%
25.6%
20.6%
0% 50% 100%
Specific textbook or computer program
Textbook from other CLS courses
Handouts only or unspecified CDs or videos
No answer
What textbook or media are you using?
15.0%
25.0%
65.0%
0% 50% 100%
Yes
No
No answer
Have you heard about "Human 
Genetics Curricula for the Health 
Professionals" Project funded by the 
U.S. Dept. of Health and Human 
Resources?
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Appendix B 
 
 
 
Molecular Content in ASCLS Model for Clinical Laboratory Levels of Practice (ASCLS, Levels Of 
Practice Position Paper, 2009). 
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Appendix B 
 
 
 
Molecular Content in ASCLS Model for Clinical Laboratory Levels of Practice (ASCLS, Levels Of 
Practice Position Paper, 2009). 
Level 
 
Practice Skills: 
 
Education 
 
Relevant 
Experience 
Certification 
 
IV Micro ID including aerobes, anaerobes, or mixed cultures 
Blood Bank antibody identification 
Manual differential with the potential for higher level 
review 
Body Fluid differential with higher level review of 
abnormal results 
Simple molecular testing that follows established 
protocols including DNA Probes 
Associate  
(plus 
training) 
Yes  CLT / MLT 
V Advanced Techniques in Blood Bank Bacca-
laureate 
Entry 
Level 
CLS / MT  
Body Fluid Differential without Higher Level Review 
Immunology 
Advanced Techniques Microbiology 
Advanced molecular testing that follows established 
protocols including DNA Probes 
Advanced Techniques in Hematology / Bone Marrows 
Advanced Techniques in Coagulation 
Advanced Techniques in Chemistry (Electrophoresis, 
etc.) 
Advanced Techniques in Immunochemistry and Drug 
Testing (HPLC, etc.) 
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Appendix B – continued 
 
 
Level 
of  
Practice Skills: 
 
Education 
 
Relevant 
Experience 
Certification 
 
VI Advanced Techniques in Body Fluids  
 Micro Array 
 Flow Cytometry 
 PCR 
Infection Control/Epidemiology 
Bacca-
laureate + 
additional 
education  
Yes  CLS / MT  
 
Method Evaluation/Test Development 
Patient Education 
 POC Oversight    
Technical Supervision 
 Discipline Specific 
 Employee Supervision 
 Daily Operations, QC Review, etc. 
Research Protocols 
Safety Officer 
Oversight of Student/Staff Education and Training 
Technical Consultation 
Informatics 
Cellular Therapy - Stem Cell Transplantation 
Educators: 
 Develop and teach didactic and laboratory 
sessions to reflect current practice 
 Assess student performance 
 Available to students for counseling 
 Engage in service and scholarly activities. 
 
   
Cytogenetics Bacca-
laureate + 
additional 
education 
Yes  Specialty 
Certification Advanced Molecular / PCR  
 Modify existing tests 
 Troubleshooting 
 Method evaluation 
 Research and development 
Advanced Flow Cytometry (anything beyond a 
routine hematology analyzer) 
Histocompatibility 
Specialist in (BB, Chem, Heme, Coag, etc.) 
 
 
Note: Table modified from “Practice Levels and Educational Needs for Clinical Laboratory 
Personnel Position Paper” (ASCLS, Levels Of Practice Position Paper, 2009).
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Appendix C 
 
 
 
Examples of Rating Scales in Selected Delphi Studies  
Relevant to Healthcare or Healthcare Education. 
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Appendix C 
 
 
 
Examples of Rating Scales in Selected Delphi Studies  
Relevant to Healthcare or Healthcare Education. 
Author, publication year 
and title  
Question/s Rating scale 
(Davis, 1978) 
Development of 
Competency-Based, 
Career-Entry Examination 
for Clinical Laboratory 
Personnel.  
Consider/refine each 
item/competency from the 
perspective of: 
 Item accuracy and format 
 Appropriateness for career-
entry professionals 
 Assignment of taxonomic 
level 
 Corroboration of the reference 
to one or more of the 
competence statements 
(McKenzie, 1994) 
Identification of Core 
Educational Goals and 
Related Outcome Measures 
for Development of 
Assessment Programs in 
Selected Schools of Allied 
Health.  
Rate the importance of 
educational goals 
accompanied by assorted 
outcome measures 
 1 – not important, not valid, 
not feasible 
 2 – 
 3 – 
 4 – very important, valid and 
very feasible 
 
(Elder & Nick, 1997) 
Moving Toward a Core 
Curriculum in Schools of 
the Allied Health 
Professions: Knowledge 
and Skills Considered 
Important by Department 
Chairs of Four Disciplines.  
Rate the items above the 
professional accreditation, 
important to graduates of 
the baccalaureate allied 
health programs 
 4 - Most important 
 3 –  
 2 –  
 1 –  
 0 – not important 
(Zinn & Zalokowski, 1999) 
The Use of the Delphi 
Panel for Consensus 
Development on Indicators 
of Laboratory 
Performance.  
Prioritize by clarifying and 
ranking laboratory 
performance areas on the 
basis of importance 
1-6 scale 
1 – most important 
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 Appendix C – continued 
 
 
Author, publication year 
and title 
Question/s Rating scale 
(Scheffer & Rubenfeld, 
2000) 
A consensus statement on 
critical thinking in nursing.  
Provide feedback on the 
Definitions of Habits of the 
Mind and Skills of Critical 
Thinking in Nursing 
 
 Agree 
 Disagree 
 
(Staggers, Gassert, & 
Curran, 2002) 
Delphi Study to Determine 
Informatics Competencies 
for Nurses at Four Levels 
of Practice.  
Assign 304 competencies to 
the informatics levels of 
nursing practice 
4 levels of practice: 
 Beginning 
 Experienced 
 Specialists 
 Innovators 
(Kantz, 2004) 
Use of a Web-based Delphi 
for identifying critical 
components of 
a professional science 
master’s program in 
biotechnology 
1. Assign the competencies 
accordingly  
 
 Core curriculum 
 Track curriculum 
 Blank (competency not 
appropriate) 
2. Rate importance for 
inclusion in internship 
 Not important 
 Important but not absolutely 
necessary 
 Important and necessary 
3. Decide if the listed 
positions are appropriate 
for entry level graduate 
 
 Agree 
 Disagree 
 
4. Indicate the level of 
agreement with the roles 
identified for industry 
advisory board for 
professional science 
master’s program 
 
 1 - Agree strongly 
 2 - Agree 
 3 - No opinion 
 4 - Disagree 
 5 - Disagree strongly 
5. Indicate the level of 
agreement with five 
goals identified as 
appropriate for the 
program 
 
Same as above 
 
6. Indicate the level of 
agreement with skills 
identified for the core 
curriculum and tracks 
 
Same as above 
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 Appendix C – continued 
 
 
Author, publication year 
and title 
Question/s Rating scale 
(Perkins, et al., 2005) 
The Acute Care 
Undergraduate TEaching 
(ACUTE) Initiative: 
consensus development of 
core competencies in acute 
care for undergraduates in 
the United Kingdom.  
Rate 88 themes/ 
competencies grouped into 
12 domains 
 5 - very important 
 4 - important 
 3 - moderately important 
 2 - of little importance 
 1 - of no importance 
Items w/ median 4 or 5 
considered core competencies. 
Items with median of 3 optional. 
(Edgren, 2006) 
Developing a competency-
based core curriculum in 
biomedical laboratory 
science: a Delphi study.  
Rate the importance of 
competencies grouped into 
skills, knowledge, attitudes 
and generic skills 
4 point Likert scale. Items with 
mean of 3.25 retained for further 
consideration in subsequent round 
with yes/no options (include/not 
include in the curriculum) 
(Fried & Leao, 2007) 
Using Delphi Technique in 
a Consensual Curriculum 
for Periodontics. 
Rate 89 topics identified as 
foundational to clinical 
experience for possible 
inclusion in periodontic  
curriculum 
 Indispensable 
 Important 
 Relatively important 
 Of little importance 
 should not be included 
(Sizer, et al., 2007) 
Eight Critical Skill Sets 
Required for Manual 
Therapy Competency.  
Evaluate the importance of 
stand-alone skills defined by 
descriptor statements 
 Essential 
 moderately important 
 moderately unimportant 
 not at all important 
(Kirby, 2008) 
The future of clinical 
laboratory science: A 
Delphi study. 
1. Indicate predicted time 
period for the event to 
occur 
 
 Im – 1-3 yrs 
 M – 4-10 yrs 
 L – 11-20 yrs 
 Beyond 20 yrs 
 Never 
 2. Indicate potential impact 
 
 1 – very low impact/very 
undesirable 
 7 – v. high impact/v. desirable  3. Rate desirability 
(Burke, et al., 2009) 
Developing a curriculum 
statement based on clinical 
practice. 
Comment and rate the 
topics in genetics that 
should be included in 
general practice training 
 Essential 
 Needs to be included 
 Useful for inclusion 
 Need not be included 
(Russell, et al., 2011) 
Capturing Professionalism 
in Pre-Service Education: 
Professionalism Tool 
Development and 
Implementation.  
 
 
Rank attributes of 
professionalism 
 1 -  essential  
 3 - important  
 5 - not important 
Items with scores less or 
equal to 2.5 retained on the 
list 
      
134 
 
Appendix D 
 
Email sent to survey testers with the link to Delphi I practice and the actual survey downloaded 
from REDCap. 
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Appendix D 
 
Email sent to survey testers with the link to Delphi I practice and the actual survey downloaded 
from REDCap 
 
 
 
 Barbara Kraj <krajbj@mymail.vcu.edu>
 
help with research project - practice survey link 
 
Barbara Kraj <krajbj@mymail.vcu.edu> Fri, Aug 8, 2014 at 1:20 PM
To: […] 
Cc: bkraj@gru.edu 
Dear …………., 
 
Thank you for helping me with my doctoral research project on the importance of molecular 
diagnostics learning objectives in MLS curriculum. I am asking that you click the link below, enter your 
answers (for survey testing purposes) and then provide me with your feedback on the clarity of the 
questions and project explanation, time it took you to go through the survey, etc. 
 
You may open the survey in your web browser by clicking the link below: 
Importance of MD Objectives - Delphi Round 1 practice 
 
If the link above does not work, try copying the link below into your web browser: 
https://redcap.vcu.edu/rc/surveys/?s=etwqQZ459Y  
 
I would appreciate if you take the survey by Wednesday, August 13. 
 
Regards, 
 
Barbara Kraj, MS, MLS(ASCP)CMMBCM 
Virginia Commonwealth University 
Ph.D. Program in Health Related Sciences 
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Appendix E 
 
Email sent to MLS Program Directors with the link to Delphi I and the actual survey downloaded 
from REDCap. 
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Appendix E 
 
Email sent to MLS Program Directors with the link to Delphi I and the actual survey downloaded 
from REDCap 
 
 
 
Barbara Kraj <krajbj@mymail.vcu.edu> 
 
 
Survey on the Importance of Molecular Diagnostics Learning Objectives 
 
Barbara Kraj <krajbj@mymail.vcu.edu> Thu, Sep 4, 2014 at 9:07 AM
To: krajbj@vcu.edu 
Bcc: […] 
 
As program director teaching molecular methods in a medical laboratory science program in Georgia for 
the past 8 years and a doctoral candidate at Virginia Commonwealth University, I am seeking 
participants/survey respondents for my research project on the assessment of the importance of specific 
entry-level cognitive and psychomotor learning objectives pertaining to molecular diagnostics. 
The intended survey respondent is a clinical laboratory professional working in an American medical 
laboratory and actively involved in or supervising the performance of diagnostic assays based on 
molecular technology (molecular bench technologists or molecular area supervisors). If you do not 
perform molecular based tests yourself, I am asking you to serve as a “gatekeeper” and forward 
the following survey to as many laboratories/professionals as possible. Feel free to forward the link to 
both molecular reference labs, as well as smaller labs where the only molecular test performed is 
detection of N.gonorrhoe/C.trachomatis. 
 
Although not required, as a courtesy, please kindly let me know the number of laboratory professionals 
performing molecular assays who received the survey from you. Please, encourage them to help me 
collect the data to complete this project. Once the project is completed, I will share the learning objectives 
with educators and other stakeholders, to add my contribution to the improvement of the existing MLS 
content guidelines. 
 
Upon clicking on the link, the participants will be able to read a more detailed description of the study and 
either proceed or opt out. Their identity will remain confidential.
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If you have any questions pertaining to this project, please contact me at krajbj@vcu.edu or at 706-267-
4775. My research advisor is the Chair and Associate Professor at VCU Department of Clinical 
Laboratory Sciences, Dr. Teresa Nadder. She may be reached at tsnadder@vcu.edu or at 804-828-9469. 
 
Regards, 
 
Barbara Kraj, MS, MLS(ASCP)CMMBCM 
 
The survey may be opened in your web browser by clicking the link below: 
Importance of Molecular Diagnostics Learning Objectives - Delphi Round One 
 
If the link above does not work, try copying the link below into your web browser: 
https://redcap.vcu.edu/rc/surveys/?s=FRq9oxahSj 
 
The survey should be submitted by September 19, 2014. 
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Appendix F 
 
 
Delphi Round I Objectives Predetermined for Expansion in Round II 
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Appendix F 
 
 
Delphi Round I Objectives Predetermined for Expansion in Round II. 
 
Round I objective 
predetermined to be 
expanded in Round II if 
not excluded 
Follow-up objectives rated in Round II if the original objective 
was considered at least moderately important by at least 70% of 
round I respondents (objective assigned a score of 2, 3 or 4 by at 
least 70% of Round I respondents) 
 
Extract DNA and RNA 
from blood and other 
specimens. 
 
Use manual DNA and RNA extraction protocols (ex. Qiagen, 
Invitrogen, etc.). 
Use automated DNA and RNA extraction protocols (ex. 
MagNaPure LC). 
 
State clinical applications 
of various human gene 
polymorphisms. 
 
State clinical applications of Single Nucleotide Polymorphisms. 
State clinical applications of Short Tandem Repeats. 
State clinical applications of Variable Number of Tandem Repeats 
State clinical applications of Restriction Fragment Length 
Polymorphism. 
 
Perform DNA gel 
electrophoresis. 
 
Set up a horizontal or vertical gel electrophoresis system. 
Prepare electrophoretic buffer and gel. 
Select nucleic acid size markers for electrophoresis considering 
the expected product length. 
Load samples onto the electrophoretic gel without loss of volume, 
spillover between the wells, or gel disruption. 
Observe safety precautions during electrophoretic gel staining and 
UV photography. 
 
Interpret the outcomes of 
DNA electrophoresis. 
 
Assess the length of separated DNA fragments. 
Determine zygosity of an allele. 
Determine the number of sequence repeats. 
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         Appendix F – continued 
 
Round I objective 
predetermined to be 
expanded in Round II if 
not excluded 
Follow-up objectives rated in Round II if the original objective 
was considered at least moderately important by at least 70% of 
round I respondents (objective assigned a score of 2, 3 or 4 by at 
least 70% of Round I respondents) 
 
Explain the principle of 
the Polymerase Chain 
Reaction. 
 
Provide temperature ranges appropriate for the molecular events 
of the denaturation, annealing and extension steps of a PCR cycle.  
Predict the amount of DNA amplification product based on the 
number of PCR cycles. 
Explain the role of each component of a standard PCR mixture in 
DNA amplification. 
Describe the operation of a thermal cycler. 
Distinguish among the positive, negative, internal, and reagent 
blank PCR controls. 
Explain the purpose of including Uracil N-Glycosylase as it relates 
to quality control. 
Differentiate between standard PCR and reverse transcriptase 
PCR. 
Provide at least one specific application of each: standard end-
point PCR, real-time PCR, reverse-transcriptase PCR and 
multiplex PCR. 
 
Perform Polymerase 
Chain Reaction. 
 
Prepare PCR mix of assigned volume “from scratch” using 
appropriate calculations when given the concentrations of the 
stock solutions. 
Program a thermal cycler when provided with the number of PCR 
cycles, temperature conditions and duration of each reaction step. 
Apply the principles of 
PCR primer design. 
Calculate optimal annealing temperature for primers. 
Navigate the National Institute of Health GenBank database to 
download a sequence of a gene of interest. 
Given a sequence of DNA, select the best oligonucleotide PCR 
primers using the manual method. 
Given a sequence of DNA, select the best primers using computer 
primer design software. 
 
Compare and contrast the 
end-point and real-time 
PCR. 
 
Describe at least two fluorescence based detection systems, such 
as FRET or TaqMan. 
Interpret graphs representing melt curve analysis to identify 
presence and zygosity of gene mutations. 
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          Appendix F – continued 
 
Round I objective 
predetermined to be 
expanded in Round II if 
not excluded 
Follow-up objectives rated in Round II if the original objective 
was considered at least moderately important by at least 70% of 
round I respondents (objective assigned a score of 2, 3 or 4 by at 
least 70% of Round I respondents) 
 
 
 
Compare and contrast the 
principles of other 
molecular technologies 
not considered PCR and 
provide specific clinical 
applications of other 
molecular technologies 
not considered PCR (2 
objectives) 
 
Two objectives expanded in the second round by asking about the 
importance to include the following: 
 
 
Transcription Mediated 
Amplification (TMA) 
Pyrosequencing 
Branched DNA (bDNA) 
Next Generation Sequencing 
(NGS) 
Strand Displacement 
Amplification (SDA) 
Microarrays 
Invader technology 
Fluorescent in situ 
Hybridization (FISH) 
Automated Dideoxy (Sanger) 
Sequencing 
 
  
Identify methodologies 
and diagnostic equipment 
used in molecular assays 
developed to detect, 
quantify or genotype 
bacterial and viral agents. 
 
The objective expanded in the second round by asking about the 
importance to include the following: 
 
 
Neisseria gonorrhoe/Chlamydia 
trachomatis  
Group A Streptococcus  
Human Immunodeficiency Virus  Influenza Virus 
Hepatitis C Virus (HCV) Respiratory Syncytial Virus  
Mycobacterium tuberculosis  Human 
Rhinovirus/Enterovirus 
Clostridium difficile  Bordetella pertussis 
Human Papilloma Virus (HPV) Other pathogens in respiratory 
panel (Adenovirus, 
Parainfluenza, etc.) Herpes Simplex Virus (HSV) 
Cytomegalovirus (CMV) 
Methicillin Resistant 
Staphylococcus aureus 
(MRSA) 
Epstein-Barr Virus (EBV) 
 
Vancomycin Resistant 
Enterococcus (VRE) 
 
  
      
171 
 
          Appendix F - continued 
 
Round I objective 
predetermined to be 
expanded in Round II if 
not excluded 
Follow up objectives rated in Round II if the original objective 
was considered at least moderately important by at least 70% of 
round I respondents (objective assigned a score of 2, 3 or 4 by at 
least 70% of round I respondents) 
Associate specific 
mutations and 
cytogenetic 
markers/chromosomal 
abnormalities with the 
diagnosis of oncologic 
conditions. 
 
The objective expanded in the second round by asking about the 
importance to include the following: 
 
chronic myelogenous leukemia 
(CML) breast cancer 
acute lymphocytic leukemia 
(ALL) 
colon cancer 
Burkitt’s lymphoma 
bladder cancer 
 
Associate specific 
mutations and 
cytogenetic 
markers/chromosomal 
abnormalities with the 
diagnosis of inherited 
disorders. 
 
The objective expanded in the second round by asking about the 
importance to include the following: 
 
Factor II and Factor V Leiden 
dinucleotide repeat expansion 
diseases   
hereditary hemochromatosis 
Duchenne and Becker 
muscular dystrophy 
cystic fibrosis 
 
Angelman/Prader-Willi 
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Appendix G 
 
 
 
 Email sent to Delphi I participants with narrative comments to review. 
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Appendix G 
 
Email sent to Delphi I participants with narrative comments to review. 
 
 
 
Barbara Kraj <krajbj@mymail.vcu.edu>
 
Follow-up on the Survey on the Importance of Molecular Diagnostics 
Learning Objectives 
 
Barbara Kraj <krajbj@mymail.vcu.edu> Fri, Nov 14, 2014 at 6:45 AM
To: krajbj@vcu.edu 
Cc: Teresa S Nadder/HSC/VCU <tsnadder@vcu.edu> 
Bcc:[…]  
 
Dear Participant, 
  
Thank you again for submitting your answers to the first Delphi round survey in the project on the 
Importance of Molecular Diagnostics Learning Objectives in Entry Level Medical Laboratory Science 
Curriculum conducted at Virginia Commonwealth University.  The link to the second survey will be sent to 
you in a few days. In this second round per Delphi study design, each respondent will have an opportunity 
to either confirm or change his/her opinion on a particular learning objective after reviewing the overall 
results of the preceding survey. The counts and frequencies of each rating from the first round will be 
shown below each objective. 
 
The last question in the first round Delphi survey asked the participants if, upon consideration of 
all learning objectives listed, they would expand any of these objectives or would they include any 
additional objectives for entry-level medical laboratory scientist curriculum. The participants’ 
narrative answers to this last question are included in the attached document for your review. 
 
Please be on a lookout for your personal Delphi Round Two survey link. It will be sent to you directly by 
the REDCap system at Virginia Commonwealth University. Once you receive your personal link, please 
do not forward it to anyone. I will send a confirmatory email to all participants to make sure the survey 
was successfully distributed. 
If you have any questions about this project, please contact me at  krajbj@vcu.edu or 706-267-4775 or 
Teresa Nadder, PhD, MLS(ASCP)CM , my dissertation advisor (Chairman and Associate Professor, 
Department of Clinical Laboratory Science at VCU), at tsnadder@vcu.edu or 804-828-9469. 
 
Regards, 
 
Barbara Kraj, MS, MLS(ASCP)CM, MBCM
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Appendix G – continued. 
 
 
 
E-mail attachment:  
Kraj, B. Incorporation of Molecular Diagnostics into Clinical Laboratory Science Curriculum: 
Clinical Facilities Expectations. An Asynchronous, Iterative, Online Delphi Study.  
Delphi Round One Survey narrative comments 10-1-14. 
 
 
The last question in the first round Delphi survey on the Importance of Molecular Diagnostics 
Learning Objectives in Entry Level Medical Laboratory Science Curriculum conducted at 
Virginia Commonwealth University asked the participants if, upon consideration of all learning 
objectives listed, they would expand any of these objectives or would they include any additional 
objectives for entry-level medical laboratory scientist curriculum. The participants’ narrative 
answers to this last question were as follows: 
 
List above is very extensive and if a majority of these were covered individuals would be way 
ahead once they started working. 
 
Basic DNA sequencing methodologies/interpretation 
 
Not all. 
 
Laboratory Math (dilutions, DNA concentrations)  Sequencing (Sanger, other methods)  
Controls (amplification, sensitivity, internal) 
 
Pharmacogenomics 
 
Sample contamination and QA/QC procedures should be emphasized.  I have observed that 
most positions that open in the Molecular Diagnostics area in the clinical labs have been given 
to more senior level MLS.  Some of the areas of emphasis are so very specialized that it is 
difficult to cover each adequately in a lecture/lab undergraduate course, and the students 
become overwhelmed with the information. 
 
Able to use a variety of pipettes produced by different manufacturers (Rainin, Eppendorf) with 
different aspirating/expelling mechanisms.  Able to pipette in a way that limits cross 
contamination. 
 
I would also present the amount of daily cleaning needed to keep the lab quality in good shape. 
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With my limited base of knowledge in molecular diagnostics, the concepts covered in this 
survey seem to encompass the fundamentals of molecular methods. 
 
It would be useful for a Molecular Technologist to learn how to troubleshoot unexpected 
results, which can happen in every platform. i.e, crosscontamination, carryover, failed internal 
controls, low yield for DNA and RNA, etc.  After all, I think you learn the most when 
something has gone wrong and you work to find the way to prevent it. These exercises would 
probably fit better in the practical part of the curriculum. 
 
Basic understanding of extraction and components involved in PCR.  Importance of specimen 
integrity and pipetting technique. 
 
I think general molecular concepts should definitely be emphasized (especially if student has 
not taken a molecular biology course in undergrad), but even more importantly, teaching 
should focus on molecular techniques to provide optimal results and minimize 
error/contamination. 
 
Be familiar with the clinical presentation of most common viral/bacterial analytes detected by 
PCR. 
 
CAP compliance 
 
Curriculum should be basic and prepare the student to learn the application in the field. 
 
While it would be great to include all of these learning objectives in the molecular course 
curriculum I think it might be hard to squeeze it all in AND do a good job covering the 
material.  I believe our MLS students only have 2 weeks of molecular lectures and they spend 
1 week in the lab.  If you haven't seen it yet, AMP (The Association for Molecular Pathology) 
published a paper recently in JMD similar to this. 
 
For our particular purposes which is infectious disease, I think all the relevant topics were 
covered. 
 
More information on infectious disease testing using molecular methods. 
 
Since the science is moving so rapidly, I would suggest automated platforms for tests, new 
methods, and new FDA cleared assays. I would suggest that also included in the lectures is the 
need to correlate molecular results with diagnosis and disease. The presence of DNA does not 
always mean a disease process is present. 
 
Knowledge of FDA approved versus ASR for infectious disease agents (e.g. HIV, HSV, 
NG/CT, HPV, etc.) 
 
No. Believe that the basic infectious disease and amplification techniques, QC and workflow is 
entry level. Human chromosomal genetics, HLA and other molecular techniques beyond entry 
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level. Molecular is a technique like serology and the remainder should be an advanced 
specialty or masters level. We are not good at defining level of practice, we jump from B.S. to 
DCLS and should look at developing a better flow across levels of practice in all disciplines. 
 
My main concern would be for the students to understand the theory of PCR and related 
molecular techniques.  Otherwise, it is very difficult to troubleshoot problems in the lab.  In 
addition, in order to understand PCR, you would need to begin with a review (I say review, 
because this information should be covered in a basic bio class) of DNA and RNA structures 
and processes.    Although it is important to get some molecular labwork under their belts, 
there are multiple techniques for the same type of testing, so I'd say that a sampling of 
techniques is good . . . a conventional PCR, real time PCR, reverse transcriptase PCR, PFGE 
(maybe a watch-and-learn lab), Gen-Probe, etc.    Having guest speakers who can illustrate the 
real-life applications of molecular techniques!  Its' always good to know that the education that 
you're getting will actually be a benefit to someone, the world, the pharmaceutical industry, a 
patient, etc. 
 
As molecular technology is applied so broadly to so many specialties the entry level scientist 
should have strongest training in the basics and a survey of the specialties and a robust 
understanding of the application of the techniques in diagnostic testing. 
 
Although molecular testing in gaining popularity, in our area all molecular testing is a send 
out.  It is sad to say that lab directors and pathologists here are questioning why we have to 
teach molecular diagnostics when the graduates are not using the information. 
 
Focus in our program is on contamination control, basic Master mix preparation (listing 
components and describing how each one is utilized in a reaction), comparing molecular 
methods to other methods such a culture (advantages, disadvantages etc...). We also focus on 
Real-time PCR, describing the curve, how it can apply to Qualitative and Quant assays.   We 
touch on mutations/translocations, etc. and examples.  FYI-Our program does not include 
cytogenetics applications. 
 
Pipetting technique is extremely important as well as preventing contamination.  Basics on 
isolating RNA, DNA as well as PCR, etc. is important...once these are learned it is easier to 
understand the downstream testing and platforms. 
 
Must include Next Generation platforms and applications. 
 
At least make biochemistry, cell biology, and/or basic human genetics prerequisites for a 
molecular course 
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Appendix H 
 
 
 
Delphi Round Two invitation text and survey sent by REDCap system on November 17, 2014. 
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Appendix H 
 
Delphi Round Two invitation text and survey sent by REDCap system on November 17, 2014 
 
Subject Line: Round Two of Delphi Survey on the Importance of Molecular Diagnostics 
Learning Objectives  
 
Thank you very much for your participation in the first round of Delphi study on the importance 
of molecular diagnostics learning objectives in entry level medical laboratory science 
curriculum. Your expertise as a practicing medical laboratory professional with experience in 
medical molecular diagnostics is invaluable! 
Recall that the purpose of this study is to utilize the Delphi technique to gather information in 
sequential rounds of surveys sent to the same experts to reach a consensus on the investigated 
subject. In subsequent surveys, each respondent has the opportunity to either confirm or 
change his/her opinion on a particular learning objective upon reviewing the overall results of 
the preceding survey.  
 
At the end of this email you will find the link to the second Delphi round survey. Round One 
counts and frequencies of each rating are shown below each objective in Round Two. A list of 
all participants’ comments made in the first round was emailed to you a few days prior for your 
review ‐ if you have not received it ‐ please contact the investigator using the email or phone 
number provided below.  
 
You will be able to read more details about the structure of the second round survey upon 
clicking the provided link. You should be able to complete the survey in approximately 10‐20 
minutes.  
Please submit the survey by December 1, 2014. 
 
If you have any questions about this project, please contact the investigator (doctoral 
candidate) Barbara Kraj, MS, MLS(ASCP)CM, MBCM at krajbj@vcu.edu or 706‐267‐4775 or Teresa 
Nadder, PhD, MLS(ASCP)CM , dissertation advisor (Chairman and Associate Professor, 
Department of Clinical Laboratory Science at VCU), at tsnadder@vcu.edu or 804‐828‐9469. 
 
You may open the survey in your web browser by clicking the link below: 
Importance of Molecular Diagnostics Learning Objectives - Delphi Round Two 
 
If the link above does not work, try copying the link below into your web browser: 
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 
 
This link is unique to you and should not be forwarded to others.
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Pertaining to Molecular Diagnostics. 
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Appendix I 
 
 
 
Molecular Biology Concepts and Cognitive (C) and Psychomotor (P) Learning Objectives 
Pertaining to Molecular Diagnostics. 
 
Molecular biology concepts and cognitive (C) and psychomotor (P) learning objectives 
pertaining to molecular diagnostics are color coded according to the legend shown below: 
Concepts or objectives rated as very or most important by at least 70% of the respondents in Round II 
Concepts or objectives rated as very or most important by 50-69% of the respondents in Round II 
Concepts or objectives rated as very or most important by 25-49% of the respondents in Round II 
Concepts or objectives rated as very or most important by less than 25% of the respondents in Round II 
 
Delphi Round I objectives expanded in Round II are typed in blue bold font. 
Round I and Round II rating frequencies and median ratings of each concept or objective 
are shown. Rating scale was a follows: 
0 – not important (should not be taught in entry-level medical laboratory science 
curriculum) 
1 – of little importance 
2 – of moderate importance 
3 – very important 
4 – most important (absolutely must be taught in the MLS curriculum) 
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Appendix J 
 
 
Concepts and Learning Objectives Addressing Respondent Comments from Delphi Round I 
 
Delphi Round I Narrative Comments Made by 
Respondents 
Related Learning Objective(s) (number 
assigned in Round II) 
 
Basic DNA sequencing 
methodologies/interpretation 
 
 
 Compare and contrast the principles of 
other molecular technologies not 
considered PCR (#61) 
 
 
Laboratory Math (dilutions, DNA 
concentrations)  Sequencing (Sanger, other 
methods)  Controls (amplification, sensitivity, 
internal) 
 
 Calculate nucleic acid concentrations of 
DNA and RNA solutions using 
spectrophotometric measurements (#21) 
 Compare and contrast the principles of 
other molecular technologies not 
considered PCR (#61) 
 Distinguish among the positive, negative, 
internal, and reagent blank PCR controls 
(#42) 
 
 
Pharmacogenomics 
 
 List at least two clinical applications of 
pharmacogenomics (#97) 
 
 
Sample contamination and QA/QC procedures 
should be emphasized.  I have observed that 
most positions that open in the Molecular 
Diagnostics area in the clinical labs have been 
given to more senior level MLS.  Some of the 
areas of emphasis are so very specialized that 
it is difficult to cover each adequately in a 
lecture/lab undergraduate course, and the 
students become overwhelmed with the 
information. 
 
 
 Distinguish among the positive, negative, 
internal, and reagent blank PCR controls 
(#42) 
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Appendix J – continued 
 
Delphi Round I Narrative Comments Made by 
Respondents 
Related Learning Objective(s) (number 
assigned in Round II) 
 
Able to use a variety of pipettes produced by 
different manufacturers (Rainin, Eppendorf) 
with different aspirating/expelling 
mechanisms.  Able to pipette in a way that 
limits cross contamination. 
 
 Demonstrate proper use of automated, 
variable or fixed volume micropipettes 
(#13) 
I would also present the amount of daily 
cleaning needed to keep the lab quality in good 
shape. 
 
 Observe precautions against nucleic acids 
degradation and contamination (#11) 
 
It would be useful for a Molecular 
Technologist to learn how to troubleshoot 
unexpected results, which can happen in every 
platform. i.e. cross contamination, carryover, 
failed internal controls, low yield for DNA and 
RNA, etc.  After all, I think you learn the most 
when something has gone wrong and you work 
to find the way to prevent it. These exercises 
would probably fit better in the practical part 
of the curriculum. 
 
 
 Troubleshoot in case of unsuccessful 
end-point or real-time PCR product 
analysis outcome (#54) 
 
 
Basic understanding of extraction and 
components involved in PCR.  Importance of 
specimen integrity and pipetting technique. 
 
 Extract DNA and RNA from blood and 
other specimens (#18, 19) 
 Explain the role of each component of a 
standard PCR mixture in DNA 
amplification (#40) 
 Recommend proper storage conditions 
for specimens and purified nucleic acids 
according to Clinical Laboratory 
Standards Institute (CLSI) and College of 
American Pathologists (CAP) guidelines 
(#9) 
 Observe precautions against nucleic acids 
degradation and contamination (#11) 
 Demonstrate proper use of automated, 
variable or fixed volume micropipettes 
(#13) 
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Appendix J – continued 
 
Delphi Round I Narrative Comments Made by 
Respondents 
Related Learning Objective(s) (number 
assigned in Round II) 
 
I think general molecular concepts should 
definitely be emphasized (especially if student 
has not taken a molecular biology course in 
undergrad), but even more importantly, 
teaching should focus on molecular techniques 
to provide optimal results and minimize 
error/contamination. 
 
 Basic Concepts in Molecular Biology 
(#1-5) 
 Observe precautions against nucleic acids 
degradation and contamination (#11) 
 Troubleshoot in case of unsuccessful 
end-point or real-time PCR product 
analysis outcome (#54) 
 
 
Be familiar with the clinical presentation of 
most common viral/bacterial analytes detected 
by PCR. 
 
 
Identify methodologies and diagnostic 
equipment used in molecular assays 
developed to detect, quantify or genotype 
bacterial and viral agents (#66-82) 
 
 
CAP compliance 
 
 Recommend proper storage conditions 
for specimens and purified nucleic acids 
according to Clinical Laboratory 
Standards Institute (CLSI) and College of 
American Pathologists (CAP) guidelines 
(#9) 
 
 
More information on infectious disease testing 
using molecular methods. 
 
 Identify methodologies and diagnostic 
equipment used in molecular assays 
developed to detect, quantify or genotype 
bacterial and viral agents (#66-82) 
 
Since the science is moving so rapidly, I would 
suggest automated platforms for tests, new 
methods, and new FDA cleared assays. I 
would suggest that also included in the lectures 
is the need to correlate molecular results with 
diagnosis and disease. The presence of DNA 
does not always mean a disease process is 
present. 
 
 Identify (the functions of) all parts of at 
least one molecular diagnostic 
system/instrument utilized in your 
laboratory, such as amplification, 
microarray or sequencing system (#56) 
 Compare and contrast the principles of 
other molecular technologies not 
considered PCR and provide specific 
clinical applications of other molecular 
technologies not considered PCR (#57-
65) 
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Appendix J – continued 
Delphi Round I Narrative Comments Made by 
Respondents 
Related Learning Objective(s) (number 
assigned in Round II) 
 
My main concern would be for the students to 
understand the theory of PCR and related 
molecular techniques.  Otherwise, it is very 
difficult to troubleshoot problems in the lab.  
In addition, in order to understand PCR, you 
would need to begin with a review (I say 
review, because this information should be 
covered in a basic bio class) of DNA and RNA 
structures and processes. Although it is 
important to get some molecular labwork 
under their belts, there are multiple techniques 
for the same type of testing, so I'd say that a 
sampling of techniques is good, a conventional 
PCR, real time PCR, reverse transcriptase 
PCR, PFGE (maybe a watch-and-learn lab), 
Gen-Probe, etc. Having guest speakers who 
can illustrate the real-life applications of 
molecular techniques!  Its' always good to 
know that the education that you're getting will 
actually be a benefit to someone, the world, the 
pharmaceutical industry, a patient, etc. 
 
 
 
 Explain the principle of the Polymerase 
Chain Reaction (#38-45) 
 Chemical structure and bonds in DNA 
and RNA (#3) 
 DNA melting point and its relevance to 
DNA denaturation, renaturation, 
hybridization and annealing (#4) 
 
 
Focus in our program is on contamination 
control, basic Master mix preparation (listing 
components and describing how each one is 
utilized in a reaction), comparing molecular 
methods to other methods such a culture 
(advantages, disadvantages etc...). We also 
focus on Real-time PCR, describing the curve, 
how it can apply to Qualitative and Quant 
assays.   We touch on mutations/translocations, 
etc. and examples.  FYI-Our program does not 
include cytogenetics applications. 
 
 
 Observe precautions against nucleic acids 
degradation and contamination (#11) 
 Explain the principle of the Polymerase 
Chain Reaction (#40, 45) 
 
 Perform Polymerase Chain Reaction 
(#46) 
Pipetting technique is extremely important as 
well as preventing contamination.  Basics on 
isolating RNA, DNA as well as PCR, etc. is 
important...once these are learned it is easier to 
understand the downstream testing and 
platforms 
 
 Demonstrate proper use of automated, 
variable or fixed volume micropipettes 
(#13) 
      
222 
 
 Appendix J – continued 
Delphi Round I Narrative Comments Made by 
Respondents 
Related Learning Objective(s) (number 
assigned in Round II) 
 
Must include Next Generation platforms and 
applications. 
 
 Compare and contrast the principles of 
other molecular technologies not 
considered PCR and provide specific 
clinical applications of other molecular 
technologies not considered PCR: NGS 
(#63) 
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